<SEC-DOCUMENT>0001193125-23-193446.txt : 20230725
<SEC-HEADER>0001193125-23-193446.hdr.sgml : 20230725
<ACCEPTANCE-DATETIME>20230725161601
ACCESSION NUMBER:		0001193125-23-193446
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20230724
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230725
DATE AS OF CHANGE:		20230725

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			COMMUNITY HEALTH SYSTEMS INC
		CENTRAL INDEX KEY:			0001108109
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
		IRS NUMBER:				133893191
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15925
		FILM NUMBER:		231108729

	BUSINESS ADDRESS:	
		STREET 1:		4000 MERIDIAN BOULEVARD
		CITY:			FRANKLIN
		STATE:			TN
		ZIP:			37067
		BUSINESS PHONE:		615-465-7000

	MAIL ADDRESS:	
		STREET 1:		4000 MERIDIAN BOULEVARD
		CITY:			FRANKLIN
		STATE:			TN
		ZIP:			37067

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	COMMUNITY HEALTH SYSTEMS INC/
		DATE OF NAME CHANGE:	20000229
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d504605d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cyh="http://www.chs.net/20230724" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>Form 8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2023-07-24_to_2023-07-24">COMMUNITY HEALTH SYSTEMS INC</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2023-07-24_to_2023-07-24">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2023-07-24_to_2023-07-24">0001108109</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="cyh-20230724.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2023-07-24_to_2023-07-24"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001108109</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-07-24</xbrli:startDate> <xbrli:endDate>2023-07-24</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2023-07-24_to_2023-07-24">8-K</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of The Securities Exchange Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): July&#160;25, 2023 (<ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2023-07-24_to_2023-07-24" format="ixt:datemonthdayyearen">July 24, 2023</ix:nonNumeric>)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">COMMUNITY HEALTH SYSTEMS, INC.</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2023-07-24_to_2023-07-24" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2023-07-24_to_2023-07-24">001-15925</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2023-07-24_to_2023-07-24">13-3893191</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(I.R.S. Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2023-07-24_to_2023-07-24">4000 Meridian Boulevard</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2023-07-24_to_2023-07-24">Franklin</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2023-07-24_to_2023-07-24" format="ixt-sec:stateprovnameen">Tennessee</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2023-07-24_to_2023-07-24">37067</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of principal executive offices)</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2023-07-24_to_2023-07-24">(615)</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2023-07-24_to_2023-07-24">465-7000</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2023-07-24_to_2023-07-24" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2023-07-24_to_2023-07-24" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2023-07-24_to_2023-07-24" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2023-07-24_to_2023-07-24" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br />Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-07-24_to_2023-07-24">Common Stock, $0.01 par value</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-07-24_to_2023-07-24">CYH</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-07-24_to_2023-07-24" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2023-07-24_to_2023-07-24" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;1.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&#160;24, 2023, certain subsidiaries (the &#8220;CHS Selling Entities&#8221;) of Community Health Systems, Inc. (the &#8220;Company&#8221;), entered into an Asset Purchase Agreement (&#8220;Purchase Agreement&#8221;) with Florida Health Sciences Center, Inc., a Florida <span style="white-space:nowrap">non-profit</span> corporation and certain of its affiliates (collectively, &#8220;Purchaser&#8221;). Pursuant to the Purchase Agreement, and subject to the terms and conditions set forth therein, Purchaser has agreed to acquire substantially all of the assets, and assume certain liabilities, from the CHS Selling Entities related to the following acute care hospitals (and certain related businesses): (i)&#160;Bravera Health Brooksville in Brooksville, Florida, (ii)&#160;Bravera Health Spring Hill in Spring Hill, Florida and (iii)&#160;Bravera Health Seven Rivers in Crystal River, Florida (the transactions contemplated by the Purchase Agreement, the &#8220;Transaction&#8221;). The total purchase price payable by Purchaser to the CHS Selling Entities at the closing of the Transaction is estimated to be approximately $280&#160;million in cash, exclusive of anticipated purchase price adjustments for net working capital and the amount of capital leases assumed by Purchaser. Total cash consideration to be received, inclusive of these items, is estimated to be approximately $290 million. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Purchase Agreement contains various representations, warranties and covenants made by the parties. The Purchase Agreement also provides for indemnification by the parties with respect to breaches of representations, warranties and covenants by such parties, as well as with respect to certain other indemnifiable matters specified in the Purchase Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The closing of the Transaction is subject to the satisfaction or waiver of certain closing conditions set forth in the Purchase Agreement, which includes the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, as well as consent from Hernando County, the lessor, for assignment of the lease to operate certain of the hospitals. Consummation of the Transaction is currently expected to occur in the fourth quarter of 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Purchase Agreement may be terminated by either party under certain circumstances set forth in the Purchase Agreement, including if the Transaction is not consummated on or before December&#160;29, 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Purchase Agreement provides that, at closing, the parties, and/or their respective affiliates, will enter into certain ancillary agreements, including transition services agreements under which certain CHS Selling Entities and/or an affiliate(s) thereof will provide certain information technology and operational transition<span style="font-weight:bold"> </span>services to Purchaser for a period of time following the closing. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing summary of the Transaction and the terms and conditions of the Purchase Agreement is subject to, and qualified in its entirety by, the full text of the Purchase Agreement, which is attached hereto as <span style="text-decoration:underline">Exhibit 2.1</span> and incorporated herein by reference. The representations, warranties, and covenants contained in the Purchase Agreement were made solely for purposes of such agreement and as of specific dates, were solely for the benefit of the parties to the Purchase Agreement, may have been qualified in the Purchase Agreement by confidential disclosure schedules (which disclosure schedules may contain information that modifies, qualifies and creates exceptions to the representations, warranties and covenants set forth in the Purchase Agreement), may be subject to limitations and contractual risk allocation mechanisms agreed upon by the parties to the Purchase Agreement, and may be subject to standards of materiality that differ from what an investor may view as material, and thus should not be relied upon as necessarily reflecting the actual state of facts or conditions. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;8.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&#160;24, 2023, the Company issued a press release announcing the entry of the parties into the Purchase Agreement. A copy of this press release is attached hereto as <span style="text-decoration:underline">Exhibit 99.1</span> and is incorporated herein by reference. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Forward-Looking Statements </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Current Report on <span style="white-space:nowrap">Form&#160;8-K&#160;contains</span> forward-looking statements within the meaning of Section&#160;27A of the Securities Act of 1933, as amended, Section&#160;21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995 that involve risk and uncertainties. These forward-looking statements are based on the Company&#8217;s current beliefs, understandings and expectations. These forward-looking statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond the Company&#8217;s control, which could cause actual results to differ materially from those contemplated in these forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied include: (i)&#160;the parties to the Purchase </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Agreement may be unable to complete the Transaction in a timely manner or at all, because, among other reasons, conditions to the closing of the Transaction set forth in the Purchase Agreement may not be satisfied or waived; (ii)&#160;uncertainty as to the timing of completion of the Transaction; (iii)&#160;the occurrence of any event, change or other circumstances that could give rise to the termination of the Purchase Agreement; (iv)&#160;risks related to disruption of management&#8217;s attention from the Company&#8217;s ongoing business operations; (v)&#160;the outcome of any legal proceedings to the extent initiated against the parties to the Purchase Agreement or others related to the Transaction; (vi)&#160;post-closing risks related to the transition services agreement and ancillary agreements to be entered into at closing as noted above; and (vii)&#160;the ability of the Company to execute on its strategy and achieve its goals and other expectations after any completion of the Transaction, as well as the risks set forth in our Annual Report on <span style="white-space:nowrap">Form&#160;10-K&#160;for</span> the year ended December&#160;31, 2022, filed with the Securities and Exchange Commission on February&#160;17, 2023, and the Company&#8217;s other filings with the Securities and Exchange Commission. The Company undertakes no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">ITEM&#160;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(d)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Exhibits </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td style="width:92%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap">Exhibit<br />Number</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">2.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d504605dex21.htm">Asset Purchase Agreement, dated as of July&#160;24, 2023, by and among subsidiaries of CHS/Community Health Systems, Inc. and Florida Health Sciences Center, Inc. and certain of its affiliates<span style="font-weight:bold">*</span> </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d504605dex991.htm">Community Health Systems, Inc. Press Release, dated July&#160;24, 2023 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document) </td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top" align="left">*</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation <span style="white-space:nowrap">S-K.</span> The Company agrees to furnish, on a supplemental basis, a copy of such omitted schedules and exhibits to the Securities and Exchange Commission upon request. </p></td></tr></table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom" colspan="3">Date: July&#160;25, 2023</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3">COMMUNITY HEALTH SYSTEMS, INC.</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">(Registrant)</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&#160;&#160;/s/ Tim L. Hingtgen</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Tim L. Hingtgen</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Chief Executive Officer</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">(principal executive officer)</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>d504605dex21.htm
<DESCRIPTION>EX-2.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-2.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 2.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Execution Version </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ASSET PURCHASE AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BY AND BETWEEN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>HERNANDO HMA, LLC </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SPRING HILL HMA MEDICAL GROUP, LLC </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BROOKSVILLE HMA
PHYSICIAN MANAGEMENT, LLC </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BRAVERA URGENT CARE, LLC </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CITRUS HMA, LLC
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CRYSTAL
RIVER HMA PHYSICIAN MANAGEMENT, LLC </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CHS/COMMUNITY HEALTH SYSTEMS, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FHSC NEWCO I, LLC
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FHSC NEWCO
II, LLC </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FHSC REAL PROPERTY I, LLC </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TGH AMBULATORY
SERVICES COMPANY </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FLORIDA HEALTH SCIENCES CENTER, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>D/B/A TAMPA GENERAL HOSPITAL </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">July&nbsp;24, 2023 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD COLSPAN="5" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="5"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman; ">1.&#8195;&#8201;PURCHASE OF ASSETS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">1.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">1.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Excluded Assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">1.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assumed Liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">1.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Excluded Liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">1.5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase Price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">1.6</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquired Net Working Capital, Estimates and Audits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">1.7</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transition Patients and Other Supplemental Payment Programs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">1.8</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prorations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="5"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman; ">2.&#8195;&#8201;CLOSING.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">2.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">2.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Actions of Sellers at Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">2.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Actions of Buyers at Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="5"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman; ">3.&#8195;&#8201;REPRESENTATIONS AND WARRANTIES OF SELLERS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Existence and Capacity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Powers; Consents; Absence of Conflicts with Other Agreements, Etc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Binding Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financial Statements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3.5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certain Post-Balance Sheet Results</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3.6</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Licenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3.7</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Medicare Participation/Accreditation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3.8</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Regulatory Compliance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3.9</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3.10</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Real Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3.11</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title to Other Assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3.12</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Employee Benefit Plans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3.13</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Litigation or Proceedings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3.14</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Environmental Laws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3.15</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3.16</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Employee Relations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3.17</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Contracts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(continued) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3.18</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Supplies</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3.19</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Insurance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3.20</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third Party Payor Cost Reports</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3.21</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Medical Staff Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3.22</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Condition of Assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3.23</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Experimental Procedures.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3.24</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intellectual Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3.25</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Compliance Program</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3.26</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Data Handling Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3.27</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Affiliate Contracts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3.28</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Partial Subsidiaries</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="5"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman; ">4.&#8195;&#8201;REPRESENTATIONS AND WARRANTIES OF BUYERS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">4.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Existence and Capacity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">4.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Powers; Consents; Absence of Conflicts with Other Agreements, Etc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">4.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Binding Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">4.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Availability of Funds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="5"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman; ">5.&#8195;&#8201;COVENANTS OF SELLERS PRIOR TO CLOSING</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">5.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Information</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">5.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">5.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Negative Covenants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">5.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Governmental Approvals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">5.5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HSR Notifications</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">5.6</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional Financial Information</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">5.7</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">No-Shop</FONT> Clause</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">5.8</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Efforts to Close</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">5.9</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Returns</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">5.10</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notification Requirements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">5.11</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Estoppels and Contract Consents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">5.12</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Employee List</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="5"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman; ">6.&#8195;&#8201;COVENANTS OF BUYERS PRIOR TO CLOSING</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">6.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Governmental Approvals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">6.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HSR Notifications</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">6.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title Commitment and Survey</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(continued) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">6.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Efforts to Close</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">6.5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contract Consents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="5"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman; ">7.&#8195;&#8201;CONDITIONS PRECEDENT TO OBLIGATIONS OF BUYERs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">7.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Representations/Warranties/Covenants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">7.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Governmental Approvals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">7.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title Policy</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">7.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Actions/Proceedings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">7.5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Insolvency</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">7.6</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Material Adverse Change</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">7.7</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Material Consents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">7.8</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vesting/Recordation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">7.9</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hospital Lease</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">7.10</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Agreement with Essential Third Party Provider</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">7.11</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing Deliveries</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="5"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman; ">8.&#8195;&#8201;CONDITIONS PRECEDENT TO OBLIGATIONS OF SELLERS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">8.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Representations/Warranties/Covenants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">8.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Governmental Approvals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">8.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Actions/Proceedings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">8.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Insolvency</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">8.5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hospital Lease; Consents to Assignments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">8.6</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing Deliveries</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="5"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman; ">9.&#8195;&#8201;SELLERS&#146; COVENANT NOT TO COMPETE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="5"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman; ">10.&#8194;&#8201;ADDITIONAL AGREEMENTS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">10.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Allocation of Purchase Price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">10.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination Prior to Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">10.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Post-Closing Access to Information</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">10.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preservation and Access to Records After the Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">10.5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax and Medicare Effect</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">10.6</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reproduction of Documents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">10.7</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cooperation on Tax Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">10.8</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost Reports</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">10.9</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Misdirected Payments, Etc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">10.10</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Employee Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(continued) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">10.11</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indigent Care Policies</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">10.12</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Use of Controlled Substance Permits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">10.13</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Medical Staff Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">10.14</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Information Services Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">10.15</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hospital Transition Services Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">10.16</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Clinic Billing and Collection Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">10.17</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">License Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">10.18</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Access to Records Including as to Recovery and Audit Information</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">10.19</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Telephone Access</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">10.20</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Continuation of Insurance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">10.21</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Use of Excluded Marks</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">10.22</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Guaranties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">10.23</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Antitrust Cooperation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">10.24</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hospital Lease</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">10.25</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Passwords, Keys, Websites, Social Media</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">10.26</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PMATF Assessments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="5"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman; ">11.&#8194;&#8201;INDEMNIFICATION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">11.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnification by Buyers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">11.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnification by Sellers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">11.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Limitations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">11.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notice and Control of Litigation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">11.5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notice of Claim</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">11.6</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mitigation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">11.7</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Calculation of Damages</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">11.8</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exclusive Remedy</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="5"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman; ">12.&#8194;&#8201;MISCELLANEOUS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">12.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Schedules and Exhibits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">12.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional Assurances</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">12.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Consented Assignment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">12.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Consents, Approvals and Discretion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">12.5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Legal Fees and Costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">12.6</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Choice of Law; Jurisdiction</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">12.7</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Benefit/Assignment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iv </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(continued) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">12.8</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Brokerage</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">12.9</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of Transaction</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">12.10</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Confidentiality</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">12.11</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Public Announcements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">12.12</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Waivers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">12.13</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">12.14</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Severability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">12.15</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gender; Number; General Interpretation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">12.16</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Divisions and Headings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">12.17</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Survival</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">12.18</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Affiliates</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">12.19</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Waiver of Jury Trial</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">12.20</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounting Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">12.21</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Inferences</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">12.22</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Limited Third Party Beneficiaries</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">12.23</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entire Agreement/Amendment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">12.24</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk of Loss; Casualty</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">12.25</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Material Adverse Effect</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">12.26</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Radon Gas</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">12.27</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CHS Guaranty</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">12.28</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TGH Guaranty</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">12.29</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Knowledge of Sellers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">v </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBITS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="93%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Description</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B><I>&nbsp;</I></B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B><I>Exhibit</I></B></TD>
<TD NOWRAP VALIGN="bottom"><B><I>&nbsp;</I></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Limited Power of Attorney</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Information Technology Transition Services Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hospital Transition Services Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">C</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Clinic Billing and Collection Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">D</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">License Agreement for Policy and Procedure Manuals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">E</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULES </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="92%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Description</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B><I>&nbsp;</I></B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B><I>Schedule</I></B></TD>
<TD NOWRAP VALIGN="bottom"><B><I>&nbsp;</I></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Owned Real Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1(a)(i)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leased Real Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1(a)(ii)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contracts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1(g)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Medicare and Medicaid Provider Numbers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1(h)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assigned Marks</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1(k)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Excluded Assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Capital Lease Obligations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Excluded Liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquired Net Working Capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquired Net Working Capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DPP Illustration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.7(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financial Statements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certain Post-Balance Sheet Results</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Licenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Medicare Participation/Accreditation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.7(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Corporate Integrity Agreement, Investigations, etc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.7(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Regulatory Compliance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Real Property Material Violations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.10(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Zoning Compliance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.10(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tenant Leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.10(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rent Roll</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.10(d)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Eminent Domain Proceedings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.10(e)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificates of Occupancy</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.10(f)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating Leases and Seller Guaranties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.10(g)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Abatement Agreements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.10(h)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Employee Benefit Plans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Litigation or Proceedings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Environmental Laws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Employee Relations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contracts with Physicians or Physician Entities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.17(g)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Insurance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">vi </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="94%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third Party Payor Cost Reports</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Medical Staff Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intellectual Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Compliance Program</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Data Handling</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.26(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sensitive Data Security Breaches</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.26(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Affiliate Contracts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Partial Subsidiaries</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Material Consents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hospital Lease</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brokerage</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">vii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>GLOSSARY OF DEFINED TERMS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Defined Term</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B><I>&nbsp;</I></B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B><I>Section</I></B></TD>
<TD NOWRAP VALIGN="bottom"><B><I>&nbsp;</I></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounting Firm</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.6(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ACOs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.2(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquired Net Working Capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.6(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Affiliate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Aggregate Damage</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.24(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Introduction</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">AHCA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Anti-Kickback Law</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.4(n)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assigned Marks</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1(k)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assignment and Assumption Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.2(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assignment of Hospital Lease</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.2(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assignment of Ownership Interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.2(o)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assignments of Leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.2(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Association</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.28(f)(1)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assumed Liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance Sheet Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.4(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basket Amount</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Benefit Plans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.12(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Business Associate Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.2(k)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Buyer or Buyers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Introduction</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Buyer Indemnified Parties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Buyer Plans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Casualty Termination Notice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.24(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CERCLA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CHS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Introduction</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CINs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.2(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CJR</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.2(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Clinic Billing and Collection Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.2(m)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CMS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.7(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">COBRA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.4(h)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Code</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.12(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Condominium</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.28(f)(2)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Confidentiality Agreements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.10(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contracts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1(g)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Control</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Damages</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Data Handling</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.26(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Decision Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.24(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deeds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.2(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">viii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Defects</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.3(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DPP</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1(p)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DRG Transition Patients</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.7(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DSH</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.2(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effective Time</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Environmental Laws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ERISA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.12(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Excluded Assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Excluded Liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Excluded Marks</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.2(f)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Facilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Recital A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">False Claims Act</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.4(n)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FESC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.2(t)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FESC LLC Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.2(u)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financial Statements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foundation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.7(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FTC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fundamental Representations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">GAAP</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.6(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Government Entity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.8(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Governmental Programs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.7(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hazardous Substances</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hernando County</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1(g)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hernando HMA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Introduction</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HIPAA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.8(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hired Employees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.10(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hospital or Hospitals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Recital A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hospital Lease</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1(g)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hospital Leased Real Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.2(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hospital Transition Services Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.2(l)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HQI Program</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.7(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HSR Act</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">IGTs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.7(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Immaterial Contracts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnified Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnifying Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Independent Consultant</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.24(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Information Services Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.2(k)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intellectual Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interim Billings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.7(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Justice Department</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Knowledge of Sellers or Sellers&#146; Knowledge</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leased Real Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">License Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.2(n)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Liens</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Limited Powers of Attorney</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.2(j)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ix </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">LIP</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.2(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">LPPFs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.7(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">LPPF Tax Assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.7(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Material Adverse Effect</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Material Consents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Material Contracts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MCO</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.7(d)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Assigned</FONT> Contract</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">OIG</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.7(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating Leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.10(g)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ORYX</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.7(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Owned Real Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ownership Interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1(o)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Partial Subsidiary or Partial Subsidiaries</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.28(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PCI DSS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.26(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Permitted Encumbrances</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Person</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Physician Employees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.10(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PIP</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.7(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Practice Group and Equity Interests Buyer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Introduction</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Privacy and Data Handling Requirements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.26(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Privacy Laws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.26(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Privacy Policies</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.26(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase Price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchased Condominium Units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.28(f)(2)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchased FESC Units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.28(e)(2)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">QNet</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.7(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RAC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.2(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RCRA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Real Estate Buyer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Introduction</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Real Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Security Breach</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.26(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Seller or Sellers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Introduction</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Seller Cost Reports</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Seller Employees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.10(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Seller Guaranty</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Seller Indemnified Parties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Seller Plans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.10(d)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sensitive Data</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.26(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Seven Rivers Hospital Buyer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Introduction</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Spring Hill/Brooksville Hospitals Buyer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Introduction</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SSA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.16(d)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stark Law</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.4(n)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">State Health Agency</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Submittal Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.24(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Surveys</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.3(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">x </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Survival Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax or Taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Return</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination Notice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TGH</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Introduction</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title Commitment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.3(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.3(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title Evidence</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.3(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title Policy</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.3(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transition Marks</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transition Patients</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transition Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transition Services</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">WARN Act</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.16(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">xi </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ASSET PURCHASE AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THIS ASSET PURCHASE AGREEMENT (the &#147;Agreement&#148;) is made and entered into as of July&nbsp;24, 2023, by and among (i)&nbsp;HERNANDO
HMA, LLC, a Florida limited liability company (&#147;Hernando HMA&#148;), SPRING HILL HMA MEDICAL GROUP, LLC, a Florida limited liability company, BROOKSVILLE HMA PHYSICIAN MANAGEMENT, LLC, a Florida limited liability company, BRAVERA URGENT CARE,
LLC, a Delaware limited liability company, CITRUS HMA, LLC, a Florida limited liability company, and CRYSTAL RIVER HMA PHYSICIAN MANAGEMENT, LLC, a Florida limited liability company (each of which may be referred to individually as a
&#147;Seller&#148; and collectively as &#147;Sellers&#148;), (ii)&nbsp;CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation (&#147;CHS&#148;), (iii) FHSC NEWCO I, LLC, a Florida limited liability company (&#147;Seven Rivers Hospital
Buyer&#148;), FHSC NEWCO II, LLC, a Florida limited liability company (&#147;Spring Hill/Brooksville Hospitals Buyer&#148;), FHSC REAL PROPERTY I, LLC, a Florida limited liability company (&#147;Real Estate Buyer&#148;), and TGH AMBULATORY SERVICES
COMPANY, a Florida corporation (&#147;Practice Group and Equity Interests Buyer&#148;) (Seven Rivers Hospital Buyer, Spring Hill/Brooksville Hospitals Buyer, Real Estate Buyer, and Practice Group and Equity Interests Buyer may be referred to
individually as a &#147;Buyer&#148; and collectively as &#147;Buyers&#148;), and (iv)&nbsp;FLORIDA HEALTH SCIENCES CENTER, INC. D/B/A TAMPA GENERAL HOSPITAL, a Florida
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">not-for-profit</FONT></FONT> corporation (&#147;TGH&#148;). </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS: </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>A</B>.
Sellers collectively own or lease and (in both cases) operate general acute care hospitals known as Bravera Health Brooksville in Brooksville, Florida, Bravera Health Spring Hill in Spring Hill, Florida, and Bravera Health Seven Rivers in Crystal
River, Florida (collectively, the &#147;Hospitals&#148;), together with certain related businesses, including freestanding emergency departments, urgent care centers, medical office buildings and facilities, outpatient care facilities, physician
practices and facilities and ancillary services (collectively with the Hospitals, the &#147;Facilities&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>B.</B> Sellers desire
to sell to Buyers and Buyers desire to purchase from Sellers substantially all of the assets of Sellers which are directly or indirectly related to, necessary for, or used in connection with, the operation of the Facilities on the terms and
conditions set forth in this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>C.</B> CHS is a party to this Agreement for purposes of guaranteeing the obligations of its
subsidiaries or Affiliates as set forth herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>D.</B> TGH is a party to this Agreement for purposes of guaranteeing the obligations
of its subsidiaries or Affiliates as set forth herein. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NOW, THEREFORE</B>, for and in consideration of the premises and the mutual agreements, covenants, representations, and warranties
hereinafter set forth and other good and valuable consideration, the receipt and adequacy of which are forever acknowledged and confessed, the parties hereto agree as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1. PURCHASE OF ASSETS. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>1.1
</I></B><B><I>Assets</I></B>. Subject to the terms and conditions of this Agreement, as of the Closing (as defined in <U>Section</U><U></U><U>&nbsp;2.1</U> hereof), Sellers agree to sell, convey, transfer, assign and deliver to Buyers, and Buyers
agree to purchase, all right, title and interest of Sellers in and to all of the assets owned or used by Sellers in connection with the ownership and operation of the Facilities, other than the Excluded Assets (hereinafter defined), which assets
shall include, without limitation, the following (the &#147;Assets&#148;): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a) </I></B>fee simple title to the real property
described on <U>Schedule 1.1(a)(i)</U> hereto, together with all right, title and interest of Sellers in and to all improvements, any construction in progress, any other buildings and fixtures thereon, and all rights, privileges and easements
appurtenant thereto (collectively, the &#147;Owned Real Property&#148;), and valid leasehold title to the real property that is leased by Sellers pursuant to the leases described on <U>Schedule 1.1(a)(ii)</U> (collectively, the &#147;Leased Real
Property&#148;) (the Owned Real Property and the Leased Real Property are collectively referred to herein as the &#147;Real Property&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b) </I></B>all tangible personal property, including, without limitation, all major, minor or other equipment, machinery, computers,
computer hardware, data processing equipment, instruments, vehicles, furniture, fixtures and furnishings of Sellers used or held for use in respect of the Facilities, and all warranties and other rights with respect to the foregoing; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c) </I></B>all supplies, drugs, inventory and other disposables and consumables used or held for use in respect of the Facilities; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d) </I></B>all deposits, prepaid expenses, advances, escrows, prepaid taxes and claims for refunds or credits in connection with the
Facilities or Assets that will have continuing value to Buyers; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(e) </I></B>all claims of Sellers against third parties to the
extent such claims relate to the condition of the Assets or Facilities and, to the extent assignable, all warranties (express or implied) and rights and claims assertable by (but not against) Sellers related to the Assets and Facilities; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(f) </I></B>to the extent legally transferable, all right, title and interest in the financial, patient, medical staff and personnel
records relating to the Facilities (including, without limitation, all equipment records, medical administrative libraries, medical records, documents, catalogs, books, records, files, current personnel records, data and databases); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(g) </I></B>all rights and interests in the contracts, commitments, leases, licenses and agreements listed on <U>Schedule 1.1(g)</U>
hereto, including that certain Lease Agreement dated as of June&nbsp;1, 1998, by and between Hernando County, Florida (&#147;Hernando County&#148;) and Hernando HMA, as amended (the &#147;Hospital Lease&#148;), and all Immaterial Contracts
(hereinafter defined) (the contracts being assigned are referred to herein, collectively, as the &#147;Contracts&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(h)
</I></B>the Facilities&#146; Medicare, Medicaid, and other government payment program provider numbers listed on <U>Schedule 1.1(h)</U> hereto and all rights under the corresponding Medicare, Medicaid, and other government payment program provider
agreements, to the extent legally transferable; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(i) </I></B>all licenses, franchises, accreditations, registrations and permits held
by Sellers relating to the ownership, development, and operation of the Facilities (including, without limitation, any pending or approved governmental approvals), to the extent legally assignable; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(j) </I></B>any patents, copyrights, trade secrets and applications and registrations associated therewith, goodwill associated
therewith, licenses and sublicenses granted in respect thereto and rights thereunder, remedies against infringements thereof and rights to protection of interests therein; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(k) </I></B>the trade names, trademarks, service marks, and domain names and addresses of the Facilities, and all rights, registrations,
applications and goodwill associated therewith, set forth on <U>Schedule 1.1(k)</U> (the &#147;Assigned Marks&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(l)
</I></B>all goodwill associated with the Facilities and the Assets; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(m) </I></B>petty cash; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(n) </I></B>the telephone numbers used in connection with the business and operations of the Facilities; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(o) </I></B>the ownership interests in the Partial Subsidiaries (hereinafter defined) held by Sellers or their Affiliates (each an
&#147;Ownership Interest&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(p) </I></B>the LPPF Tax Assets and all rights of the Hospitals or Sellers with respect to the
Hospital Direct Payment Program (&#147;DPP&#148;) with respect to the operation of the Hospitals after the Effective Time; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(q)
</I></B>all property and rights of the foregoing types arising or acquired by Sellers between the date hereof and Closing; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(r)
</I></B>to the extent not otherwise described in this Section&nbsp;1.1, all current assets taken into account in determining Acquired Net Working Capital under Section&nbsp;1.6(a); and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(s) </I></B>all other property of every kind, character or description owned, leased or licensed by Sellers and used or held for use in
the business of the Facilities or the Assets, whether now owned or leased or hereafter acquired before Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All Assets shall be transferred at
Closing free and clear of any and all claims, security interests, liens, pledges, charges, escrows, options, proxies, rights of first refusal, preemptive rights, mortgages, deeds of trust, easements, hypothecations, prior assignments, title
retention agreements, indentures, security agreements, transfer restrictions or any other limitation, encumbrance or restriction of any kind (collectively, &#147;Liens&#148;), except for the Permitted Encumbrances and the Assumed Liabilities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>1.2 </I></B><B><I>Excluded Assets</I></B>. Those assets of Sellers described below,
together with any assets described on <U>Schedule 1.2</U> hereto, shall be retained by Sellers (collectively, the &#147;Excluded Assets&#148;) and shall not be conveyed to Buyers: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a) </I></B>cash, cash equivalents and marketable securities (except petty cash); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b) </I></B>all accounts receivable arising from the rendering of services to patients at the Hospitals, billed and unbilled, recorded
or unrecorded, with collection agencies or otherwise, accrued and existing in respect of services rendered prior to the Effective Time; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c) </I></B>all amounts payable to Sellers in respect of third party payors pursuant to retrospective settlements (including, without
limitation, pursuant to Medicare, Medicaid and CHAMPUS/TRICARE cost reports filed or to be filed by Sellers for periods prior to the Effective Time (hereinafter defined), retrospective payment of claims that are the subject of CMS Recovery Audit
Contractor (&#147;RAC&#148;) appeals, all payments associated with any Medicare accountable care organizations (&#147;ACOs&#148;), clinically integrated networks (&#147;CINs&#148;), or the Medicare Comprehensive Care for Joint Replacement Model
(&#147;CJR&#148;) with respect to periods prior to the Effective Time, and all payments for periods prior to the Effective Time related to all Medicaid payments and programs, including, but not limited to (i)&nbsp;settlements or adjustments to prior
Medicaid payments resulting from the State&#146;s audit or other recalculation of Medicaid payments for services rendered prior to the Effective Time, (ii)&nbsp;Disproportionate Share (&#147;DSH&#148;), (iii) Low Income Pool (&#147;LIP&#148;), and
(iv)&nbsp;DPP, and all appeals and appeal rights of Sellers relating to such settlements, including cost report settlements, for periods prior to the Effective Time; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d) </I></B>to the extent that the applicable Buyer does not need the same in connection with the operation of the Facilities or to
defend any claims arising after the Effective Time, all records of Sellers relating to (i)&nbsp;litigation files and records, cost report records relating to periods of time prior to the Effective Time, tax returns and minute books, and
(ii)&nbsp;the Excluded Assets and Excluded Liabilities, as well as all records which by law Sellers are required to maintain in their possession; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(e) </I></B>prepaid insurance, prepaid assets dedicated to Sellers&#146; benefit plans and any reserves or prepaid expenses related to
Excluded Assets and Excluded Liabilities (such as prepaid legal expenses or insurance premiums); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(f) </I></B>any and all names,
symbols, trademarks, logos or other symbols used in connection with the Facilities and the Assets which include the names &#147;CHS,&#148; &#147;Community Health Systems,&#148; &#147;HMA&#148; or any variants thereof or any other names which are
proprietary to Sellers or their Affiliates (the &#147;Excluded Marks&#148;) (subject to the license rights set forth herein with respect thereto); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(g) </I></B>any computer software, systems and programs which are proprietary to Sellers or their Affiliates; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(h) </I></B>receivables from Sellers or their Affiliates; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(i) </I></B>except as expressly set forth in <U>Section</U><U></U><U>&nbsp;12.24</U>
with respect to damage and loss to the Facilities arising prior to the Effective Time, Sellers&#146; insurance proceeds arising from <FONT STYLE="white-space:nowrap">pre-Effective</FONT> Time incidents and Sellers&#146; assets held in connection
with any self-funded insurance programs and reserves, if any; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(j) </I></B>any claims of Sellers against third parties to the extent
(and only to the extent) that such claims relate to the operation of the Facilities prior to the Effective Time or to the Excluded Assets or Excluded Liabilities; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(k) </I></B>all of Sellers&#146; or any Affiliate&#146;s proprietary manuals, marketing materials, policy and procedure manuals,
standard operating procedures and marketing brochures, data and studies or analyses (subject to the terms of the License Agreement to be executed and delivered at Closing); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(l) </I></B>all rights in connection with and the assets of Sellers&#146; employee benefit plans; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(m) </I></B>all assets relating to home health or hospice operations; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(n) </I></B>all national or regional contracts of Sellers or any Affiliate of Sellers which are made available to any of the Facilities
by virtue of the Facilities being an Affiliate of Sellers (provided, however, that certain services provided under such contracts may be made available to Buyers pursuant to the Information Services Agreement); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(o) </I></B>the electronic funds transfer accounts of the Facilities; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(p) </I></B>inventory or supplies that are expired or beyond their useful life; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(q) </I></B>all rights of Sellers in any contracts, commitments, leases and agreements which are not included in the Contracts; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(r) </I></B>any claims against third party payors relating to underpayments or violation of prompt pay statutes with respect to periods
prior to the Effective Time; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(s) </I></B>all rights of Sellers under this Agreement and its related documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>1.3 </I></B><B><I>Assumed Liabilities</I></B>. In connection with the conveyance of the Assets hereunder, Buyers shall assume, as of the
Effective Time, the future payment and performance of the following liabilities (the &#147;Assumed Liabilities&#148;) of Sellers: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a) </I></B>all obligations first accruing from and after the Effective Time with respect to the Contracts, including, without
limitation, the Hospital Lease (but only to the extent that such obligations thereunder are required to be performed after the Effective Time and do not relate to any failure to perform, improper performance, warranty or other breach, default or
violation by any Seller or any of their Affiliates prior to the Effective Time); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b) </I></B>the capital lease obligations set
forth on <U>Schedule 1.3</U> hereto; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c) </I></B>all obligations and liabilities as of the Effective Time in respect of accrued
vacation and holiday benefits of employees at the Hospitals who are hired by Buyers as of the Effective Time, and related taxes, but only to the extent included in the determination of Acquired Net Working Capital. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>1.4 </I></B><B><I>Excluded Liabilities</I></B>. Except for the Assumed Liabilities,
Buyers shall not assume and under no circumstances shall Buyers be obligated to pay or assume, and none of the assets of Buyers shall be or become liable for or subject to any liability, indebtedness, commitment, or obligation of Sellers or their
Affiliates, or with respect to the Facilities, whether known or unknown, fixed or contingent, recorded or unrecorded, currently existing or hereafter arising or otherwise (collectively, the &#147;Excluded Liabilities&#148;), including, without
limitation, the following Excluded Liabilities: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a) </I></B>any debt, obligation, expense or liability that is not an Assumed
Liability (including but not limited to accounts payable, accrued salaries and accrued liabilities); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b) </I></B>any liability or
obligation arising out of or in connection with the Assets and/or ownership and operation of the Facilities prior to the Effective Time, including without limitation claims or potential claims for medical malpractice or general liability relating to
acts, events or omissions asserted to have existed or occurred prior to the Effective Time; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c) </I></B>those claims and
obligations (if any) specified in <U>Schedule 1.4</U> hereto; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d) </I></B>all litigation, claims, actions, proceedings, liabilities
and obligations relating to, in connection with or arising out of matters described or referred to (or required to be described or referred to) on <U>Schedule 3.13</U>; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(e) </I></B>any liabilities or obligations associated with or arising out of any of the Excluded Assets; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(f) </I></B>liabilities and obligations of Sellers or their Affiliates (with respect to the Facilities or Assets) in respect of periods
prior to the Effective Time arising under the terms of the Medicare, Medicaid, CHAMPUS/TRICARE, BlueCross, or other third party payor programs, including, without limitation, in respect of third party payors pursuant to retrospective settlements
(including, without limitation, pursuant to Medicare, Medicaid and CHAMPUS/TRICARE cost reports filed or to be filed by Sellers for periods prior to the Effective Time, RAC appeals, ACOs, CINs, CJR, and all liabilities and obligations for periods
prior to the Effective Time related to all Medicaid payments and programs, including, but not limited to (i)&nbsp;settlements or adjustments to prior Medicaid payments resulting from the State&#146;s audit or other recalculation of Medicaid payments
for services rendered prior to the Effective Time, (ii)&nbsp;DSH, (iii) LIP, and (iv)&nbsp;DPP), and all appeals and appeal rights of Sellers relating to such settlements, any audit under the Medicare RAC program or any noncompliance with applicable
law or contractual obligations related to the billing or collection of services, any ACOs, CINs, CJR, and any liability arising pursuant to the Medicare, Medicaid, CHAMPUS/TRICARE, Blue Cross, or any other third party payor programs as a result of
the consummation of any of the transactions contemplated under this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(g) </I></B>federal, state or local Tax liabilities
or obligations of Sellers or their Affiliates in respect of periods prior to the Effective Time or resulting from the consummation of the transactions contemplated herein including, without limitation, (1)&nbsp;any income tax, any franchise tax, any
tax recapture, any sales and/or use tax, and any FICA, FUTA, workers&#146; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
compensation, and (2)&nbsp;any and all other taxes or amounts due and payable as a result of the exercise by the employees at the Facilities that are hired by Buyers following Closing of such
employees&#146; right to vacation, sick leave, and holiday benefits accrued while in the employ of Sellers (provided, however, that this clause (g)(2) shall not apply to any and all such taxes payable with respect to any employee benefits
constituting Assumed Liabilities); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(h) </I></B>liability for any and all claims by or on behalf of employees, independent
contractors, directors, officers, managers or other persons of Sellers, their Affiliates (with respect to the Facilities or Assets) or the Facilities relating to periods prior to the Effective Time including, without limitation, liability for any
compensation-related payments, pension, profit sharing, deferred compensation, equity or equity-related compensation, incentive compensation, fringe benefit, tuition reimbursement, severance, termination pay, change in control or retention payments,
bonuses or any other employee benefit plan of whatever kind or nature or any employee health and welfare benefit plans, liability for any unemployment compensation claim, or workers&#146; compensation claim, and any liabilities or obligations to
former employees of Sellers, their Affiliates (with respect to the Facilities) or the Facilities under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&#147;COBRA&#148;), (provided, however, that this clause (h)&nbsp;shall
not apply to any and all employee accrued vacation and holiday benefits constituting Assumed Liabilities under <U>Section</U><U></U><U>&nbsp;1.3(c)</U> hereof); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(i) </I></B>any obligation or liability accruing, arising out of, or relating to any federal, state or local investigations of, or
claims or actions against, Sellers or any of their Affiliates (with respect to the Facilities or Assets) or any of their employees, medical staff, agents, vendors or representatives with respect to acts, events, circumstances or omissions prior to
the Effective Time; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(j) </I></B>any civil or criminal obligation or liability accruing, arising out of, or relating to any acts or
omissions of Sellers, their Affiliates or, to the extent related to their services to Sellers or their Affiliates or to the Facilities, their directors, officers, employees and agents, claimed to violate or not comply with any constitutional
provision, statute, ordinance or other law, rule, regulation or order, consent decree, continuing disclosure agreement, license, permit or other agreement of or with any Government Entity; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(k) </I></B>liabilities or obligations arising out of any breach, <FONT STYLE="white-space:nowrap">non-compliance</FONT> or default by
Sellers or their Affiliates under any Contract prior to the Effective Time; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(l) </I></B>liabilities or obligations arising (whether
as a result of any breach, <FONT STYLE="white-space:nowrap">non-compliance</FONT> or default by Sellers or their Affiliates, or otherwise) at any time under any contract or commitment that is not expressly assumed by Buyers in this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(m) </I></B>any debt, obligation, expense, or liability of Sellers arising out of or incurred as a result of any transaction, act or
omission of Sellers or their Affiliates (with respect to the Facilities) occurring after the Effective Time; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(n) </I></B>any
liability or obligation of Sellers and their Affiliates (with respect to the Facilities or Assets) relating to any violation or <FONT STYLE="white-space:nowrap">non-compliance</FONT> with federal, state, foreign or other laws, rules, regulations,
orders or decrees regulating fraud, including but not limited to those described on any disclosure schedule (including, for example, <U>Schedule 3.8</U>, <U>Schedule 3.10</U>, <U>Schedule 3.14</U>, <U>Schedule 3.16</U>) and the federal Anti-Kickback
Law (42 U.S.C. &#167; <FONT STYLE="white-space:nowrap">1320(a)-7(b)</FONT> <U>et</U> <U>seq</U>.) (the &#147;Anti-Kickback Law&#148;), the Ethics in Patient Referrals Act (42 U.S.C. &#167; 1395nn <U>et</U> <U>seq</U>.) (the &#147;Stark Law&#148;),
and the False Claims Act (31 U.S.C. &#167; 3729 <U>et</U> <U>seq</U>.) (the &#147;False Claims Act&#148;); and </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(o) </I></B>all liabilities and obligations relating to any oral agreements, oral
contracts or oral understandings with any referral sources including, but not limited to, physicians, unless reduced to writing, identified on <U>Schedule 1.1(g)</U> hereto, and expressly assumed as part of the Contracts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>1.5 </I></B><B><I>Purchase Price</I></B>. The purchase price (the &#147;Purchase Price&#148;) for the Assets shall be Two Hundred Eighty
Million Dollars ($280,000,000), <U>plus</U> the amount of the Acquired Net Working Capital (as defined in <U>Section</U><U></U><U>&nbsp;1.6(a)</U>) of Sellers as of the Effective Time, and <U>minus</U> the amount of capitalized/finance leases set
forth on <U>Schedule 1.3</U>, that are assumed by Buyers hereunder (but expressly excluding, for this purpose, the Hospital Lease and any other real property leases that are classified as capitalized/finance leases). The Purchase Price shall be
calculated as of the Closing based upon the estimated Acquired Net Working Capital (as determined in accordance with <U>Section</U><U></U><U>&nbsp;1.6(b)</U>), and shall be due and payable at the Closing by wire transfer of immediately available
funds to an account designated by Sellers. The Purchase Price shall be further adjusted after the Closing in accordance with <U>Section</U><U></U><U>&nbsp;1.6(a)</U> to reflect the actual Acquired Net Working Capital as of the Effective Time (as
determined in accordance with <U>Section</U><U></U><U>&nbsp;1.6(b)</U>). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>1.6 </I></B><B><I>Acquired Net Working Capital, Estimates
and Audits</I></B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a) </I></B><B><I>Acquired Net Working Capital</I></B>. As used herein, the term &#147;Acquired Net Working
Capital&#148; shall mean the aggregate current assets of Sellers conveyed to Buyers pursuant to <U>Section</U><U></U><U>&nbsp;1.1</U> hereof (excluding those Excluded Assets which would otherwise be included in current assets), minus the aggregate
current liabilities of Sellers assumed by Buyers pursuant to <U>Section</U><U></U><U>&nbsp;1.3</U> hereof (excluding those Excluded Liabilities which would otherwise be included in current liabilities), all as determined in accordance with generally
accepted accounting principles (&#147;GAAP&#148;) and as further described in and limited by this <U>Section</U><U></U><U>&nbsp;1.6</U> and <U>Schedule 1.6</U>. In any case with respect to the computation of Acquired Net Working Capital (i)&nbsp;the
following shall be included in current assets (and no Excluded Assets shall be included in current assets): petty cash, prepaid expenses, escrows and deposits paid by Sellers (including the LPPF Tax Assets), and supplies and inventory (valued as
determined by an independent appraiser retained by Buyers), and (ii)&nbsp;only the following shall be included in current liabilities: accrued liabilities for vacation and holiday benefits for employees of Sellers who are hired by Buyers as of the
Effective Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b) </I></B><B><I>Estimates and Adjustments.</I></B> Attached hereto as <U>Schedule 1.6</U> is a schedule of the
mutually agreed upon Acquired Net Working Capital as of May&nbsp;31, 2023, together with the principles, specifications and methodologies used in determining such Acquired Net Working Capital. At least ten (10)&nbsp;business days prior to Closing,
Sellers shall deliver to Buyers a reasonable estimate of Acquired Net Working Capital as of the end of the most recently ended calendar month prior to the Closing Date for which financial statements are available and containing reasonable detail and
supporting documents showing the derivation of such estimate. Such calculation of the Acquired Net Working Capital shall be estimated following the same </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
mutually agreed upon principles, specifications and methodologies used to determine the Acquired Net Working Capital as of May&nbsp;31, 2023, as specified in <U>Schedule 1.6</U>, and shall be
used for purposes of calculating the Purchase Price at the Closing. Within ninety (90)&nbsp;days after the Closing, Sellers shall deliver to Buyers their determination of the actual Acquired Net Working Capital as of the Effective Time (following
the same principles, specifications and methodologies used to determine the Acquired Net Working Capital as set forth on <U>Schedule 1.6</U> and the estimated Acquired Net Working Capital at the Closing as provided for in this Section&nbsp;1.6
above). Each party shall have full access to the financial books and records pertaining to the Facilities to confirm or audit Acquired Net Working Capital computations. Should Buyers disagree with Sellers&#146; determination of Acquired Net Working
Capital, they shall notify Sellers within sixty (60)&nbsp;days after Sellers&#146; delivery of their determination of Acquired Net Working Capital. If Sellers and Buyers fail to agree within thirty (30)&nbsp;days after Buyers&#146; delivery of
notice of disagreement on the amount of Acquired Net Working Capital, such disagreement shall be resolved in accordance with the procedure set forth in <U>Section</U><U></U><U>&nbsp;1.6(c)</U>, which shall be the exclusive remedy for resolving
accounting disputes relative to the determination of Acquired Net Working Capital. The Purchase Price shall be increased or decreased based on actual Acquired Net Working Capital as of the Effective Time, and within five (5)&nbsp;business days after
determination thereof any increase shall be paid in cash by Buyers to Sellers, and any decrease shall be paid in cash to Buyers by Sellers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c) </I></B><B><I>Dispute of Adjustments</I></B>. In the event that Sellers and Buyers are not able to agree on the actual Acquired Net
Working Capital within thirty (30)&nbsp;days after Buyers&#146; delivery of notice of disagreement, Sellers and Buyers shall each have the right to require that such disputed determination be submitted to PwC or another independent certified public
accounting firm as Sellers and Buyers may then mutually agree upon in writing (the &#147;Accounting Firm&#148;) for computation or verification in accordance with the provisions of this Agreement. The Accounting Firm shall review the matters in
dispute and, acting experts and not as arbitrators, shall promptly decide the proper amounts of such disputed entries (which decision shall also include a final calculation of actual Acquired Net Working Capital). The Accounting Firm&#146;s
determination shall be binding upon Sellers and Buyers, and such Accounting Firm&#146;s fees and expenses shall be borne equally by Sellers and Buyers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>1.7 </I></B><B><I>Transition Patients</I></B><B><I> and Other Supplemental Payment Programs</I></B>. To compensate Sellers for services
rendered and medicine, drugs and supplies provided up to the Effective Time with respect to patients who are admitted as inpatients to the Hospitals prior to the Effective Time but who are not discharged until after the Effective Time (such patients
being referred to herein as the &#147;Transition Patients&#148; and services rendered to them being referred to herein as the &#147;Transition Services&#148;), the parties shall take the following actions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a) </I></B>As soon as practicable after the Closing Date, there shall be delivered to both parties a statement itemizing the Transition
Services provided by each of the parties to Transition Patients whose medical care is paid for, in whole or in part, by Medicare, Medicaid, TRICARE, Blue Cross or any other third party payor who pays on a DRG, case rate or other similar basis (the
&#147;DRG Transition Patients&#148;). As soon as practicable after the Closing Date, Sellers shall deliver to Buyers a list of Transition Patients which shall contain the number of patient days and list of detailed charges for each such Transition
Patient as of the Effective Time. Buyers shall pay to Sellers an amount equal to (i)&nbsp;the total DRG and outlier payments (including capital and any deposits, deductibles or <FONT STYLE="white-space:nowrap">co-payments</FONT> received by Buyers)
per the remittance advice received by </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Buyers on behalf of a DRG Transition Patient, multiplied by a fraction, the numerator of which shall be the total charges for the Transition Services provided to such DRG Transition Patient by
Sellers (less <FONT STYLE="white-space:nowrap">non-covered</FONT> charges), and the denominator of which shall be the sum of the total charges for all services provided to such DRG Transition Patient by Sellers and Buyers both up to and after the
Effective Time (less <FONT STYLE="white-space:nowrap">non-covered</FONT> charges), minus (ii)&nbsp;any deposits, deductibles or <FONT STYLE="white-space:nowrap">co-payments</FONT> made or payable by such DRG Transition Patients to Sellers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b) </I></B>As of Effective Time, <FONT STYLE="white-space:nowrap">cut-off</FONT> billings (&#147;Interim Billings&#148;) for all
Transition Patients not covered by <U>Section</U><U></U><U>&nbsp;1.7(a)</U> shall be prepared and sent following the discharge of the Transition Patients from the Hospitals. Any payments received by either Buyers or Sellers for such Interim Billings
are the property of Sellers and shall be paid to Sellers, when and as received by Buyers, within ten (10)&nbsp;business days of the end of the month in which such payments are received. Any payments received by Sellers for services provided to such
Transition Patients for Transition Services rendered by Buyers after the Effective Time are the property of Buyers and shall be paid to Buyers, when and as received by Sellers, within ten (10)&nbsp;business days of the end of the month in which such
payments are received. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c) </I></B>The Medicaid DPP program is funded through provider taxes paid to local provider participation
funds (&#147;LPPFs&#148;). The Hospitals participate in LPPFs with Citrus and Hernando Counties. The &#147;LPPF Tax Assets&#148; shall consist of all accumulated tax funds paid by the Hospitals to the LPPFs prior to the Effective Time, which the
LPPFs have not submitted to the State of Florida through intergovernmental transfers (&#147;IGTs&#148;), and which the parties do not anticipate the LPPFs will submit retrospectively to the State of Florida through IGTs with respect to any Medicaid
program year that ended prior to the Effective Time. Adelanto HealthCare Ventures (AHCV) or a similar entity maintains reconciliation workbooks that document each Hospital&#146;s LPPF Tax Assets, which are calculated as the net of the following:
taxes paid by the Hospitals, interest income earned by unused taxes, IGTs remitted by the LPPFs to the State of Florida, administrative expenses, other miscellaneous adjustments, and grant payments. If LPPFs refund LPPF Tax Assets to the Hospitals,
the refunds belong to the party or parties that owned the associated LPPF Tax Assets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As the owners of the LPPF Tax Assets, at and after
the Effective Time, Buyers shall be entitled to the benefit of any payments that increase the amounts of the LPPF Tax Assets, including, without limitation: (i)&nbsp;grant payments received from the Florida Essential Healthcare Partnerships
Foundation or a similar entity (the &#147;Foundation&#148;), and (ii)&nbsp;refunds received by the LPPFs from the State of Florida. Correspondingly, as the owners of the LPPF Tax Assets, at and after the Effective Time, Buyers shall be responsible
for grant payments to the Foundation relating to <FONT STYLE="white-space:nowrap">in-county</FONT> providers (if any, and none are anticipated). Grant payments made to the Foundation relating to <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">out-of-county</FONT></FONT> providers (if any, and none are anticipated) shall be the responsibility of the party or parties who received the DPP program payments for the respective program year, and shall be included as
part of the allocation set forth in <U>Section</U><U></U><U>&nbsp;1.7(d)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that an outside agency audits the LPPF program
and/or its participants, Buyers and Sellers will jointly select representation for audit defense. The costs of the representation will be borne in a proportion commensurate to the proportion of Foundation grant payments received by the parties that
operated the Hospitals during the period(s) under audit. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Schedule 1.7(c)</U> provides an illustration of the statements in this
<U>Section</U><U></U><U>&nbsp;1.7(c)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d) </I></B>If Buyers receive amounts related to any Medicare, Medicaid or other third
party payor program such as DSH payments, LIP payments, DPP payments from Medicaid managed care organizations (&#147;MCOs&#148;) (inclusive of quality payments), medical education payments, Citrus or Hernando County payments, periodic interim
payments (&#147;PIP&#148;), <FONT STYLE="white-space:nowrap">bi-weekly</FONT> payments for Medicare bad debt, settlements for the retrospective audit or recalculation of Medicaid or county rates, payments, or programs, or payments for costs paid on
a pass-through basis (such as capital costs), associated with the operation of the Hospitals prior to the Effective Time, Buyers shall tender the amount applicable to the period up to the Effective Time to Sellers within thirty (30)&nbsp;days of
receipt. If Sellers receive amounts related to any Medicare, Medicaid or other third party payor program such as DSH payments, LIP payments, DPP payments from Medicaid MCOs (inclusive of quality payments), medical education payments, Citrus or
Hernando County payments, PIP payments, <FONT STYLE="white-space:nowrap">bi-weekly</FONT> payments for Medicare bad debt, settlements for the retrospective audit or recalculation of Medicaid or county rates or payments or programs, or payments for
costs paid on a pass-through basis (such as capital costs), associated with the operations of the Hospitals relating to periods after the Effective Time, Sellers shall tender the same to Buyers within thirty (30)&nbsp;days of receipt. It is the
intent of the parties that Buyers and Sellers shall receive amounts related to such payments applicable to the period of time the Hospitals were owned by such party during the period attributable to the payment. If the payment does not relate solely
to a period prior to or after the Effective Time, each party will receive an amount equal to the payment multiplied by a fraction, the numerator of which shall be the number of days the Hospitals were owned by the party during the period
attributable to the payment and the denominator of which shall be the total number of days attributable to the payment. In conjunction with a Medicare cost report, the Medicare Audit Contractor (MAC) may apply
<FONT STYLE="white-space:nowrap">bi-weekly</FONT> payments to a party that are not applicable to its period of ownership. If this occurs, the parties agree to make payments to one another so that each party receives third party payments applicable
to the period of time it owned the Hospitals in accordance with the methodology delineated above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(e) </I></B>All payments required
by this <U>Section</U><U></U><U>&nbsp;1.7</U> shall be made within thirty (30)&nbsp;days of a party&#146;s receipt of payment (or the end of the month in which payment was received, as applicable) with respect to a Transition Patient, accompanied by
copies of remittances and other supporting documentation as are available and reasonably required by the other party. In the event that Buyers and Sellers are unable to agree on any amount to be paid under this <U>Section</U><U></U><U>&nbsp;1.7</U>,
then such amount shall be determined through the binding process provided in <U>Section</U><U></U><U>&nbsp;1.6(c)</U> at the joint equal expense of Buyers and Sellers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>1.8 </I></B><B><I>Prorations</I></B>. Except as otherwise provided herein (for example, with respect to the determination of Acquired
Net Working Capital) or as settled at the Closing, within ninety (90)&nbsp;days after the Closing Date (hereinafter defined), Sellers and Buyers shall prorate as of the Effective Time any amounts which become due and payable on or after the Closing
Date with respect to (i)&nbsp;the Contracts, (ii)&nbsp;ad valorem taxes, if any, on the Assets (which shall be prorated as of the Closing), (iii) personal property taxes on the Assets (which shall be prorated as of the Closing) and (iv)&nbsp;all
utilities servicing any of the Assets, including water, sewer, telephone, electricity and gas service. Any such amounts which are not available within ninety (90)&nbsp;days after the Closing Date shall be similarly prorated as soon as practicable
thereafter. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. CLOSING. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>2.1 </I></B><B><I>Closing</I></B>. Subject to the satisfaction or waiver by the appropriate party of all of the conditions precedent to
Closing specified in <U>Sections 7</U> and <U>8</U> hereof, the consummation of the transactions contemplated by and described in this Agreement (the &#147;Closing&#148;) shall take place via electronic exchange of closing deliverables on
November&nbsp;30, 2023 (with required original documents listed in <U>Section</U><U></U><U>&nbsp;2.2</U> to be delivered into escrow prior to Closing), or on such other date or at such other location as the parties may mutually designate in writing
(the date of consummation is referred to herein as the &#147;Closing Date&#148;). The Closing shall be effective as of 12:00:01 a.m., local time, on the first day of the next calendar month immediately following the Closing Date, or at such other
time as the parties may mutually designate in writing (such time, the &#147;Effective Time&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>2.2 </I></B><B><I>Actions of
Sellers at Closing</I></B>. At the Closing and unless otherwise waived in writing by Buyers, Sellers shall deliver to Buyers the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a)</I></B><B><I></I></B>&nbsp;(i) Original deeds containing special warranty of title (the &#147;Deeds&#148;), fully executed by each
applicable Seller in recordable form, conveying to each applicable Buyer fee simple title to the Owned Real Property, (ii)&nbsp;an original assignment of the Hospital Lease in form and substance reasonably acceptable to the parties (the
&#147;Assignment of Hospital Lease&#148;), fully executed by Hernando HMA in recordable form, assigning to the applicable Buyer leasehold title to the real property leased by Hernando HMA pursuant to the Hospital Lease (the &#147;Hospital Leased
Real Property&#148;), and (iii)&nbsp;assignments of leases in form and substance reasonably acceptable to the parties (the &#147;Assignments of Leases&#148;), fully executed by each applicable Seller, assigning to each applicable Buyer leasehold
title to the Leased Real Property other than the Hospital Lease, in each case, subject only to the Permitted Encumbrances and the Assumed Liabilities; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b) </I></B>With respect to each applicable Buyer, a General Assignment, Conveyance and Bill of Sale in form and substance reasonably
acceptable to the parties, fully executed by each applicable Seller, conveying to each applicable Buyer all of such Seller&#146;s right, title and interest in the Assets, free and clear of all liabilities and Liens other than the Assumed Liabilities
and Permitted Encumbrances; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c) </I></B>With respect to each applicable Buyer, an Assignment and Assumption Agreement in form and
substance reasonably acceptable to Buyers (the &#147;Assignment and Assumption Agreement&#148;), fully executed by the applicable Seller, conveying to each applicable Buyer such Seller&#146;s interests in the Contracts free and clear of all
liabilities and Liens other than the Assumed Liabilities and Permitted Encumbrances; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d) </I></B>Copies of limited liability or
corporate resolutions, as the case may be, duly adopted by the Board of Directors or applicable managers and/or members of each Seller, authorizing and approving the consummation and performance of the transactions contemplated hereby and the
execution and delivery of this Agreement and the documents described herein, certified as true and of full force as of the Closing, by the appropriate members, managers or officers of each Seller; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(e) </I></B>A Certificate of the President or a Vice President of each Seller,
certifying as to the satisfaction of the conditions precedent contained in <U>Section</U><U></U><U>&nbsp;7.1</U> and <U>Section</U><U></U><U>&nbsp;7.5</U> of this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(f) </I></B>Certificates of incumbency for the respective managers and/or officers of each Seller and Affiliate executing this Agreement
and any other agreements or instruments contemplated herein or making certifications for the Closing dated as of the Closing Date; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(g) </I></B>Certificates of existence and good standing of each Seller from the state in which it is incorporated or formed, dated
within ten (10)&nbsp;business days prior to the Closing; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(h) </I></B>All original Certificates of Title or similar documents of
title (endorsed in blank) and other documents evidencing an ownership interest conveyed as part of the Assets; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(i) </I></B>A
standard form owner&#146;s affidavit (modified as necessary to make factually accurate) from the appropriate Seller as required by the Title Company (as defined in <U>Section</U><U></U><U>&nbsp;6.3</U> hereof) to issue the Title Policy (as defined
in <U>Section</U><U></U><U>&nbsp;6.3</U> hereof) as described in and provided by <U>Section</U><U></U><U>&nbsp;7.3</U> hereof; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(j)
</I></B>Limited Powers of Attorney as contemplated by <U>Section</U><U></U><U>&nbsp;10.12</U> (the &#147;Limited Powers of Attorney&#148;), fully executed by the applicable Sellers; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(k) </I></B>An Information Technology Transition Services Agreement as contemplated by <U>Section</U><U></U><U>&nbsp;10.14</U> (the
&#147;Information Services Agreement&#148;) and the Business Associate Agreement, in substantially the form attached thereto (the &#147;Business Associate Agreement&#148;), fully executed by the appropriate Affiliate(s) of Sellers; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(l) </I></B>A Hospital Transition Services Agreement as contemplated by <U>Section</U><U></U><U>&nbsp;10.15</U> (the &#147;Hospital
Transition Services Agreement&#148;), fully executed by the appropriate Affiliate(s) of Sellers; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(m) </I></B>A Clinic Billing and
Collection Agreement as contemplated by <U>Section</U><U></U><U>&nbsp;10.16</U> (the &#147;Clinic Billing and Collection Agreement&#148;), fully executed by the appropriate Affiliate(s) of Sellers; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(n) </I></B>A License Agreement for Policy and Procedure Manuals as contemplated by <U>Section</U><U></U><U>&nbsp;10.17</U> (the
&#147;License Agreement&#148;), fully executed by the appropriate Affiliate(s) of Sellers; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(o) </I></B>An assignment of the
Ownership Interest in FESC in form and substance reasonably acceptable to the parties (the &#147;Assignment of Ownership Interest&#148;), fully executed by the appropriate Seller or Affiliate, conveying to the appropriate Buyer such Ownership
Interest free and clear of all Liens other than any restrictions set forth in the governing documents of FESC (other than any applicable consent requirements, if any, and similar rights in connection with the assignment of such Ownership Interest to
the applicable Buyer, which are to be satisfied in connection with Closing) and applicable securities laws; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(p) </I></B>A certification (in such form as may be reasonably requested by Buyers)
conforming to the requirements of Treasury Regulations <FONT STYLE="white-space:nowrap">1.1445-2(c)(3)</FONT> and <FONT STYLE="white-space:nowrap">1.897-2(h);</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(q) </I></B>Copies of the Material Consents, which shall be in full force and effect as of the Closing, and copies of other consents and
estoppels obtained by Sellers pursuant to <U>Section</U><U></U><U>&nbsp;5.11</U>; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(r) </I></B>Payoff letters, termination
statements, releases and other evidence satisfactory to Buyers of the release of all Liens on, attached to, or otherwise associated with any of the Assets (other than Permitted Encumbrances); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(s) </I></B>A duly completed and executed IRS Form <FONT STYLE="white-space:nowrap">W-9</FONT> for each Seller; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(t) </I></B>A copy of resolutions duly adopted by the Board of Directors or applicable managers of Florida Endoscopy Surgery Center,
LLC, a Florida limited liability company (&#147;FESC&#148;), authorizing and approving the admission of the Practice Group and Equity Interests Buyer as a member of FESC having the rights of an &#147;HMA Member&#148; as such term is defined in the
FESC LLC Agreement, certified as true, correct and complete and in full force as of the Closing, by the Secretary or other appropriate officer or manager of FESC; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(u) </I></B>A copy of the notice of the <FONT STYLE="white-space:nowrap">co-sale</FONT> rights under Section&nbsp;11.05 of the Second
Amended and Restated Limited Liability Company Agreement of FESC dated effective as of March&nbsp;31, 2021 (the &#147;FESC LLC Agreement&#148;), delivered to each of the members of FESC; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(v) </I></B>Resignation letters from the individuals who serve as members of the Board of Directors or managers or officers of FESC
appointed by the HMA Member (including in such individual&#146;s capacity as a direct and as an officer or manager of FESC) effective as of the Effective Time; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(w) </I></B>Such other instruments, agreements and documents as the parties reasonably agree are appropriate and necessary to effect the
transactions contemplated hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>2.3 </I></B><B><I>Actions of Buyers at Closing</I></B>. At the Closing and unless otherwise
waived in writing by Sellers, Buyers shall deliver to Sellers the following: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a) </I></B>An amount equal to the Purchase Price in
immediately available funds; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b) </I></B>The Assignment of Hospital Lease, fully executed by the appropriate Buyer; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c) </I></B>The Assignments of Leases, fully executed by each applicable Buyer, pursuant to which Buyers shall assume the future payment
and performance of the leases of the Leased Real Property as provided in this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d) </I></B>The Assignment and Assumption
Agreements, fully executed by each applicable Buyer, pursuant to which Buyers shall assume the future payment and performance of the Contracts and the Assumed Liabilities as provided in this Agreement; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(e) </I></B>Copies of resolutions duly adopted by the Board of Directors or the
applicable members and/or managers of each Buyer authorizing and approving their respective performance of the transactions contemplated hereby and the execution and delivery of this Agreement and the documents described herein, certified as true
and in full force as of the Closing, by the appropriate officers of each Buyer; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(f) </I></B>Certificate of the Chief Executive
Officer, President, Chief Financial Officer or a Vice President of each Buyer, certifying as to the satisfaction of the condition precedent contained in <U>Section</U><U></U><U>&nbsp;8.1</U> of this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(g) </I></B>Certificates of incumbency for the respective officers and managers of each Buyer executing this Agreement and any other
agreements or instruments contemplated herein or making certifications for the Closing dated as of the Closing Date; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(h)
</I></B>Certificates of existence and good standing of each Buyer from the state in which each is incorporated or formed, dated within ten (10)&nbsp;business days prior to the Closing; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(i) </I></B>The Limited Powers of Attorney, fully executed by the applicable Buyers; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(j) </I></B>The Information Services Agreement and the Business Associate Agreement in substantially the form attached thereto, fully
executed by Buyers or their Affiliates(s), as applicable; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(k) </I></B>The Hospital Transition Services Agreement, fully executed by
Buyers or their Affiliates(s), as applicable; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(l) </I></B>The Clinic Billing and Collection Agreement, fully executed by Buyers or
their Affiliates(s), as applicable; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(m) </I></B>The License Agreement, fully executed by Buyers or their Affiliates(s), as
applicable; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(n) </I></B>The Assignment of Ownership Interest, fully executed by the appropriate Buyer; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(o) </I></B>Such other instruments and documents as the parties reasonably agree are appropriate and necessary to effect the
transactions contemplated hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3. </B><B>REPRESENTATIONS AND WARRANTIES OF SELLER</B><B>S</B>. As of the date hereof, and, when read in light of
any Schedules which have been updated in accordance with the provisions of <U>Section</U><U></U><U>&nbsp;12.1</U> hereof, as of the Closing Date, Sellers jointly and severally represent and warrant to Buyers the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.1 </I></B><B><I>Existence and Capacity</I></B>. Each Seller is a limited liability company, duly organized and validly existing in
good standing or in active status (as applicable) under the laws of the state of its formation. Each Seller has the requisite power and authority to conduct its business as now being conducted. CHS is a corporation, duly organized and validly
existing in good standing under the laws of the State of Delaware. CHS has the requisite power and authority to enter into this Agreement, to perform its obligations hereunder and to conduct its business as now being conducted. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.2 </I></B><B><I>Powers; Consents; Absence of Conflicts with Other Agreements,
Etc.</I></B> The execution, delivery, and performance by each Seller and their Affiliates, including CHS, of this Agreement and all other agreements referenced herein, or ancillary hereto, to which such Seller or its Affiliate(s) are a party, and
the consummation by each Seller and its Affiliates, including CHS, of the transactions contemplated by this Agreement and the documents described herein, as applicable: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a) </I></B>are within its corporate or limited liability company powers, are not in contravention of corporate or limited liability
company law or of the terms of its organizational documents, and have been duly authorized by all appropriate corporate or limited liability company action; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b) </I></B>except as contemplated by <U>Sections 5.4</U> and <U>5.5</U>, do not require any approval or consent required to be obtained
by Sellers or their Affiliates of, or filing required to be made by Sellers or their Affiliates with, any Government Entity bearing on the validity of this Agreement which is required by law or the regulations of any such Government Entity; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c) </I></B>assuming the receipt of any consents required pursuant to the Contracts, will neither conflict with, nor result in any
breach or contravention of, nor give rise to any early termination right or accelerate any right or remedy under, or the creation of any Lien under, any indenture, agreement, lease, instrument or understanding to which it is a party or by which it
or the Assets and Facilities are bound or subject; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d) </I></B>will not violate any statute, law, rule, or regulation of any
Government Entity to which it or the Assets may be subject; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(e) </I></B>will not violate any judgment, decree, order, writ or
injunction of, or agreement with, any Government Entity to which it, the Facilities or the Assets may be subject. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.3
</I></B><B><I>Binding Agreement</I></B>. This Agreement and all agreements to which any Seller or its Affiliates, including CHS, will become a party pursuant hereto are and will constitute the valid and legally binding obligations of such Seller or
Affiliate, respectively, and are and will be enforceable against it or them in accordance with the respective terms hereof or thereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.4 </I></B><B><I>Financial Statements</I></B>. Sellers have delivered to Buyers copies of the following financial statements of Sellers
and FESC (&#147;Financial Statements&#148;), which Financial Statements are maintained on an accrual basis: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a) </I></B>Unaudited
Balance Sheet dated as of May&nbsp;31, 2023 (the &#147;Balance Sheet Date&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b) </I></B>Unaudited Income Statement for the
five (5)&nbsp;month period ended on the Balance Sheet Date; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c) </I></B>Unaudited Balance Sheets and Income Statements for the fiscal years ended
December&nbsp;31, 2021 and 2022. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as set forth in <U>Schedule 3.4</U>, such Financial Statements have been (and the monthly
financial statements delivered pursuant to <U>Section</U><U></U><U>&nbsp;5.6</U> will be) prepared in accordance with GAAP, applied on a consistent basis throughout the periods indicated. Such Balance Sheets present fairly in all material respects
(and, in the case of financial statements delivered pursuant to <U>Section</U><U></U><U>&nbsp;5.6</U>, will present fairly in all material respects) the financial condition of each Seller or FESC as of the dates indicated thereon, and such Income
Statements present fairly in all material respects (and, in the case of financial statements delivered pursuant to <U>Section</U><U></U><U>&nbsp;5.6</U>, will present fairly in all material respects) the results of operations of each Seller and FESC
for the periods indicated thereon. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.5 </I></B><B><I>Certain Post-Balance Sheet Results</I></B>. Except as set forth in <U>Schedule
3.5</U> hereto, since the Balance Sheet Date there has not been any: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a) </I></B>Material Adverse Effect (hereinafter defined); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b) </I></B>material damage, destruction, or loss (whether or not covered by insurance) to any Hospital or free-standing emergency
department, or affecting the Facilities (taken as a whole); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c) </I></B>actual or threatened employee strike, work stoppage, or
labor dispute pertaining to the Facilities; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d) </I></B>sale, assignment, transfer, or disposition of any item of property, plant
or equipment included in the Assets having a value in excess of Twenty-Five Thousand Dollars ($25,000) (other than supplies), except in the ordinary course of business consistent with past practices; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(e) </I></B>general increases in the compensation payable by Sellers to any of their employees or independent contractors outside of the
ordinary course of business, or any increase in, or institution of, any bonus, insurance, pension, profit-sharing or other employee benefit plan, remuneration or arrangements made to, for or with such employees; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(f) </I></B>adoption, modification, or termination of any employment, severance, retention, or other agreement with any current or
former employee, officer, director, independent contractor, or consultant of Sellers with respect to the Facilities that increase the costs to operate the Facilities or perform under the Contracts in any material respect; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(g) </I></B>changes in the composition of the medical staff of the Facilities outside the ordinary course of business; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(h) </I></B>loan to (or forgiveness of any loan to), or entry into any other transaction with, any current or former directors,
officers, or employees of Sellers or the Partial Subsidiaries with respect to the Facilities; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(i) </I></B>material adjustments or
write-offs in accounts receivable or reductions in reserves for accounts receivable outside the ordinary course of business; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(j) </I></B>changes in the accounting methods or practices employed by Sellers or the
Partial Subsidiaries, or changes in depreciation or amortization policies; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(k) </I></B>material transaction pertaining to any of
the Facilities outside the ordinary course of business; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(l) </I></B>adoption of any plan of merger, consolidation, reorganization,
liquidation, or dissolution or filing of a petition in bankruptcy under any provisions of federal or state bankruptcy laws or consent to the filing of any bankruptcy petition against it under any similar law; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(m) </I></B>acceleration, termination, material modification to, or cancellation of any material license or permit; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(n) </I></B>incurrence, assumption or guaranty of any indebtedness for borrowed money in connection with the operation of the Facilities
(other than such indebtedness incurred in the ordinary course as will be repaid in full or released at Closing); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(o)
</I></B>disposition or lapse of any material rights in respect of any Intellectual Property rights owned or licensed by any Seller that were used in the operation of the Facilities as of the Balance Sheet Date; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(p) </I></B>change in its historical practices with respect to purchasing inventory and supplies; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(q) </I></B>reduction in the licensed bed capacity or discontinuation of any clinical services of the Facilities; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(r) </I></B>material Tax election made, revised or rescinded, material Tax liability or Tax refund claim settled or compromised,
material amendment to any Tax Return, or any material position on any Tax Return taken that is inconsistent with past practice, in each case, relating to the Assets, the Facilities or the operation of the Facilities; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(s) </I></B>commitment to make any single capital expenditure in excess of Twenty-Five Thousand Dollars ($25,000) with respect to the
Facilities, or commitment to make aggregate capital expenditures in excess of Two Hundred Fifty Thousand Dollars ($250,000) (on a consolidated basis) with respect to the Facilities, which expenditures, in either case, will not be paid in full prior
to Closing; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(t) </I></B>contract or undertaking to do any of the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.6 </I></B><B><I>Licenses</I></B>. Each Facility is, and for the past five (5)&nbsp;years has been, duly licensed pursuant to the
applicable laws of the State of Florida and is, and has been, at all times during the last five (5)&nbsp;years, in compliance in all material respects with all state and local licensure rules and regulations. The pharmacies, laboratories, and all
other ancillary departments owned or operated by Sellers and located at the Facilities or operated for the benefit of the Facilities which are required to be specially licensed are duly licensed by the appropriate licensing agency (the &#147;State
Health Agency&#148;) and have been, at all times during the last five (5)&nbsp;years, in compliance in all </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
material respects with all legal requirements of the State Health Agency. Sellers and FESC have all material licenses, registrations, permits, and approvals which are needed to operate the
businesses owned or operated by them at the Facilities. Set forth on <U>Schedule 3.6</U> is an accurate and complete list of all such licenses, registrations, permits and approvals owned or held by Sellers or FESC relating to the ownership,
development, or operation of the Facilities or the Assets, all of which are now and as of the Closing shall be in good standing. To the Knowledge of Sellers, no event has occurred and no facts exist with respect to any such license, registration,
permit or approval that would be reasonably likely to result in, after notice or lapse of time or both, the suspension, revocation, termination, or impairment of any such license, registration, permit or approval. Except as set forth on <U>Schedule
3.6</U>, none of Sellers nor the Facilities have received, during the last five (5)&nbsp;years, any written notice from any Government Entity alleging any violation of any license, registration, permit or approval owned or held by any Seller or any
Facility, except to the extent such alleged violation has been corrected to the satisfaction of the applicable Government Entity through the submission by Sellers of plans of correction or similar processes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.7 </I></B><B><I>Medicare Participation/Accreditation</I></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a) </I></B>Each Hospital and free-standing emergency department is qualified for participation in the Medicare, Medicaid and
CHAMPUS/TRICARE programs (collectively, the &#147;Governmental Programs&#148;), is currently enrolled and a participating provider in such programs, has current and valid provider contracts with such programs, is and has been, for the last five
(5)&nbsp;years, in compliance in all material respects with the conditions of participation in such programs, and has received all approvals or qualifications necessary for capital reimbursement for each Hospital. Each Hospital and free-standing
emergency department is duly accredited, with no contingencies (except as set forth on <U>Schedule 3.7(a)</U>), by The Joint Commission. Copies of the most recent accreditation letters and survey reports for the last five (5)&nbsp;years from The
Joint Commission pertaining to each Hospital and free-standing emergency department have been made available to Buyers. During the last five (5)&nbsp;years, all billing practices of Sellers with respect to the Facilities to all third party payors,
including the Governmental Programs and private insurance companies, have been in material compliance with all applicable laws, regulations and policies of such third party payors and Governmental Programs, and neither Sellers nor the Facilities
have billed or received any payment or reimbursement in excess of amounts allowed by law. During the last five (5)&nbsp;years, Sellers have timely filed, submitted, or obtained in the ordinary course of business all material reports, billings, and
documents required to be filed, submitted, or obtained to receive reimbursement from Medicare, Medicaid, or other third-party payment programs, as applicable, for services furnished by the Facilities. Neither Sellers nor the Facilities, or any of
their officers, managers, directors, managing employees, service providers or controlling members or shareholders are excluded from participation in the Governmental Programs, nor to Sellers&#146; knowledge is any such exclusion threatened. Sellers
perform periodic searches of relevant data bases to confirm no such individuals have been excluded from participation in the Governmental Programs. Except as set forth on <U>Schedule 3.7(a)</U>, no Seller or FESC has received any written notice from
any of the Governmental Programs, or any other third party payor programs of any pending or, to Sellers&#146; knowledge, threatened investigations or surveys relating to the Facilities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b) </I></B>The Facilities have registered with the QNet Exchange (&#147;QNet&#148;)
as and to the extent required by The Centers for Medicare and Medicaid Services (&#147;CMS&#148;) under its Hospital Quality Initiative Program (the &#147;HQI Program&#148;). The Facilities have submitted all quality data required under the HQI
Program to CMS or its agent and otherwise complied in all material respects with all requirements of the HQI Program, and have submitted all quality data required under the ORYX Core Measure Performance Measurement System (&#147;ORYX&#148;) to The
Joint Commission, for all calendar quarters concluded during the last five (5)&nbsp;years, except for any quarter for which the respective reporting deadlines have not yet expired. All such submissions of quality data have been made in accordance in
all material respects with applicable reporting deadlines and in the form and manner required by CMS and The Joint Commission, respectively. The Facilities have not received written notice of any reduction in reimbursement under the Medicare program
resulting from their failure to report quality data to CMS or its agent as required under the HQI Program. Sellers have provided Buyers with the HQI Program &#147;validation results&#148; for all calendar quarters concluded during the last five
(5)&nbsp;years, except for any quarter for which the respective reporting deadlines have not yet expired. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c) </I></B>Except as set
forth on <U>Schedule 3.7(c)</U>, no Seller or Facility (i)&nbsp;is a party or subject to a Corporate Integrity Agreement with the Office of Inspector General of the United States Department of Health and Human Services (the &#147;OIG&#148;), (ii)
has any reporting obligations pursuant to any settlement agreement entered into with any Government Entity, (iii)&nbsp;has been, to Sellers&#146; knowledge, within the past five (5)&nbsp;years, the subject of any governmental payer program
investigation conducted by any federal or state enforcement agency, (iv)&nbsp;is not and has not been, within the past five (5)&nbsp;years a defendant in any unsealed qui tam/False Claims Act litigation, (v)&nbsp;during the past five (5)&nbsp;years
has been served with or received any search warrant, subpoena, civil investigative demand, or, to Sellers&#146; knowledge, contact letter or telephone or personal contact by or from any federal, state or local enforcement agency, (vi)&nbsp;to the
knowledge of Sellers, during the past five (5)&nbsp;years, has been the subject of any focused reviews, Zone Program Integrity Contractor audits, RAC audits, Medicaid Integrity Program audits, Comprehensive Error Rate Testing Contractor audits,
Supplemental Medical Review Contractor audits, MAC audits or any other similar audits with respect to any Governmental Program, (vii)&nbsp;during the past five (5)&nbsp;years, has made a filing pursuant to the OIG&#146;s Self Disclosure Protocol or
other voluntary disclosure to the OIG, CMS or other Government Entity, and (viii)&nbsp;has not during the past five (5)&nbsp;years received any written complaints from any employee, independent contractor, vendor, physician or other person or
organization that would indicate (or alleging any such violation) that such Seller has violated in any material respect any healthcare law or regulation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.8 </I></B><B><I>Regulatory Compliance</I></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a) </I></B>Except as set forth on <U>Schedule 3.8</U> hereto, Sellers are, and during the past six (6)&nbsp;years have been, in
compliance in all material respects with all applicable statutes, rules, regulations, and requirements of the Government Entities having jurisdiction over the Facilities and the operations of the Facilities. As used herein, &#147;Government
Entity&#148; means any government or any branch, agency, bureau, board, directorate, commission, court, department, official, political subdivision, tribunal or other instrumentality of any government, whether federal, state or local, or any entity
exercising executive, legislative, judicial, regulatory or administrative functions of or pertaining to government, including any Government Program. Sellers and the Facilities have timely and accurately filed all reports, data, and other
information required to be filed with the Government Entities. None of Sellers, the Facilities nor any of their employees, officers or directors has committed a violation of federal or state laws regulating fraud, including but not limited to the
federal Anti-Kickback Law, the Stark Law, and the False Claims Act. Sellers&#146; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
contracts with physicians are in compliance in all material respects with all applicable state corporate practice of medicine and <FONT STYLE="white-space:nowrap">fee-splitting</FONT> laws and
regulations. Sellers and the Facilities are, and during the past six (6)&nbsp;years have been, in compliance in all material respects with the Health Insurance Portability and Accountability Act of 1996, as amended by Subtitle D of the Health
Information Technology for Economic and Clinical Health Act of 2009, and any regulations promulgated thereunder, as each may be amended from time to time (&#147;HIPAA&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b) </I></B>Neither any Seller nor any employee, agent or contractor of a Seller in their capacity as such or otherwise relating to a
Seller or the Facilities, has offered, paid, solicited or received any remuneration, kickback, bribe or rebate to or from any person in exchange for business or payments from or to any such person in violation of applicable law. All contracts or
other formal or informal arrangements, including the terms, methodology, amount and payment of any compensation, benefits or other remuneration provided, paid or made available thereto (directly or indirectly), between a Seller and any referral
source or other person in a position to make or influence referrals or to otherwise generate business for any Seller, is and has been in compliance in all material respects with applicable health care laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c) </I></B>An Affiliate of Sellers has received written confirmation from the OIG with respect to that certain Corporate Integrity
Agreement dated July&nbsp;28, 2014, between the OIG and Community Health Systems, Inc., as amended and extended effective September&nbsp;21, 2018, acknowledging that such Corporate Integrity Agreement is no longer in force or effect and which
Corporate Integrity Agreement continues to no longer be in force or effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.9 </I></B><B><I>Equipment</I></B>. Sellers have
delivered to Buyers a schedule as of the Balance Sheet Date which includes and takes into consideration all the material equipment associated with, or constituting any part of, the Facilities and the Assets. Since March&nbsp;15, 2023, Sellers have
not moved any material fixed assets that were in use at the Facilities off of the premises of the Facilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.10
</I></B><B><I>Real Property</I></B>. Sellers own good and indefeasible fee simple and/or good and valid leasehold title, as the case may be, to the Real Property. The Real Property will be conveyed to Buyers free and clear of any and all Liens
except (i)&nbsp;any lien for ad valorem and <FONT STYLE="white-space:nowrap">non-ad</FONT> valorem property taxes not yet due and payable, (ii)&nbsp;any lease obligations under the Contracts assumed by Buyers, (iii)&nbsp;easements, restrictions and
other matters of record, so long as such matters do not, collectively or individually, materially interfere with the operations of the Hospitals and other Facilities in a manner consistent with the current use, (iv)&nbsp;zoning regulations and other
governmental laws, rules, regulations, codes, orders and directives affecting the Real Property, (v)&nbsp;unrecorded easements, discrepancies, boundary line disputes, overlaps, encroachments and other matters that would be revealed by an accurate
survey or inspection of the Real Property, so long as such matters do not, collectively or individually, materially interfere with the operations of the Hospitals and other Facilities in a manner consistent with the current use, (vi)&nbsp;any
encumbrances or defects that do not materially interfere with the operations of the Hospitals and other Facilities in a manner consistent with the current use, (vii)&nbsp;any Liens arising under the Contracts assumed by Buyers, and (viii)&nbsp;with
respect to the Leased Real Property, any encumbrances which encumber the fee interest in such property (collectively, the &#147;Permitted Encumbrances&#148;). With respect to the Real Property: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a) </I></B>Except as set forth in <U>Schedule 3.10(a)</U>, no Seller has received
during the past five (5)&nbsp;years written notice from any Government Entity of a material violation of any applicable ordinance or other law, rule, code, order, directive or regulation with respect to the Owned Real Property or the Hospital Leased
Real Property, which violation has not been corrected; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b) </I></B>Except as set forth in <U>Schedule 3.10(b)</U>, to the knowledge
of Sellers, the Owned Real Property and its operation are in material compliance with all applicable zoning regulations or ordinances or are considered legally <FONT STYLE="white-space:nowrap">non-conforming</FONT> or &#147;grandfathered&#148;
thereunder; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c) </I></B>There are no tenants or other persons or entities occupying any space in the Real Property, other than
pursuant to tenant leases described in <U>Schedule 3.10(c)</U>, and no tenants have paid rent in advance for more than one month and no improvement credit or other tenant allowance of any nature is owed by Sellers to any tenant pursuant to such
tenant leases, nor is any landlord improvement work required to be completed by Sellers pursuant to such tenant leases, and, to the knowledge of Sellers, no tenant is in material default under such tenant leases, except as disclosed in <U>Schedule
3.10(c)</U>; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d) </I></B>Attached to <U>Schedule 3.10(d)</U> is a &#147;rent roll&#148; which sets forth for those leases where a
Seller is landlord (i)&nbsp;the names of then current tenants, (ii)&nbsp;the rental payments for the then current month under each of the leases, and (iii)&nbsp;the security deposits held by Sellers for each tenant listed on the rent roll; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(e) </I></B>Except as set forth on <U>Schedule 3.10(e),</U> no Seller has received during the past five (5)&nbsp;years any written
notice from any Government Entity of any (i)&nbsp;existing, proposed or contemplated plans to modify or realign any street or highway or any existing, proposed or contemplated eminent domain proceeding that would result in the taking of all or any
part of the Owned Real Property or the Hospital Leased Real Property or that would materially and adversely affect the current use of any part of the Owned Real Property or the Hospital Leased Real Property, (ii)&nbsp;public improvements that are
required to be made and which have not heretofore been assessed against the Owned Real Property or the Hospital Leased Real Property, or (iii)&nbsp;pending or threatened special, general or other assessments against or affecting any of the Owned
Real Property or Hospital Leased Real Property (other than municipal or county-wide assessments in the ordinary course) which have not heretofore been assessed; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(f) </I></B>Except as set forth on <U>Schedule 3.10(f)</U>, all permanent certificates of occupancy and all other material licenses,
permits, authorizations, consents, certificates and approvals required by all Governmental Entities having jurisdiction for the current use of the Owned Real Property have been issued for the Owned Real Property, have been paid for and are in full
force and effect; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(g) </I></B><U>Schedule 3.10(g)</U> sets forth an accurate and complete list of all written and oral leases,
subleases, licenses or other rental agreements that grant or will grant to any Seller as lessee, sublessee or licensee thereunder a possessory interest in and to any space in the Leased Real Property necessary for the operation of the Facilities as
currently conducted, including any ground leases and any leases for parking (collectively, the &#147;Operating Leases&#148;). Sellers have delivered or otherwise made available to Buyers materially complete, correct and current copies
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of all Operating Leases. Except as set forth on <U>Schedule 3.10(g)</U>, there are no Seller Guaranties with respect to the Operating Leases and the Operating Leases are assignable by the
applicable Seller to the applicable Buyer, subject to obtaining any required consents to such assignment. The Operating Leases have not been modified, amended or assigned by Sellers, except as set forth on <U>Schedule 3.10(g)</U>, are legally valid,
binding and enforceable against the applicable Seller and, to Sellers&#146; knowledge, all other parties thereto in accordance with their respective terms and are in full force and effect. Except as set forth on <U>Schedule 3.10(g)</U>, there are no
material defaults by Sellers or, to Sellers&#146; knowledge, any other party under any of the Operating Leases, and, to the knowledge of Sellers, no event has occurred which with the giving of notice or passage of time, or both, would constitute a
material default under any of the Operating Leases; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(h) </I></B>Except as set forth on <U>Schedule 3.10(h)</U>, no Seller is a
party to or subject to any Tax abatement agreement relating to the Owned Real Property nor are there any outstanding waivers or agreements extending the statute of limitations for any period with respect to any Tax to which the Owned Real Property
may be subject following the Closing; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(i) </I></B>To Sellers&#146; knowledge, Sellers have made available to Buyers true and
materially complete copies of all written title reports, land surveys, title policies and environmental or geotechnical assessments in the possession of Sellers or their Affiliates that were created or conducted by third parties within the past five
(5)&nbsp;years relating to the Owned Real Property or the Hospital Leased Real Property; provided, however, that Sellers have not made and are not making any representations or warranties relating to such items, and Buyers utilize such items at
their own risk; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(j) </I></B>The Real Property comprises all of the real property owned or leased or otherwise used or occupied
by Sellers that is associated with or employed in the operation of the Facilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.11 </I></B><B><I>Title to Other
Assets</I></B>. As of the Closing, Sellers shall own and hold good and valid title or leasehold interests, as the case may be, to all of the tangible Assets other than the Real Property, and at the Closing Sellers will assign and convey to Buyers
such title or leasehold interests, as the case may be, to all of such Assets, subject only to the Permitted Encumbrances and the Assumed Liabilities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.12 </I></B><B><I>Employee Benefit Plans</I></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a) </I></B><U>Schedule 3.12</U> sets forth a true, complete and correct list of all &#147;employee benefit plans,&#148; as defined in
Section&nbsp;3(3) of the Employee Retirement Income Security Act of 1974, as amended (&#147;ERISA&#148;), all specified fringe benefit plans as defined in Section&nbsp;6039D of the Internal Revenue Code of 1986, as amended (the &#147;Code&#148;),
and all other bonus, incentive compensation, deferred compensation, profit sharing, stock option, severance, supplemental unemployment, layoff, salary continuation, retirement, pension, health, life insurance, disability, group insurance, vacation,
holiday, sick leave, welfare plan or employment, change in control, confidentiality or <FONT STYLE="white-space:nowrap">non-competition</FONT> agreement or any other similar plan, agreement, policy or understanding (whether oral or written,
qualified or <FONT STYLE="white-space:nowrap">non-qualified)</FONT> and any trust, escrow or other funding arrangement related thereto (collectively, the &#147;Benefit Plans&#148;), which is currently or has been sponsored, maintained or contributed
to for or on behalf of the employees, former employees, independent contractors or directors (or any of their dependents) of Sellers or pursuant to which Sellers have any liability or obligation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b) </I></B>To Sellers&#146; knowledge, (i)&nbsp;each of the Benefit Plans is and has
been maintained and administered in all material respects in compliance with its terms and applicable legal requirements (including ERISA), (ii) there have been no prohibited transactions, breaches of fiduciary duty or other breaches or violations
of any law applicable to the Benefit Plans that could subject Buyers to any liability, (iii)&nbsp;each Benefit Plan intended to be qualified under Section&nbsp;401(a) of the Code has a current favorable determination letter (or, in the case of a
master and prototype or regional prototype plan, a favorable opinion or notification letter, as applicable) or an application therefore is pending with the IRS, (iv)&nbsp;no event has occurred which could cause any of the Benefit Plans to become
disqualified or fail to comply with the applicable requirements of Section&nbsp;401(a) of the Code, or that would otherwise cause a distribution therefrom that is otherwise eligible for rollover treatment under Section&nbsp;408 of the Code to be
ineligible to be rolled into an individual retirement account or a plan that is qualified under Section&nbsp;401(a) of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c) </I></B>Except as set forth on <U>Schedule 3.12</U>, for the past six (6)&nbsp;years, no Seller nor any ERISA Affiliate of Sellers
or Sellers&#146; sponsors, has maintained, contributed to, or been required to contribute to an employee benefit plan that is (i)&nbsp;a &#147;multiemployer plan,&#148; as such term is defined in Section&nbsp;3(37) of ERISA, (ii)&nbsp;subject to
Title IV of ERISA, Sections 302 or 303 of ERISA or Sections 412 or 436 of the Code, or (iii)&nbsp;a multiple employer plan as defined in Section&nbsp;413(c) of the Code. ERISA Affiliate shall mean any entity that would be treated as a single
employer with Sellers or any of their subsidiaries under the provisions of the Code and ERISA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d) </I></B>None of the Benefit
Plans listed on <U>Schedule 3.12</U> that are &#147;welfare benefit plans,&#148; within the meaning of Section&nbsp;3(1) of ERISA, provide for continuing benefits or coverage after termination or retirement from employment, except for COBRA rights
under a &#147;group health plan&#148; as defined in Section&nbsp;4980B(g) of the Code and Section&nbsp;607 of ERISA. The consummation of the transactions contemplated hereby will not (i)&nbsp;result in an increase in or accelerate the vesting of any
of the benefits available under any benefit plan, or (ii)&nbsp;otherwise entitle any employee to severance pay or any other payment from Sellers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.13 </I></B><B><I>Litigation or Proceedings</I></B>. Sellers have delivered to Buyers an accurate list and summary description (which
is set forth as <U>Schedule 3.13</U>) of all currently pending litigation or legal proceedings with respect to the Sellers, Facilities and the Assets. Except to the extent set forth on <U>Schedule 3.13</U>, there are no claims, actions, suits,
proceedings, or investigations pending, or to the knowledge of Sellers, threatened, against Sellers, the Facilities or the Assets (or against Sellers or any of their other Affiliates and relating, in whole or in part, to the Facilities or the
Assets) at law or in equity, or before or by any federal, state, municipal, or other governmental department, commission, board, bureau, agency, or instrumentality wherever located. There are no judgments, orders, decrees, citations, fines or
penalties heretofore assessed against Sellers or their Affiliates affecting the Assets, the Facilities or the Assumed Liabilities under any federal, state or local law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.14 </I></B><B><I>Environmental Laws</I></B>. Except as set forth on <U>Schedule
3.14</U> hereto, (i)&nbsp;to the knowledge of Sellers, neither the Owned Real Property nor the Hospital Leased Real Property are subject to any material environmental hazards, risks or liabilities, (ii)&nbsp;Sellers and, to the knowledge of Sellers,
the Facilities are not in violation of any federal, state or local statutes, regulations, laws or orders pertaining to the protection of the environment (collectively, &#147;Environmental Laws&#148;), including, without limitation, the Comprehensive
Environmental Response Compensation and Liability Act, as amended (&#147;CERCLA&#148;), and the Resource Conservation and Recovery Act, as amended (&#147;RCRA&#148;), and (iii)&nbsp;no Seller has received any written notice alleging or asserting
either a violation of any Environmental Law or an obligation to investigate, assess, remove, or remediate the Owned Real Property or the Hospital Leased Real Property, under or pursuant to any Environmental Law. No &#147;Hazardous Substances&#148;
(which for purposes of this <U>Section</U><U></U><U>&nbsp;3.14</U> shall mean and include polychlorinated biphenyls, asbestos, and any substances, materials, constituents, wastes, or other elements which are included under or regulated by any
Environmental Law, including, without limitation, CERCLA and RCRA) have been disposed of on or released or discharged from or onto, or threatened to be released from or onto, the Owned Real Property or the Hospital Leased Real Property (including
groundwater) by Sellers, or to Sellers&#146; knowledge, any third party, in violation of or which could result in liability under any applicable Environmental Law. No Seller, nor to Sellers&#146; knowledge, any prior owners, operators or occupants
of the Owned Real Property or the Hospital Leased Real Property, have allowed any Hazardous Substances to be discharged, possessed, managed, processed, released, or otherwise handled on the Owned Real Property or the Hospital Leased Real Property in
a manner which is in violation of or which could give liability under any Environmental Law, and Sellers have complied with all Environmental Laws applicable to any part of the Owned Real Property or the Hospital Leased Real Property.
Notwithstanding anything contained herein to the contrary, this <U>Section</U><U></U><U>&nbsp;3.14</U> contains the exclusive representations and warranties of Sellers with respect to environmental matters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.15 </I></B><B><I>Taxes</I></B>. Except as set forth on <U>Schedule 3.15</U>, each Seller and FESC has timely filed all federal, state
and local Tax Returns required to be filed by it (all of which are true, correct and complete in all material respects) and has duly paid or made provision for the payment of all Taxes (including any interest or penalties and amounts due state
unemployment authorities) which are owed by it (whether or not shown on any Tax Return) to the appropriate tax authorities. Except as set forth on <U>Schedule 3.15</U>, no Seller or FESC is the beneficiary of any extension of time within which to
file a Tax Return. Except as set forth on <U>Schedule 3.15</U>, no deficiencies for any of such Taxes have been asserted or to the knowledge of Sellers, threatened, and no audit or other administrative proceeding or court proceeding with respect to
Taxes is currently pending or under way or to the knowledge of Sellers, threatened. Except as set forth on <U>Schedule 3.15</U>, there are no outstanding agreements by any Seller or FESC for the extension of time for the assessment of, or waiver of
statutes of limitations with respect to, any Taxes. There are no tax liens on any of the Assets or any assets of FESC and no basis exists for the imposition of any such liens. No claim has ever been made by an authority in a jurisdiction where any
Seller or FESC does not file Tax Returns that it is or may be subject to taxation by that jurisdiction. There is no dispute or claim concerning any Tax liability of any Seller or FESC either (a)&nbsp;claimed or raised by a tax authority in writing
or (b)&nbsp;as to which any of the directors, managers and officers of any Seller, as applicable, has knowledge. Each Seller and FESC has withheld or collected and paid to the proper Government Entity or other person all Taxes required to be
withheld, collected, or paid by it and has complied, in all material respects, with all informational reporting and other legal requirements related to such withholding or collection obligations. No Seller or FESC is a party to any Tax sharing, Tax
allocation or similar agreement entered into for the principal purpose of apportioning or allocating Tax liabilities between the parties thereto (excluding, for the avoidance of doubt, Tax indemnities in real estate leases, employment agreements,
loan agreements or other agreements </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the primary subject matter of which is not Taxes). No Seller or Partial Subsidiary has participated in any &#147;reportable transaction&#148; as defined in Treasury Regulation <FONT
STYLE="white-space:nowrap">Section&nbsp;1.6011-4(b).</FONT> Sellers have made available to Buyers copies of all federal, state, local and foreign income, franchise and similar Tax Returns, examination reports, and statements of deficiencies assessed
against, or agreed to by, each Partial Subsidiary for all Tax periods ending after December&nbsp;31, 2018. Except as set forth on <U>Schedule 3.15</U>, no private letter rulings, technical advice memoranda or similar agreement or rulings have been
requested, entered into or issued by any taxing authority with respect to any Seller or FESC within the past six (6)&nbsp;years. FESC has not been a member of an affiliated, combined, consolidated or unitary Tax group for Tax purposes. No Seller or
FESC has liability for Taxes of any person under Treasury Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.1502-6</FONT> (or any corresponding provision of state, local or foreign Law), as transferee or successor, by contract or
otherwise. FESC will not be required to include any item of income in, or exclude any item or deduction from, taxable income for any taxable period or portion thereof ending after the Closing Date as a result of: (i)&nbsp;any change in a method of
accounting under Section&nbsp;481 of the Code (or any comparable provision of state, local or foreign Tax laws), or use of an improper method of accounting, for a taxable period ending on or prior to the Closing Date; (ii)&nbsp;an installment sale
or open transaction occurring on or prior to the Closing Date; (iii)&nbsp;a prepaid amount received on or before the Closing Date; (iv)&nbsp;any closing agreement under Section&nbsp;7121 of the Code, or similar provision of state, local or foreign
law; or (v)&nbsp;any election under Section&nbsp;108(i) of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As used herein, &#147;Tax&#148; or &#147;Taxes&#148; means any
federal, state, local or foreign income, gross receipts, license, payroll, employment, excise, severance, stamp, occupation, premium, windfall profits, environmental (including taxes under Code &#167; 59A), customs duties, capital stock, franchise,
profits, withholding, social security (or similar), unemployment, disability, real property, personal property, sales, use, transfer, registration, value added, alternative or <FONT STYLE="white-space:nowrap">add-on</FONT> minimum, estimated, or
other tax of any kind whatsoever, whether computed on a separate or consolidated, unitary or combined basis or in any other manner, relating to the Assets or assets of FESC, the Facilities or the operation of the Facilities, including any interest,
penalty or addition thereto, whether disputed or not and including any obligation to indemnify or otherwise assume or succeed to the Tax liability of any other person. &#147;Tax Return&#148; means any return, declaration, report, claim for refund,
or information return or statement relating to Taxes, including any schedule or attachment thereto, and including any amendment thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.16 </I></B><B><I>Employee Relations</I></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a) </I></B>Except as set forth on <U>Schedule 3.16(a)</U>, all employees of the Facilities are employees of Sellers. Except as set
forth on <U>Schedule 3.16(a)</U>, during the past three (3)&nbsp;years, each individual performing services for any of the Facilities who has been classified as an independent contractor or as any other
<FONT STYLE="white-space:nowrap">non-employee</FONT> category has been correctly so classified, and neither Sellers nor any of the Facilities have received, in writing, a claim or threatened claim that an employer-employee relationship exists as to
any such individual. There is no actual, and to Sellers&#146; knowledge, there is no threatened employee strike, work stoppage, or labor dispute pertaining to the Facilities. Except as set forth on <U>Schedule 3.16(a)</U>, no employees of any of the
Facilities are represented by a labor union with respect to their employment with the Facilities and no union representation question exists respecting any employees of Sellers. No collective bargaining agreement exists or is currently being
negotiated by Sellers, no written demand has been received for recognition by a labor organization by or with respect to any employees of Sellers, no union </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
organizing activities by or with respect to any employees of Sellers are, to the knowledge of Sellers, taking place, and none of the employees of Sellers or the Facilities is represented by any
labor union or organization. There is no pending or threatened (in writing) unfair practice claim against Sellers before the National Labor Relations Board, nor any strike, dispute, slowdown, or stoppage pending or threatened against or involving
the Facilities, and none has occurred within the last three (3)&nbsp;years. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b) </I></B>Except as set forth in <U>Schedule
3.16(b)</U>, Sellers are, and for the past three (3)&nbsp;years have been, in compliance in all material respects with all legal requirements relating to employment, employment practices, terms and conditions of employment, equal employment
opportunity, nondiscrimination, immigration, wages, hours, benefits, payment of employment, social security, and similar taxes, occupational safety and health, and plant closing. Each current employee of Sellers and the Facilities, and each employee
terminated within the past three (3)&nbsp;years, has completed, and Sellers have retained, an Immigration and Naturalization Service Form <FONT STYLE="white-space:nowrap">I-9,</FONT> to the extent required by applicable rules and regulations. No
Seller is liable for the payment of any compensation, damages, taxes, fines, penalties, interest, or other amounts, however designated, for failure to comply with any of the foregoing legal requirements. Except as set forth on <U>Schedule
3.16(b)</U>, there are no pending or, to the knowledge of Sellers, threatened claims before the Wage and Hour Division of the U.S. Department of Labor, the Office of Federal Contract Compliance Programs or Equal Employment Opportunity Commission (or
any comparable state civil or human rights commission or other entity), complaints before the Occupational Safety and Health Administration (or any comparable state safety or health administration or other entity), with respect to wage and hour
claims, or the like. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c) </I></B><U>Schedule 3.16(c)</U> states or will state the number of employees terminated by each Seller
within ninety (90)&nbsp;days prior to the Closing Date, laid off by each Seller within the six (6)&nbsp;months prior to the Closing Date, or whose hours of work have been reduced by more than fifty percent (50%) by a Seller in the six
(6)&nbsp;months prior to the Closing Date, and contains a complete and accurate list of the following information for each such employee: (i)&nbsp;the date of termination, layoff, or reduction in work hours; (ii)&nbsp;the reason for termination,
layoff, or reduction in work hours; and (iii)&nbsp;the location to which the employee was assigned. In relation to the foregoing, except as set forth in <U>Schedule 3.16(c)</U>, no Seller has violated the Worker Adjustment and Retraining
Notification Act (the &#147;WARN Act&#148;) or any similar state or local legal requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d) </I></B>All necessary visa or
work authorization petitions required to be filed by Sellers have been timely and properly filed on behalf of any employees of any Facility requiring a visa stamp, <FONT STYLE="white-space:nowrap">I-9</FONT> status document, employment authorization
document, or any other immigration document to legally work for the Facilities in the United States and all paperwork retention requirements with respect to such applications and petitions have been met. No current employee of any Seller has ever
worked for such Seller without employment authorization from the Department of Homeland Security or any other government agency that must authorize such employment. <FONT STYLE="white-space:nowrap">I-9</FONT> Forms have been timely and properly
completed by Sellers for all current employees of the Facilities. <FONT STYLE="white-space:nowrap">I-9</FONT> Forms have been lawfully retained and <FONT STYLE="white-space:nowrap">re-verified</FONT> by Sellers. Except as set forth on <U>Schedule
3.16(d)</U>, there are no claims, lawsuits, actions, arbitrations, administrative or other proceedings, or to Sellers&#146; knowledge, governmental investigations or inquiries pending or threatened against any Seller relating to Sellers&#146; or the
Facilities&#146; compliance with immigration laws. Except as set forth on <U>Schedule 3.16(d)</U>, there have been no letters received by any Seller from the Social Security Administration (&#147;SSA&#148;) regarding the failure of such Facility
employee&#146;s Social Security number to match their name in the SSA database. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(e) </I></B>Except as set forth on <U>Schedule 3.16(e)</U>, no key employee (i.e., the
CEO, COO, CFO or CNO) of Sellers or the Facilities has given written notice to any Seller that any such employee intends to terminate his or her employment with the Facilities. Except as set forth on <U>Schedule 3.16(e)</U>, no employed physician
nor group of employed physicians of the Facilities has given written notice to any Seller that any such employee or group intends to terminate his, her or their employment with any Facility. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.17 </I></B><B><I>The Contracts</I></B>. Sellers have made available to Buyers true, correct and materially complete copies of the
Contracts other than the Immaterial Contracts (the &#147;Material Contracts&#148;), and have given, and will give, the agents, employees and representatives of Buyers access to the originals of the Contracts to the extent originals are available.
&#147;Immaterial Contracts&#148; are commitments, contracts, leases and agreements which individually involve future payments to or by any Seller of any amount or value less than Fifty Thousand Dollars ($50,000) on an annual basis, and that are not
with physicians or other referral sources. Sellers represent and warrant with respect to the Contracts that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a) </I></B>The
Material Contracts constitute legal, valid and binding obligations of Sellers and, to the knowledge of Sellers, the other parties with respect thereto, and are enforceable against Sellers and, to the knowledge of Sellers, the other parties with
respect thereto in accordance with their terms; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b) </I></B>Each Material Contract constitutes the entire agreement by and between
the respective parties thereto with respect to the subject matter thereof; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c) </I></B>Assuming the receipt of any consents
required in connection with the assignment of the Contracts identified on <U>Schedule 1.1(g)</U>, all obligations required to be performed by Sellers and, to the knowledge of Sellers, the other parties with respect thereto under the terms of the
Contracts have been performed in all material respects to the extent such obligations to perform have accrued, and no acts or omissions by Sellers or, to the knowledge of Sellers, the other parties with respect thereto have occurred or failed to
occur which, with the giving of notice, the lapse of time or both would constitute a default by Sellers or, to the knowledge of Sellers, the other parties with respect thereto under the Material Contracts; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d) </I></B>Except as expressly set forth on <U>Schedule 1.1(g)</U>, none of the Material Contracts requires consent to the assignment
and assumption of such Contracts by Buyers, and Sellers will use commercially reasonable efforts to obtain any required consents prior to the Closing; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(e) </I></B>Except as expressly set forth on <U>Schedule 1.1(g)</U>, the assignment of the Material Contracts to and assumption of such
Material Contracts by Buyers will not result in any penalty or premium, or variation of the rights, remedies, benefits or obligations of any party thereunder, or give rise to any early termination right or accelerate any right or remedy thereunder;
and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(f) </I></B>Except as set forth on <U>Schedule 1.1(g)</U>, no Contract is subject to a
Seller Guaranty (as hereafter defined) and a true, correct and materially complete copy of each Seller Guaranty has been provided to Buyers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(g) </I></B><U>Schedule 3.17(g)</U> sets forth a list of each Contract with any physician (as such term is defined in 42 C.F.R. &#167;
411.351), group of physicians, or entity that is owned or controlled by one or more physicians. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.18
</I></B><B><I>Supplies</I></B>. All the inventory and supplies constituting any part of the Assets are substantially of a quality and quantity usable and salable in the ordinary course of business of the Facilities. Obsolete items have been written
off the Financial Statements. Inventory and supplies are carried at the lower of cost or market, on a <FONT STYLE="white-space:nowrap">first-in,</FONT> <FONT STYLE="white-space:nowrap">first-out</FONT> basis and are properly stated in the Financial
Statements. The inventory levels are maintained reasonably consistent with the past practices of Sellers at the Facilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.19
</I></B><B><I>Insurance</I></B>. Sellers maintain insurance policies (or self-insurance) covering the ownership and operation of the Facilities and the Assets with reputable insurers and in reasonable and customary amounts for the industry in which
the Facilities and Assets operate. Sellers have delivered to Buyers an accurate and materially complete schedule (<U>Schedule 3.19</U>) listing the current insurance policies covering the ownership and operations of the Facilities and the Assets,
which <U>Schedule 3.19</U> reflects the policies&#146; numbers, identity of insurers, amounts, and coverage. All of such policies are in full force and effect with no premium arrearage. Sellers have given in a timely manner to their insurers all
notices required to be given under their insurance policies with respect to all of the claims and actions covered by insurance, and no insurer has denied coverage of any such claims or actions. Sellers have not (a)&nbsp;received any written notice
or other communication from any such insurance company canceling or materially amending any of such insurance policies, and, to Sellers&#146; knowledge, no such cancellation or amendment is threatened or (b)&nbsp;failed to give any written notice or
present any claim which is still outstanding under any of such policies with respect to the Facilities or any of the Assets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.20
</I></B><B><I>Third Party Payor Cost Reports</I></B>. Each Seller has duly filed all required cost reports for all the fiscal years through and including the fiscal year specified on <U>Schedule 3.20</U>. All of such cost reports accurately reflect
in all material respects the information required to be included thereon and such cost reports do not claim and neither the Facilities nor Sellers have received reimbursement in any amount in excess of the amounts provided by law or any applicable
agreement. True and materially complete copies of all such cost reports for the three (3)&nbsp;most recent fiscal years of Sellers have been made available to the Buyers. <U>Schedule 3.20</U> indicates which of such cost reports have not been
audited and finally settled and a brief description of any and all notices of program reimbursement, proposed or pending audit adjustments, disallowances, appeals of disallowances, and any and all other unresolved inquiries, claims or disputes in
respect of such cost reports. Sellers have established adequate reserves to cover any potential reimbursement liabilities that Sellers may have under such cost reports and such reserves are set forth in Sellers&#146; Financial Statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.21 </I></B><B><I>Medical Staff Matters</I></B>. Sellers have provided to Buyers
true, correct, and complete copies of the bylaws and rules and regulations of the medical staff of the Hospitals (including free-standing emergency departments), as well as a list of all current members of the medical staffs of the Hospitals
(including free-standing emergency departments). Except as set forth on <U>Schedule 3.21</U> hereto, (i)&nbsp;there are no adverse actions with respect to any medical staff members or any applicant thereto for which a medical staff member or
applicant has requested a judicial review hearing which has not been scheduled or has been scheduled but has not been completed; (ii)&nbsp;there are no pending or, to the knowledge of Sellers, threatened disputes with applicants, staff members, or
health professional affiliates; and (iii)&nbsp;all appeal periods in respect of any medical staff member or applicant against whom an adverse action has been taken have expired. Except as set forth on <U>Schedule 3.21</U>, no medical staff members
of any of the Facilities have (i)&nbsp;resigned or had their privileges revoked or suspended since the Balance Sheet Date, or (ii)&nbsp;been excluded from participation in any &#147;federal health care program&#148; as defined in 42 U.S.C. <FONT
STYLE="white-space:nowrap">&#167;1320a-7b(f)</FONT> (including Medicare, state Medicaid programs, state CHIP programs, TRICARE and similar or successor programs with or for the benefit of any Government Entity) or any other state payment or
reimbursement programs that are under the authority of any state Government Entity, or, to Sellers&#146; knowledge, is under investigation that may result in any exclusion from such participation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.22 </I></B><B><I>Condition of Assets</I></B>. The Assets and the Excluded Assets constitute all assets that are held or used by
Sellers and, except for the computer systems and other property that are located in the offices of CHS and certain of its Affiliates (other than Sellers) and used to provide certain back-office and administrative services for the Facilities,
necessary for the conduct of the business and operation of the Facilities in substantially the same manner as currently conducted. Other than with respect to the representations and warranties provided in this Agreement (and the Deeds delivered in
connection with Closing), Sellers shall transfer the Assets to Buyers and Buyers shall accept the Assets from Sellers AS IS WITH NO WARRANTY OF HABITABILITY OR FITNESS FOR HABITATION, WITH RESPECT TO THE LAND, BUILDINGS AND IMPROVEMENTS, AND WITH NO
WARRANTIES, INCLUDING WITHOUT LIMITATION, THE WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, WITH RESPECT TO THE EQUIPMENT, INVENTORY, AND SUPPLIES, AND ANY AND ALL OF WHICH WARRANTIES SELLERS HEREBY DISCLAIM. All of the Assets
shall be further subject to normal wear and tear on the land, buildings, improvements and equipment and normal and customary use and disposal of inventory and supplies in the ordinary course of business up to the Closing Date. Sellers further
explicitly do not represent that the Facilities are in compliance with the Americans with Disabilities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.23
</I></B><B><I>Experimental Procedures.</I></B> Sellers have not performed or permitted the performance of any experimental or research procedures or studies involving patients of the Facilities not authorized and conducted in accordance with the
procedures of the Institutional Review Board of the relevant Facility. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.24 </I></B><B><I>Intellectual Property</I></B>.
<U>Schedule 3.24</U> lists all (a)&nbsp;registered and material <FONT STYLE="white-space:nowrap">non-registered</FONT> trademarks, service marks and trade names, (b)&nbsp;domain names and social media websites and accounts, and (c)&nbsp;registered
copyrights and applications therefor, currently owned by Sellers and used in connection with the Facilities, except for the Excluded Assets (collectively, the &#147;Intellectual Property&#148;). Except as set forth on <U>Schedule 3.24</U>, (x) no
Seller has received written notice that any proceedings have been instituted or are pending which challenge the validity of the ownership by Sellers of the Intellectual Property, (y)&nbsp;no Seller has licensed anyone to use the Intellectual
Property and Sellers have no knowledge of the use or the infringement of the Intellectual Property by any other person, and (z)&nbsp;to the knowledge of Sellers, Sellers own (or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
possess enforceable licenses or other rights to use) all the Intellectual Property. To Sellers&#146; knowledge, none of Sellers, the Assets, and the operation of the Facilities has infringed,
misappropriated, or violated, or is infringing, misappropriating, or violating any intellectual property of any third party. During the last five (5)&nbsp;years, no claim or other proceeding has been made, is pending or, to the knowledge of Sellers,
threatened, against any Seller, alleging any infringement, misappropriation, or violation of any intellectual property of any third party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.25 </I></B><B><I>Compliance Program</I></B>. Sellers and the Facilities maintain and adhere to, in all material respects, a written
compliance program in compliance with all healthcare laws and ethical standards applicable to the Facilities, and appropriate employee training and education programs are in place consistent with compliance program guidelines. Sellers have made
available to Buyers a summary description of Sellers&#146; current compliance program and related materials. Sellers and the Facilities have conducted their operations in all material respects in accordance with their respective compliance programs.
<U>Schedule 3.25</U> includes a description of each open complaint submitted using the compliance &#147;hotline&#148;, material audit and investigation conducted by any Seller relating to any of the Facilities pursuant to their respective compliance
programs during the last three (3)&nbsp;years as well as a description of each audit and investigation conducted by Sellers pursuant to their compliance programs during the last three (3)&nbsp;years relating to material healthcare regulatory issues
involving Sellers or the Facilities.&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this Agreement, the term &#147;compliance program&#148; refers to provider programs of the type described in the compliance guidance published by the OIG. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.26 </I></B><B><I>Data Handling Matters</I></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a) </I></B>Except as set forth on <U>Schedule 3.26(a)</U>, the Data Handling practices by Sellers and with respect to the Facilities
are, and for the past six (6)&nbsp;years have been, in compliance in all material respects with all applicable Privacy Laws, Privacy Policies, terms of use, and contracts (collectively, &#147;Privacy and Data Handling Requirements&#148;) applicable
to Sellers and the Facilities and, in the last six (6)&nbsp;years, there have not been any Security Breaches or audits, proceedings or investigations conducted, claims asserted, or written or oral notice or complaint by or from any other Person
(including any Government Entity) regarding the collection or use of or any other Data Handling with respect to any Sensitive Data in connection with the Facilities&#146; business or Sellers&#146; or any of their agents&#146;, business
associates&#146; or subcontractors&#146; compliance with any Privacy and Data Handling Requirements, and to the knowledge of Sellers, no such claim has been threatened. &#147;Data Handling&#148; means, any operation or set of operations which is
performed on data, including Sensitive Data, including the collection, storage, processing, use, transmission, disclosure, securing of, or other activity related to Sensitive Data. &#147;Privacy Laws&#148; means all applicable laws and industry
self-regulatory programs concerning Sensitive Data or any Data Handling, including: HIPAA; state consumer protection, data security, and breach notification laws; the Federal Trade Commission Act; the Telephone Consumer Protection Act and the
Controlling the Assault of <FONT STYLE="white-space:nowrap">Non-Solicited</FONT> Pornography And Marketing Act of 2003 and their state law equivalents; the Fair Credit Reporting Act, and its state law equivalents; the Payment Card Industry Data
Security Standard and related card brand rules (&#147;PCI DSS&#148;); and implementing regulations concerning all such laws. &#147;Privacy Policies&#148; means each then-current external or internal policy, notice and/or statement relating to
Sensitive Data, including those previously or currently published on any of Sellers&#146; websites or mobile applications or otherwise made available by any of Sellers. &#147;Sensitive Data&#148; means: (i)&nbsp;any data that identifies, relates to,
describes, is </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
capable of being associated with, or could be reasonably linked to, alone or in combination with other data, allow the identification of any individual; (ii)&nbsp;any data that is governed,
regulated or protected by one or more Privacy Laws, including &#147;personal information,&#148; &#147;personally identifiable information,&#148; &#147;protected health information&#148;, &#147;personal data,&#148; and similar terms as defined by
Privacy Laws; (iii)&nbsp;information required by any applicable law or industry standard or requirement to be encrypted, masked or otherwise protected from disclosure, including &#147;cardholder data&#148; and &#147;sensitive authentication
data&#148; as defined by the PCI DSS; (iv)&nbsp;government identifiers, such as social security or other tax identification numbers, driver&#146;s license numbers and other government-issued identification numbers; (v)&nbsp;account, credit or debit
card numbers, with or without any required security code, access code, personal identification number or password that would permit access to an individual&#146;s financial account, and account information, including balances and transaction data;
(vi)&nbsp;names, email addresses, passwords, or other credentials for accessing an individual&#146;s account; and (vii)&nbsp;any other sensitive information regarding an individual or their employment, family, health or financial status, such as
salary, benefits, marital status, geo location data, and DNA information. &#147;Security Breach&#148; means any (A) &#147;breach&#148; of &#147;unsecured protected health information&#148; (as such terms are defined by HIPAA); (B) material Security
Incident (as defined by HIPAA); (C) material unauthorized &#147;use&#148; or &#147;disclosure&#148; of &#147;protected health information&#148; (as such terms are defined by HIPAA); or (D) &#147;breach,&#148; &#147;breach of security,&#148;
&#147;breach of system security,&#148; or similar event as defined under an applicable Privacy and Data Handling Requirement, including any such incident that would require a Seller to notify any Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b) </I></B>Sellers and the Facilities maintain policies, procedures and practices governing Sensitive Data and Data Handling that have
been and are commercially reasonable, in compliance in all material respects with all Privacy and Data Handling Requirements, and regularly and consistently followed in all material respects in the conduct of the business of the Facilities, and on
which Sellers conduct training and monitor compliance therewith. All of Sellers&#146; and the Facilities&#146; workforce (as such term is defined in 45 C.F.R. &#167; 160.103) have received training with respect to compliance with HIPAA. To the
knowledge of Sellers, Sensitive Data has been, and is, collected, stored, processed, used, transmitted, disclosed, and otherwise subject to Data Handling by the Facilities as, and have not been, and are not, maintained by the Facilities for longer
than is, required and/or permitted, by applicable laws and contracts or is otherwise reasonable. To the knowledge of Sellers, Sensitive Data is not transmitted or otherwise provided to any other Person by, or on behalf of, Sellers or the Facilities
except by a secure, encrypted means and subject to obligations of confidentiality and a requirement that the recipient treat any such Sensitive Data securely and as required by applicable Privacy and Data Handling Requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c) </I></B>Except as set forth on <U>Schedule 3.26(c)</U>, to the knowledge of Sellers, during the past six (6)&nbsp;years, (i) no
Sensitive Data handled by or on behalf of Sellers or the Facilities has been lost, inappropriately accessed, misappropriated, or misused or in any manner that is in violation of any applicable Privacy and Data Handling Requirement, (ii)&nbsp;there
have been no breaches in the security of any of the computer systems, including the software, firmware, hardware, networks, interfaces, platforms and related systems owned leased or licensed by any Seller, and (iii)&nbsp;there have been no
violations of any Privacy and Data Handling Requirement or other policy or applicable laws, or contracts, regarding Data Handling or Sensitive Data or information used by or on behalf any Seller or Facility. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d) </I></B>To the knowledge of Sellers, Sellers and each subcontractor of Sellers,
have, to the extent required by HIPAA and other applicable Privacy Laws, undertaken surveys, audits, inventories, reviews, analyses and/or risk assessments and addressed any known deficiencies identified thereby and provided training with respect to
compliance with HIPAA to its &#147;workforce&#148; (as defined in HIPAA) for the past six (6)&nbsp;years. Sellers and the Facilities have entered into business associate agreements with all third parties acting as a business associate as defined in
45 C.F.R. &#167; 160.103. Except as set forth on <U>Schedule 3.26(d)</U>, no Seller or Facility has, within the past six (6)&nbsp;years, received notice of any alleged violation of, and, to the Knowledge of Sellers, none of Sellers or the Facilities
is under investigation (other than customary investigations in the ordinary course) by any Government Entity for, a violation of HIPAA or any other Privacy Law, including receiving any notices from the United States Department of Health and Human
Services Office for Civil Rights, FTC or Justice Department relating to any such violations. Sellers have made available to Buyers accurate and materially complete copies of any written complaint(s) delivered to Sellers or the Facilities during the
past six (6)&nbsp;years alleging a violation of HIPAA or other Privacy Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(e) </I></B>The execution, delivery and performance of
this Agreement and the consummation of the transactions contemplated hereby, in each case on the part of Sellers, will not violate any Privacy and Data Handling Requirements or result in or give rise to any right of termination or other right to
impair or limit Sellers&#146; rights to own, use, or disclose any Sensitive Data used in or necessary for the operation of the business of the Facilities as currently conducted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.27 </I></B><B><I>Affiliate Contracts</I></B>. Except as set forth on <U>Schedule </U><U>3.27</U>, there are no Contracts between any
Seller or any Affiliate of any Seller, on the one hand, and any Seller or Partial Subsidiary, on the other hand, related to the Facilities, the Assets or the Assumed Liabilities that are material to any of such Assets or Assumed Liabilities or the
Facilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.28 </I></B><B><I>Partial Subsidiaries</I></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a) </I></B>For purposes of this Agreement, the term &#147;Partial Subsidiary&#148; means any corporation, partnership, limited
liability company or other entity in which any Seller owns or holds common stock, partnership interests, membership interests or other interests amounting to less than one hundred percent (100%) of the total outstanding common stock, partnership
interests, membership or other interests of such entity. &#147;Partial Subsidiaries&#148; means all such persons and entities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b)
</I></B><U>Schedule 3.28</U> sets forth for each Partial Subsidiary: (1)&nbsp;its name and jurisdiction of incorporation, formation or organization; (2)&nbsp;the Ownership Interest held by the appropriate Seller and which will be assigned to the
appropriate Buyer; and (3)&nbsp;its directors and officers, general partners or managers, or other governing body or controlling persons, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c) </I></B>Sellers have delivered to Buyers accurate and complete copies of the organizational documents of each Partial Subsidiary,
including, as applicable, articles of incorporation, articles of organization, declaration, charter, bylaws, operating agreement, partnership agreement, declaration of condominium (including condominium rules), shareholders or membership agreement,
and similar agreements and documents, as amended to date, of each Partial Subsidiary. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d) </I></B>The appropriate Seller (as indicated on <U>Schedule 3.28</U>) has good and
marketable title to the Ownership Interest of the respective Partial Subsidiaries and such Ownership Interests are free and clear of any Liens. Except as set forth on <U>Schedule 3.28</U>, Sellers have the right to (and shall at Closing) sell,
assign, transfer and deliver the same to Buyers, free and clear of all Liens, except those arising under applicable federal or state securities laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(e) </I></B><U>FESC</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><I>(1) </I>FESC is a limited liability company duly organized, validly existing and in active status under the laws of the state of Florida
and has full limited liability power and authority to own, operate or lease the properties and assets now owned, operated or leased by it and to carry on its business as it has been and is currently conducted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><I>(2) </I>Hernando HMA owns of record and beneficially two hundred ninety-five and <FONT STYLE="white-space:nowrap">six-tenths</FONT>
(295.6) units of limited liability company membership interest in FESC (the &#147;Purchased FESC Units&#148;). Upon consummation of the transactions contemplated by this Agreement, Practice Group and Equity Interests Buyer shall own all of the
Purchased FESC Units, free and clear of all Liens. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><I>(3) </I>All of the Purchased FESC Units were issued in compliance with applicable
laws. None of the Purchased FESC Units were issued in violation of any agreement, arrangement or commitment to which any Seller or FESC is a party or is subject to or in violation of any preemptive or similar rights of any person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><I>(4) </I>There are no outstanding or authorized options, warrants, convertible securities or other rights, agreements, arrangements or
commitments of any character relating to the Purchased FESC Units or obligating Hernando HMA to sell any equity in FESC. FESC does not have outstanding or authorized any equity appreciation, phantom unit, profit participation or similar rights.
Except for the FESC LLC Agreement, there are no voting trusts, member agreements, proxies or other agreements or understandings in effect with respect to the voting or transfer of any of the FESC Units. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(f) </I></B><I><U>Association</U></I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><I>(1) </I>Seven Hills Community Medical Center Condominium Association (&#147;Association&#148;) is a not for profit corporation duly
organized, validly existing and in active status under the laws of the State of Florida. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><I>(2) </I>Hernando HMA owns units 102, 104,
105, 106, 107, 200, 201, 203, 205, 207, 302, 306 and 307 (the &#147;Purchased Condominium Units&#148;) in the Seven Hills Community Medical Center, a condominium (the &#147;Condominium&#148;), is duly admitted as a member of Association and is the
holder of the requisite voting percentage interest in Association represented by such units. Upon consummation of the transactions contemplated by this Agreement, Real Estate Buyer shall own all of the Purchased Condominium Units, free and clear of
all Liens except Permitted Encumbrances. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><I>(3) </I>To Seller&#146;s knowledge, except for the articles of incorporation, bylaws,
and declaration of condominium of Association, there are no voting trusts, member agreements, proxies or other agreements or understandings in effect with respect to the voting or transfer of the Purchased Condominium Units. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4. </B><B>REPRESENTATIONS AND WARRANTIES OF BUYER</B><B>S</B>. As of the date hereof, and, when read in light of any Schedules which have been updated in
accordance with the provisions of <U>Section</U><U></U><U>&nbsp;12.1</U> hereof, as of the Closing Date, Buyers jointly and severally represent and warrant to Sellers the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>4.1 </I></B><B><I>Existence and Capacity</I></B>. Each Buyer is a corporation or limited liability company, duly incorporated or
organized, validly existing and in active status under the laws of the State of Florida. Each Buyer has the requisite power and authority to conduct its business as now being conducted. TGH is a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">not-for-profit</FONT></FONT> corporation, duly incorporated, validly existing and in active status under the laws of the State of Florida. TGH has the requisite power and authority to enter into this Agreement, to perform
its obligations hereunder, and to conduct its business as now being conducted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>4.2 </I></B><B><I>Powers; Consents; Absence of
Conflicts with Other Agreements, Etc.</I></B> The execution, delivery, and performance of this Agreement by each Buyer and TGH and all other agreements referenced herein, or ancillary hereto, to which such Buyer or TGH is a party, and the
consummation by each Buyer and TGH of the transactions contemplated by this Agreement and the documents described herein, as applicable: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a) </I></B>are within its corporate or limited liability company powers, are not in contravention of corporate or limited liability
company law or of the terms of its organizational documents, and have been duly authorized by all appropriate corporate or limited liability company action; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b) </I></B>except as contemplated by <U>Sections 6.1</U> and <U>6.2</U>, do not require any approval or consent required to be obtained
by Buyers of, or filing required to be made by Buyers with, any Government Entity bearing on the validity of this Agreement which is required by law or the regulations of any such agency or authority; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c) </I></B>will neither conflict with, nor result in any breach or contravention of, or the creation of any lien, charge or encumbrance
under, any indenture, agreement, lease, instrument or understanding to which it is a party or by which it is bound; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d)
</I></B>will not violate any statute, law, rule, or regulation of any Government Entity to which it may be subject; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(e)
</I></B>will not violate any judgment, decree, writ, or injunction of any court or Government Entity to which it may be subject. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>4.3 </I></B><B><I>Binding Agreement</I></B>. This Agreement and all agreements to which any Buyer or TGH will become a party pursuant
hereto are and will constitute the valid and legally binding obligations of such Buyer or TGH, respectively, and are and will be enforceable against it or them in accordance with the respective terms hereof and thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>4.4 </I></B><B><I>Availability of Funds</I></B>. Buyers have the ability to obtain
funds in cash in amounts equal to the Purchase Price by means of credit facilities or otherwise and will at the Closing have immediately available funds which will be sufficient to enable Buyers to pay the Purchase Price. Buyers have the ability to
assume and perform all duties and obligations under the Hospital Lease, including, without limitation, all indigent care obligations, capital expenditure commitments, and guarantees of performance or financial obligations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5. </B><B>COVENANTS OF SELLERS PRIOR TO CLOSING</B>. Between the date of this Agreement and the Closing (or termination of this Agreement in accordance
with its terms) Sellers, jointly and severally, covenant as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>5.1 </I></B><B><I>Information</I></B>. Sellers shall afford to
the officers and authorized representatives and agents (which shall include accountants, attorneys, bankers, and other consultants) of Buyers full and complete access to and the right to inspect the plants, properties, books, and records of the
Facilities, and will allow Buyers reasonable access to the medical staff and personnel of the Facilities to confirm and establish relationships, and will furnish Buyers with such additional financial and operating data and other information as to
the business and properties of Sellers which pertain to the Facilities or their operations as Buyers may from time to time reasonably request. Buyers&#146; right of access and inspection shall be exercised in such a manner as not to interfere
unreasonably with the operations of the Facilities. Buyers agree that no inspections shall take place and no employees or other personnel of the Facilities shall be contacted by Buyers without Buyers first providing reasonable notice to Sellers and
coordinating such inspection or contact with Sellers. Notwithstanding anything contained herein to the contrary, Buyers may not conduct any invasive environmental, health or safety or property condition investigations of the Real Property,
including, without limitation, any sampling or testing of soils, surface water, groundwater, ambient air, or improvements at, on or under the Real Property, without Sellers&#146; prior written consent (not to be unreasonably withheld, conditioned or
delayed) and the execution of a commercially reasonable right of entry agreement by the appropriate Buyers. Sellers agree that it is reasonable for Buyers to conduct or cause to be conducted property inspections, typical environmental reports for
due diligence to include Phase I reports, and, if recommended by the Phase I reports, and subject to the appropriate Buyers executing a commercially reasonable right of entry agreement with the applicable Seller, Phase II reports, and surveys of the
Owned Real Property and the Material Leased Real Property. Buyers shall repair all damage to the Real Property resulting from Buyers&#146; exercise of their rights under this section or caused by Buyers (or any of their agents, employees,
contractors or representatives) prior to the Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>5.2 </I></B><B><I>Operations</I></B>. Sellers will not engage in any
practice, take any action, or enter into any transaction outside the ordinary course of business. Without limiting the generality of the foregoing, Sellers shall use commercially reasonably efforts to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a) </I></B>conduct the business of the Facilities in compliance in all material respects with all legal requirements; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b) </I></B>preserve in good standing all licenses and permits reasonably necessary to conduct the business of the Facilities; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c) </I></B>carry on their business pertaining to the Facilities in substantially the
same manner as presently conducted and not make any material change in personnel, operations, finance, accounting policies, or real or personal property pertaining to the Facilities; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d) </I></B>maintain the Facilities and all parts thereof in good operating condition, ordinary wear and tear excepted; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(e) </I></B>perform in all material respects all of their obligations under agreements relating to or affecting the Facilities or the
Assets or Assumed Liabilities; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(f) </I></B>pay or otherwise satisfy, as and when due, all liabilities and obligations of Sellers in
respect of the Facilities or the Assets or Assumed Liabilities, in the ordinary course of business; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(g) </I></B>maintain the books
and records pertaining to the Facilities in the ordinary course of business and consistent with past practices; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(h) </I></B>keep in
full force and effect present insurance policies or other comparable insurance pertaining to the Facilities; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(i)
</I></B>maintain and preserve their business organizations intact, retain their present employees at the Facilities and maintain their relationships with physicians, suppliers, customers, and others having business relations with the Facilities.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>5.3 </I></B><B><I>Negative Covenants</I></B>. Sellers shall not, with respect to the business or operation of the Facilities or
otherwise regarding the Assets, without the prior written consent of Buyers: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a) </I></B>amend, modify, terminate or cancel any of
the Contracts, or enter into any material new contract or commitment (including any contract or commitment that requires payments of more than Fifty Thousand Dollars ($50,000) in any year or with a term greater than a year that cannot be terminated
with ninety (90)&nbsp;days or less notice) that is to be assumed by Buyers, except (in each case) as provided herein (including amendments to the Hospital Lease that are required as a condition to Closing as contemplated in
<U>Section</U><U></U><U>&nbsp;7.9</U>) and except for renewals, extensions or replacements (on substantially similar terms) of Contracts in the ordinary course of business; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b) </I></B>increase compensation payable or to become payable or make any bonus payment to or otherwise enter into one or more bonus
agreements with any employee at the Facilities, except in the ordinary course of business in accordance with existing personnel policies; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c) </I></B>acquire (whether by purchase or lease) or sell, assign, lease, or otherwise transfer or dispose of any property, plant, or
equipment except in the normal course of business with comparable replacement thereof when appropriate; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d) </I></B>add, modify,
terminate or not renew any third-party payor agreement with respect to the Facilities, except immaterial amendments or modifications in the ordinary course of business; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(e) </I></B>purchase capital assets or incur costs in respect of <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">construction-in-progress</FONT></FONT> in excess of Two Hundred Fifty Thousand Dollars ($250,000) in the aggregate; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(f) </I></B>with respect to any Partial Subsidiary, change or rescind any Tax election, amend any Tax Return or take any position on any
Tax Return, or take any action, omit to take any action or enter into any other transaction that would have the effect of increasing the Tax liability or reducing any Tax asset of Buyers or a Partial Subsidiary in respect of any Post-Closing Tax
Period; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(g) </I></B>create or assume any new Lien upon the Assets or the Owned Real Property that cannot be removed in connection
with the Closing; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(h) </I></B>change or transfer their ownership in any Partial Subsidiary, cause, implement or permit any
amendments or modifications to any of the organizational documents of any Partial Subsidiary (as described in <U>Section</U><U></U><U>&nbsp;3.28</U>), or otherwise modify their rights or obligations with respect to any Partial Subsidiary; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(i) </I></B>take any material action outside the ordinary course of business of the Facilities, except as may be required in order to
consummate the transactions contemplated by this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>5.4 </I></B><B><I>Governmental Approvals</I></B>. Sellers shall
(i)&nbsp;use commercially reasonable efforts to obtain all governmental approvals (or exemptions therefrom) necessary or required to allow Sellers to perform their obligations under this Agreement; and (ii)&nbsp;assist and cooperate with Buyers and
their representatives and counsel in obtaining all governmental consents, approvals, and licenses which Buyers deem necessary or appropriate and in the preparation of any document or other material which may be required by any Government Entity as a
predicate to or as a result of the transactions contemplated herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>5.5 </I></B><B><I>HSR
Notification</I></B><B><I>s</I></B><B><I>. </I></B>Sellers shall, if and to the extent required by law, file all forms, notifications, reports or other documents required or requested by the Federal Trade Commission (&#147;FTC&#148;) or the United
States Department of Justice (&#147;Justice Department&#148;) under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (&#147;HSR Act&#148;), and all regulations promulgated thereunder, concerning the transactions contemplated hereby, and
during the initial thirty <FONT STYLE="white-space:nowrap">(30)-day</FONT> waiting period specified in the HSR Act (or, in the event of a mutually agreed upon &#147;withdraw and refile,&#148; during the initial thirty
<FONT STYLE="white-space:nowrap">(30)-day</FONT> waiting period triggered by such refiling) shall comply promptly with any requests by the FTC or Justice Department for additional information concerning such transactions, so that the waiting period
will expire as soon as reasonably possible after the execution and delivery of this Agreement. Sellers agree to furnish to Buyers such information concerning Sellers as Buyers need to perform their obligations under
<U>Section</U><U></U><U>&nbsp;6.2</U> of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>5.6 </I></B><B><I>Additional</I></B><B><I> Financial Information</I></B>.
Within thirty (30)&nbsp;days following the end of each calendar month prior to Closing, Sellers shall deliver to Buyers true and complete copies of the unaudited balance sheets and the related unaudited statements of income of, or relating to, each
Seller and FESC for each month then ended, together with a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">year-to-date</FONT></FONT> compilation and the notes, if any, related thereto, which shall have been prepared from and in
accordance with the books and records of Sellers and FESC, and shall fairly present in all material respects the financial position and results of operations of Sellers and of the related Facility and/or FESC, as applicable, as of the date and for
the period indicated. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>5.7 </I></B><B><I><FONT STYLE="white-space:nowrap">No-Shop</FONT> Clause</I></B>.
Sellers agree that, from and after the date of the execution and delivery of this Agreement by Sellers until the termination of this Agreement in accordance with its terms, Sellers will not, and shall cause their Affiliates and any other Person
acting for or on behalf of Sellers or their Affiliates to not, without the prior written consent of Buyers or except as otherwise permitted by this Agreement, whether directly or indirectly: (i)&nbsp;offer for sale or lease or license all or any
material portion of the Assets or any ownership interest in any Partial Subsidiary or any entity owning any of the Assets, (ii)&nbsp;solicit offers to buy any material portion of the Assets or any ownership interest in any Partial Subsidiary or any
entity owning any of the Assets, (iii)&nbsp;initiate, encourage or provide any documents or information to any third party in connection with, discuss or negotiate with any person regarding any inquires, proposals or offers relating to any
disposition of any material portion of the Assets or a merger or consolidation of any Partial Subsidiary or any entity owning any of the Assets, or (iv)&nbsp;enter into any agreement or discussions with any party (other than Buyers) with respect to
the sale, assignment, or other disposition of all or any material portion of the Assets or any ownership interest in any Partial Subsidiary or any entity owning any of the Assets or with respect to a merger or consolidation of any Partial Subsidiary
or any entity owning any of the Assets. Notwithstanding the foregoing, Buyers acknowledge and agree that the foregoing restrictions shall not apply with respect to any negotiations between Sellers and Hernando County, in connection with the
assignment of the Hospital Lease required as a condition to Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>5.8 </I></B><B><I>Efforts to Close</I></B>. Sellers shall use
commercially reasonable efforts to satisfy all of the conditions precedent set forth in <U>Section</U><U></U><U>&nbsp;7</U> to the extent that Sellers&#146; action or inaction can control or influence the satisfaction of such conditions, in a good
faith effort to have Closing occur on or before November&nbsp;30, 2023. Without limiting the generality of the foregoing, Sellers shall use commercially reasonable efforts to facilitate and assist the Spring Hill/Brooksville Hospitals Buyer with
negotiations with respect to the assignment and amendment of the Hospital Lease described in <U>Section</U><U></U><U>&nbsp;8.5</U>. Notwithstanding the foregoing or anything contrary in this Agreement, in no event shall Sellers or any of their
Affiliates be obligated to litigate, pursue or defend against any proceeding (including any temporary restraining order or preliminary injunction) challenging the transactions contemplated by this Agreement as violative of applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>5.9 </I></B><B><I>Tax Returns</I></B><B><I>.</I></B> Sellers shall prepare and file on a timely basis (or seek appropriate extensions as
permitted) all Tax Returns relating to Sellers and the Facilities with respect to all periods or portions thereof ending prior to the Effective Time. Sellers shall pay or cause to be paid when due all Taxes relating to Sellers and the Facilities
with respect to all periods or portions thereof ending prior to the Effective Time, except as included in the Assumed Liabilities or otherwise expressly assumed by Buyers pursuant to this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>5.10 </I></B><B><I>Notification Requirements</I></B>. Sellers shall give prompt written notice to Buyers of (a)&nbsp;any written notice
or other written communication received by any Seller after the date of this Agreement and prior to the Closing which includes any statements or allegations that, if correct, constitute or, with notice or lapse of time or both, would constitute any
breach of a Fundamental Representation of any Seller, (b)&nbsp;any event of which any Seller obtains knowledge that constitutes or that would reasonably be expected to constitute a Material Adverse Effect, or (c)&nbsp;any written notice or other
written communication received by any Seller from any third party alleging that the consent of such third party is or may be required in connection with the parties&#146; consummation of the transactions contemplated by this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>5.11 </I></B><B><I>Estoppels and Contract Consents</I></B>. Sellers shall use
commercially reasonable efforts to obtain, prior to the Closing Date, (a)&nbsp;estoppel letters, in a form reasonably acceptable to Buyers, under those material Operating Leases that are among the Contracts, and (b)&nbsp;consents from third parties
under each Contract which, by the terms of such Contract, requires such consent to convey and assign such Contract to Buyers, in a form reasonably acceptable to Buyers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>5.12 </I></B><B><I>Employee List</I></B>. No later than forty-five (45)&nbsp;days prior to Closing, Sellers shall provide to Buyers a
true, complete and correct list of all individuals who are employees, independent contractors or consultants of Sellers and the Facilities, including any employee who is on a leave of absence of any nature, paid or unpaid, authorized or
unauthorized, setting forth for each individual the following: (i)&nbsp;name; (ii) classification as employee, independent contractor or consultant; (iii)&nbsp;if an employee, the individual&#146;s title or position (including whether full or part
time, and exempt or <FONT STYLE="white-space:nowrap">non-exempt</FONT> status); (iv) hire date; (v)&nbsp;current base compensation rate on an annual, monthly, <FONT STYLE="white-space:nowrap">bi-weekly</FONT> or hourly basis as appropriate to the
individual&#146;s status; (vi)&nbsp;commission, bonus or other incentive-based compensation; (vii)&nbsp;the number of such employee&#146;s accrued vacation, sick leave, PTO, and holiday hours; and (viii)&nbsp;a description of the fringe benefits
provided to each such individual. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>6. </B><B>COVENANTS OF BUYERS PRIOR TO CLOSING</B>. Between the date of this Agreement and the Closing (or
termination of this Agreement in accordance with its terms), Buyers, jointly and severally, covenant as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>6.1
</I></B><B><I>Governmental Approvals</I></B>. Buyers shall (i)&nbsp;use commercially reasonable efforts to obtain all governmental approvals (or exemptions therefrom) necessary or required to allow Buyers to perform their obligations under this
Agreement; and (ii)&nbsp;assist and cooperate with Sellers and their representatives and counsel in obtaining all governmental consents, approvals, and licenses which Sellers deem necessary or appropriate and in the preparation of any document or
other material which may be required by any Government Entity as a predicate to or as a result of the transactions contemplated herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>6.2 </I></B><B><I>HSR Notification</I></B><B><I>s</I></B>. Buyers shall, if and to the extent required by law, file all forms,
notifications, reports or other documents required or requested by the FTC or the Justice Department under the HSR Act, and all regulations promulgated thereunder, concerning the transactions contemplated hereby, and during the initial <FONT
STYLE="white-space:nowrap">30-day</FONT> waiting period specified in the HSR Act (or, in the event of a mutually agreed upon &#147;withdraw and refile,&#148; during the initial <FONT STYLE="white-space:nowrap">30-day</FONT> waiting period and the
second <FONT STYLE="white-space:nowrap">30-day</FONT> waiting period triggered by such refiling) shall comply promptly with any requests by the FTC or Justice Department for additional information concerning such transactions, so that the waiting
period will expire as soon as reasonably possible after the execution and delivery of this Agreement. Buyers agree to furnish to Sellers such information concerning Buyers as Sellers need to perform their obligations under
<U>Section</U><U></U><U>&nbsp;5.5</U> of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>6.3 </I></B><B><I>Title Commitment and Survey</I></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a) </I></B><B><I>Title Commitment</I></B>. Within forty-five (45)&nbsp;days after the date hereof, Buyers shall, at their expense, seek
to obtain a current title commitment with respect to the Owned Real Property and the Hospital Leased Real Property (the &#147;Title Commitment&#148;), from First American Title Insurance Company (the &#147;Title Company&#148;), together with legible
copies of all exceptions to title referenced therein, sufficient for the issuance of an owner&#146;s policy of title insurance for the Owned Real Property and the Hospital Leased Real Property (the &#147;Title Policy&#148;). Buyers shall promptly
upon their receipt provide a copy of the Title Commitment and exception documents to Sellers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b) </I></B><B><I>Survey</I></B>.
Within forty-five (45)&nbsp;days after the date hereof, Buyers may, at their expense, obtain current <FONT STYLE="white-space:nowrap">as-built</FONT> surveys of the Owned Real Property and the Hospital Leased Real Property (the &#147;Surveys&#148;)
or such portions thereof as Buyers elect. Buyers shall promptly upon their receipt furnish a copy of the Surveys to Sellers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c)
</I></B><B><I>Title Defects and Cure</I></B>. The Title Commitment and the Surveys (to the extent obtained by Buyers pursuant to <U>Section</U><U></U><U>&nbsp;6.3(a)</U> and <U>Section</U><U></U><U>&nbsp;6.3(b)</U> above) are collectively referred
to as &#147;Title Evidence&#148;. Buyers shall give notice to Sellers within ten (10)&nbsp;business days after Buyers&#146; receipt of the last of the Title Evidence of any liens, claims, encroachments, exceptions or defects disclosed in the Title
Evidence which do not constitute Permitted Encumbrances (collectively, &#147;Defects&#148;). Sellers, at their cost and expense, shall cure the Defects at or before the Closing or Sellers may elect to not cure the Defects and shall give written
notice to Buyers within ten (10)&nbsp;business days of their receipt of Buyers&#146; notice of the Defects of Sellers&#146; decision whereupon Buyers may waive such Defects and close or may terminate this Agreement, which election shall be made
within ten (10)&nbsp;business days of Buyers&#146; receipt of Sellers&#146; written notice. If Sellers fail to timely give such notice, Sellers shall be deemed to have elected not to cure the Defects, whereupon Buyers may waive such Defects and
close or may terminate this Agreement, which election by Buyers shall be made within ten (10)&nbsp;business days following the expiration of the period during which Sellers could have given notice that Sellers elected not to cure the Defects
pursuant to the foregoing. Upon termination of this Agreement under the terms of this <U>Section</U><U></U><U>&nbsp;6.3(c)</U>, no party to this Agreement shall have any further claims under this Agreement against any other party, except for matters
that expressly survive termination of this Agreement. Any matters shown by the Title Evidence to which Buyers do not object or any Defects which are waived by Buyers as herein provided shall be deemed to be Permitted Encumbrances. Notwithstanding
anything contained in this <U>Section</U><U></U><U>&nbsp;6.3(c)</U> to the contrary, at the Closing, Sellers shall cause all mortgages, deeds of trust, financing statements and other similar liens encumbering Sellers&#146; fee interest in the Owned
Real Property or leasehold interest in the Hospital Leased Real Property, and arising by, through or under Sellers, or any of their Affiliates, to be released (other than liens for ad valorem and <FONT STYLE="white-space:nowrap">non-ad</FONT>
valorem property taxes not yet due and payable and any mechanic&#146;s or materialmen&#146;s liens relating solely to the Assumed Liabilities). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d) Costs</I></B>. <U>Section</U><U></U><U>&nbsp;12.9</U> shall govern which party or parties hereto shall bear the costs and expenses
of the Title Commitment, the Title Policy and the Surveys. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>6.4 </I></B><B><I>Efforts to Close</I></B>. Buyers shall use their reasonable
commercial efforts to satisfy all of the conditions precedent set forth in <U>Section</U><U></U><U>&nbsp;8</U> to the extent that Buyers&#146; action or inaction can control or influence the satisfaction of such conditions, in a good faith effort to
have Closing occur on or before November&nbsp;30, 2023. Notwithstanding the foregoing or anything contrary in this Agreement, in no event shall Buyers or any of their Affiliates be obligated to litigate, pursue or defend against any proceeding
(including any temporary restraining order or preliminary injunction) challenging the transactions contemplated by this Agreement as violative of applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>6.5 </I></B><B><I>Contract Consents</I></B>. Buyers shall cooperate reasonably with Sellers in obtaining consents from third parties
under Contracts requiring consent to assignment; provided, however, in connection with such consents, Buyer shall not be required to acquiesce to amendments to Contracts or other terms that require the payment of additional money or other material
undertakings by Buyers as a condition for such consent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7. </B><B>CONDITIONS PRECEDENT TO OBLIGATIONS OF BUYER</B><B>S</B>. Notwithstanding anything
herein to the contrary, the obligations of Buyers to consummate the transactions described herein are subject to the fulfillment, at or prior to the Closing, of the following conditions precedent unless (but only to the extent) waived in writing by
Buyers at the Closing: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>7.1 </I></B><B><I>Representations/Warranties</I></B><B><I>/Covenants</I></B>. The representations and
warranties of Sellers contained in this Agreement (other than the Fundamental Representations) shall be true and correct when made and, when read in light of any Schedules which have been updated in accordance with the provisions of
<U>Section</U><U></U><U>&nbsp;12.1</U> hereof, as of the Closing Date as though such representations and warranties had been made on and as of such Closing Date (except to the extent such representations and warranties address matters as of
particular dates, in which case, such representations and warranties shall be true and correct in all respects on and as of such dates), except to the extent that the failure of any such representations and warranties to be true and correct would
not, or would not be reasonably likely to, in the aggregate, have a Material Adverse Effect. The representations and warranties of Sellers set forth in <U>Sections 3.1</U>, <U>3.2</U>, <U>3.3</U>, <U>3.7(c)(i)</U>, <U>3.8(c)</U>,<U> 3.10</U> (the
first sentence only), <U>3.11</U> and <U>12.8</U> (the &#147;Fundamental Representations&#148;) shall be true and correct in all respects as of the Closing Date. Each and all of the terms, covenants, and conditions of this Agreement to be complied
with or performed by Sellers at or before the Closing pursuant to the terms hereof shall have been duly complied with and performed in all material respects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>7.2 </I></B><B><I>Governmental Approvals</I></B>. All material consents, authorizations, orders and approvals of (or filings or
registrations with) any Government Entity required in connection with the execution, delivery and performance of this Agreement (including reasonable assurances from AHCA as to the issuance of hospital licenses with respect to the Hospitals
post-Closing but effective as of the Effective Time) shall have been obtained or made by Buyers when so required, except as for any documents required to be filed, or consents, authorizations, orders or approvals required to be issued, after the
Closing Date, and the waiting period applicable to the transaction under the HSR Act shall have expired or have been terminated without conditions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>7.3 </I></B><B><I>Title Policy</I></B>. At the Closing, the Title Company shall be ready, willing and able to issue a pro forma of the
Title Policy (or marked Title Commitment containing no additional exceptions to title to the Owned Real Property and/or the Hospital Leased Real Property) to Buyers. The Title Policy shall be issued, at Buyers&#146; expense, on an ALTA Form 2006
Owner&#146;s Title Policy in an amount equal to the portion of the Purchase Price being allocated to the Owned </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Real Property and the Hospital Leased Real Property and shall insure to Buyers fee title to the Owned Real Property and leasehold title to the Hospital Leased Real Property subject only to the
Permitted Encumbrances and the standard exceptions contained in an owner&#146;s title policy prescribed for use in the State of Florida, (i)&nbsp;with the standard exception as to taxes and assessments limited to taxes and assessments for the
current and subsequent years, not yet due and payable, (ii)&nbsp;with the standard exception as to facts, rights, interests, or claims which are not shown by the public records deleted, and with the standard exception as to encroachments,
encumbrances, violations, variations or adverse circumstances that would be disclosed by an accurate and complete land survey modified to except matters shown on the Surveys (in each case, only to the extent that the Surveys are sufficient for the
Title Company to delete and/or modify the same), (iii) with the standard exception as to liens, or any right to liens, for services, labor or materials furnished to the Owned Real Property and the Hospital Leased Real Property deleted (other than
any such liens or rights relating to Assumed Liabilities), and (iv)&nbsp;with the standard exception for rights or claims of parties in possession limited to rights of tenants under recorded or unrecorded leases included in the Contracts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>7.4 </I></B><B><I>Actions/Proceedings</I></B>. No action or proceeding before a court or any other Government Entity shall have been
instituted or threatened to restrain, challenge, restrict, impose conditions on or prohibit the transactions herein contemplated, and no Government Entity shall have taken any other action or made any request of any party hereto as a result of which
Buyers reasonably and in good faith deem it inadvisable to proceed with the transactions hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>7.5
</I></B><B><I>Insolvency</I></B>. No Seller shall (i)&nbsp;be in receivership or dissolution, (ii)&nbsp;have made any assignment for the benefit of creditors, (iii)&nbsp;have admitted in writing their inability to pay their debts as they mature,
(iv)&nbsp;have been adjudicated a bankrupt, or (v)&nbsp;have filed a petition in voluntary bankruptcy, a petition or answer seeking reorganization, or an arrangement with creditors under the federal bankruptcy law or any other similar law or statute
of the United States or any state, nor shall any such petition have been filed against any Seller. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>7.6 </I></B><B><I>No Material
Adverse Change</I></B>. Since the date of this Agreement, there shall not have occurred any Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>7.7
</I></B><B><I>Material Consents</I></B>. Sellers shall have obtained and delivered to Buyers all consents of third parties that are material to the consummation of the transactions contemplated in this Agreement as specified in <U>Schedule 7.7</U>
(collectively, the &#147;Material Consents&#148;). The Material Consents shall be in form and substance reasonably satisfactory to Buyers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>7.8 </I></B><B><I>Vesting/Recordation</I></B>. Sellers shall have furnished to Buyers, in form and substance reasonably satisfactory to
Buyers, assignments or other instruments of transfer necessary or appropriate to transfer to and effectively vest in Buyers all right, title, and interest in and to the Assets, in proper statutory form for recording if such recording is necessary or
appropriate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>7.9 </I></B><B><I>Hospital Lease</I></B><B><I>.</I></B><B><I>&nbsp;&nbsp;&nbsp;&nbsp;</I></B>Sellers shall have
obtained the consent of Hernando County to the assignment of the Hospital Lease to the Spring Hill/Brooksville Hospitals Buyer. Such consent shall be in a form reasonably acceptable to Buyers. The amendments to the Hospital Lease described as
conditions to closing on <U>Schedule 10.24</U> shall also have been obtained from Hernando County. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>7.10 </I></B><B><I>Agreement with Essential Third Party Provider</I></B>. Buyers shall
have obtained a written agreement with athenahealth to provide Buyers as of the Closing with the products and services substantially similar to the services provided to Sellers and their Affiliates with respect to the Facilities immediately prior to
the Closing, which agreement shall be on customary commercial terms reasonably satisfactory to the Buyer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>7.11
</I></B><B><I>Closing Deliveries</I></B>. Sellers shall have delivered to Buyers, in accordance with the terms of this Agreement, all contracts, agreements, instruments, and documents required to be delivered by Sellers to Buyers pursuant to
<U>Section</U><U></U><U>&nbsp;2.2</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>8. </B><B>CONDITIONS PRECEDENT TO OBLIGATIONS OF SELLER</B><B>S</B>. Notwithstanding anything herein to the
contrary, the obligations of Sellers to consummate the transactions described herein are subject to the fulfillment, at or prior to the Closing, of the following conditions precedent unless (but only to the extent) waived in writing by Sellers at
the Closing: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>8.1 </I></B><B><I>Representations/Warranties</I></B><B><I>/Covenants</I></B>. The representations and warranties of
Buyers contained in this Agreement shall be true and correct in all material respects when made and, when read in light of any Schedules which have been updated in accordance with the provisions of <U>Section</U><U></U><U>&nbsp;12.1</U> hereof, as
of the Closing Date as though such representations and warranties had been made on and as of such Closing Date (except to the extent such representations and warranties address matters as of particular dates, in which case such representations and
warranties shall be true and correct in all material respects on and as of such dates). Each and all of the terms, covenants, and conditions of this Agreement to be complied with or performed by Buyers at or before the Closing pursuant to the terms
hereof shall have been duly complied with and performed in all material respects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>8.2 </I></B><B><I>Governmental Approvals</I></B>.
All material consents, authorizations, orders and approvals of (or filings or registrations with) any Government Entity required in connection with the execution, delivery and performance of this Agreement shall have been obtained or made by Sellers
when so required, except for any documents required to be filed, or consents, authorizations, orders or approvals required to be issued, after the Closing Date, and the waiting period applicable to the transaction under the HSR Act shall have
expired or have been terminated without conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>8.3 </I></B><B><I>Actions/Proceedings</I></B>. No action or proceeding before a
court or any other Government Entity shall have been instituted or threatened to restrain, challenge, restrict, impose conditions on or prohibit the transactions herein contemplated, and no Government Entity shall have taken any other action or made
any request of any party hereto as a result of which Sellers reasonably and in good faith deem it inadvisable to proceed with the transactions hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>8.4 </I></B><B><I>Insolvency</I></B>. Buyers shall not (i)&nbsp;be in receivership or dissolution, (ii)&nbsp;have made any assignment
for the benefit of creditors, (iii)&nbsp;have admitted in writing their inability to pay their debts as they mature, (iv)&nbsp;have been adjudicated a bankrupt, or (v)&nbsp;have filed a petition in voluntary bankruptcy, a petition or answer seeking
reorganization, or an arrangement with creditors under the federal bankruptcy law or any other similar law or statute of the United States or any state, nor shall any such petition have been filed against Buyers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>8.5 </I></B><B><I>Hospital Lease; Consents to Assignments</I></B><B><I>.
</I></B>Sellers shall have obtained the consent of Hernando County to the assignment of the Hospital Lease to the Spring Hill/Brooksville Hospitals Buyer. Such consent shall be in a form reasonably acceptable to Sellers, and shall include the full
and unconditional release of Sellers and their Affiliates from all obligations under the Hospital Lease arising as of or after the Effective Time, including, without limitation, any capital expenditure commitments or guarantees of performance or
financial obligations. Sellers also shall have obtained the consents, waivers and estoppel of third parties which are reasonably necessary to complete effectively the transactions contemplated by this Agreement, including, without limitation, the
consents to transfer the Ownership Interests to Buyers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>8.6 </I></B><B><I>Closing Deliveries</I></B>. Buyers shall have delivered
to Sellers, in accordance with the terms of this Agreement, all contracts, agreements, instruments and documents required to be delivered by Buyers to Sellers pursuant to <U>Section</U><U></U><U>&nbsp;2.3</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>9. </B><B>SELLERS</B><B>&#146;</B><B> COVENANT NOT TO COMPETE</B>. Sellers hereby covenant that at all times from the Closing Date until the fifth (5th)
anniversary of the Closing Date, Sellers and their Affiliates shall not, directly or indirectly, own, operate, develop, construct, lease, manage, finance, control or otherwise be affiliated with an acute care hospital or ambulatory or other type of
surgery center, emergency or outpatient care facility, medical office building or physician practice, other ancillary healthcare or physician services of the nature provided by each Hospital, or ACO, within a thirty (30)-mile radius of each
Hospital&#146;s primary location without Buyers&#146; or TGH&#146;s prior written consent (which Buyers may withhold in their sole and absolute discretion); provided, however, that the foregoing restriction shall not apply with respect to ACO
activities of Sellers or their Affiliates through December&nbsp;31, 2023. In the event of a breach of this <U>Section</U><U></U><U>&nbsp;9</U>, Sellers recognize that monetary damages shall be inadequate to compensate Buyers and Buyers shall be
entitled, without the posting of a bond or similar security, to an injunction restraining such breach, with the reasonable costs (including reasonable attorneys&#146; fees) of securing such injunction to be borne by Sellers. Nothing contained herein
shall be construed as prohibiting Buyers from pursuing any other remedy available to them for such breach or threatened breach. All parties hereto hereby acknowledge the necessity of protection against the competition of Sellers and their Affiliates
and that the nature and scope of such protection has been carefully considered by the parties. Sellers further acknowledge and agree that the covenants and provisions of this <U>Section</U><U></U><U>&nbsp;9</U> form part of the consideration under
this Agreement and are among the inducements for Buyers entering into and consummating the transactions contemplated herein. The period provided and the area covered are expressly represented and agreed to be fair, reasonable and necessary. The
consideration provided for herein is deemed to be sufficient and adequate to compensate for agreeing to the restrictions contained in this <U>Section</U><U></U><U>&nbsp;9</U>. If, however, any court determines that the foregoing restrictions are not
reasonable, such restrictions shall be modified, rewritten or interpreted to include as much of their nature and scope as will render them enforceable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>10. ADDITIONAL AGREEMENTS. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.1
</I></B><B><I>Allocation of Purchase Price</I></B>. The Purchase Price shall be allocated among the various classes of Assets in accordance with and as provided by Section&nbsp;1060 of the Code. Within ninety (90)&nbsp;days of the Closing, Sellers
shall provide Buyers with a preliminary allocation of the Purchase Price for Buyers&#146; review and approval. If Sellers and Buyers cannot agree, initially, on an allocation, then the matter shall be submitted to the Accounting Firm for final
resolution of all </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
allocation matters. The parties agree that any tax returns or other tax information they may file or cause to be filed with any Government Entity shall be prepared and filed consistently with
such agreed upon allocation. In this regard, the parties agree that, to the extent required, they will each properly prepare and timely file Form 8594 in accordance with Section&nbsp;1060 of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.2 </I></B><B><I>Termination Prior to Closing</I></B>. Notwithstanding anything herein to the contrary, this Agreement may be
terminated at any time: (i)&nbsp;at or prior to the Closing by mutual, written consent of Sellers and Buyers; (ii)&nbsp;by Buyers by written notice to Sellers if any event occurs or condition exists which causes Sellers to be unable to satisfy one
or more conditions to the obligations of Buyers to consummate the transactions contemplated by this Agreement as set forth in <U>Section</U><U></U><U>&nbsp;7</U>; (iii) by Sellers by written notice to Buyers if any event occurs or condition exists
which causes Buyers to be unable to satisfy one or more conditions to the obligation of Sellers to consummate the transactions contemplated by this Agreement as set forth in <U>Section</U><U></U><U>&nbsp;8</U>; (iv) by Buyers or Sellers if any
federal or state agency, including without limitation, the FTC or the Office of the Attorney General of the State of Florida, states an intention to continue or continues to investigate the transactions contemplated by this agreement beyond the
expiration of the HSR Act&#146;s initial thirty <FONT STYLE="white-space:nowrap">(30)-day</FONT> waiting period (or, in the event of a mutually agreed upon &#147;withdraw and refile,&#148; beyond the expiration of the second thirty <FONT
STYLE="white-space:nowrap">(30)-day</FONT> waiting period triggered by such refiling) or has requested, orally or in writing, that the transactions contemplated by this Agreement be delayed or postponed; (v)&nbsp;by Sellers or Buyers if the Closing
shall not have taken place on or before 5:00 p.m. Central Time on December&nbsp;29, 2023 (which date may be extended by mutual agreement of Sellers and Buyers) (and, notwithstanding the provisions of Section&nbsp;2.1 to the contrary, any such
Closing that occurs on December&nbsp;29, 2023 would have an Effective Time of 12:00:01 a.m. on January&nbsp;1, 2024), provided that the right to terminate pursuant to this subsection (v)&nbsp;shall not be available to any party whose breach or
default of any obligation or provision under this Agreement has been the cause of, or resulted in, the failure of the Closing to occur by such date; (vi)&nbsp;by either Sellers or Buyers pursuant to <U>Section</U><U></U><U>&nbsp;12.1</U> hereof; or
(vii)&nbsp;by Buyers pursuant to <U>Section</U><U></U><U>&nbsp;6.3</U> hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.3 </I></B><B><I>Post-Closing Access to
Information</I></B>. Sellers and Buyers acknowledge that subsequent to Closing each party may need access to information or documents in the control or possession of the other party(ies) for the purposes of concluding the transactions herein
contemplated, audits, compliance with governmental requirements and regulations, and the prosecution or defense of third party claims. Accordingly, Sellers and Buyers agree that for a period of ten (10)&nbsp;years after Closing each will, unless
prohibited by law or regulation, make reasonably available to the other&#146;s agents, independent auditors, counsel, and/or Government Entities upon written request and at the expense of the requesting party such documents and information as may be
available relating to the Assets for periods prior and subsequent to Closing to the extent necessary to facilitate concluding the transactions herein contemplated, audits, compliance with governmental requirements and regulations, and the
prosecution or defense of claims. Sellers and Buyers shall cause their respective Affiliates to retain their books and records for the periods specified in their respective document retention policies. All reasonable documented <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses associated with the delivery of the requested documents shall be promptly paid by a requesting party to the other party. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.4 </I></B><B><I>Preservation and Access to Records After the Closing</I></B>. After
the Closing, Buyers shall, in the ordinary course of business and as required by law, keep and preserve in their original form all medical and other records of the Facilities existing as of the Closing, and which constitute a part of the Assets
delivered to Buyers at the Closing. For purposes of this Agreement, the term &#147;records&#148; includes all documents, electronic data and other compilations of information in any form. Buyers acknowledge that, as a result of entering into this
Agreement and operating the Facilities, Buyers will gain access to patient and other information which is subject to rules and regulations regarding confidentiality. Buyers agree to abide by any such rules and regulations relating to the
confidential information Buyers acquire. Buyers agree to maintain the patient and personnel records delivered to Buyers at the Closing at the Facilities after Closing in accordance with applicable law (including, if applicable,
Section&nbsp;1861(v)(i)(I) of the Social Security Act (42 U.S.C. &#167; 1395(v)(l)(i)), the privacy requirements of HIPAA and applicable state requirements with respect to medical privacy, and requirements of relevant insurance carriers, all in a
manner consistent with the maintenance of patient and personnel records generated at the Facilities after the Closing. Upon reasonable notice, during normal business hours, at the sole cost and expense of Sellers and upon the applicable Buyer&#146;s
receipt of any legally required consents and authorizations, such Buyer will afford to the representatives of Sellers, including their counsel and accountants, full and complete access to, and copies of, the patient records transferred to Buyers at
the Closing (including, without limitation, access to patient records in respect of patients treated by Sellers at the Facilities). Upon reasonable notice, during normal business hours and at the sole cost and expense of Sellers, Buyers shall also
make their officers and employees available to Sellers at reasonable times and places after the Closing. Any access to the Facilities, their records or the applicable Buyer&#146;s personnel granted to Sellers in this Agreement shall be upon the
condition that any such access be consistent with applicable law and not materially interfere with the business operations of any Buyer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.5 </I></B><B><I>Tax and Medicare Effect</I></B>. None of the parties (nor such parties&#146; counsel or accountants) has made or is
making any representations to any other party (nor such party&#146;s counsel or accountants) concerning any of the tax or Medicare effects of the transactions provided for in this Agreement as each party hereto represents that each has obtained, or
may obtain, independent tax and Medicare advice with respect thereto and upon which it, if so obtained, has solely relied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.6
</I></B><B><I>Reproduction of Documents</I></B>. This Agreement and all documents relating hereto, including, without limitation, (a)&nbsp;consents, waivers and modifications which may hereafter be executed, (b)&nbsp;the documents delivered at the
Closing, and (c)&nbsp;financial statements, certificates and other information previously or hereafter furnished to Sellers or to Buyers may, subject to the provisions of <U>Section</U><U></U><U>&nbsp;12.10</U> hereof, be reproduced by Sellers and
by Buyers by any photographic, photostatic, microfilm, micro-card, miniature photographic or other similar process and Sellers and Buyers may destroy any original documents so reproduced. Sellers and Buyers agree and stipulate that any such
reproduction shall be admissible in evidence as the original itself in any judicial, arbitral or administrative proceeding (whether or not the original is in existence and whether or not such reproduction was made by Sellers or Buyers in the regular
course of business) and that any enlargement, facsimile or further reproduction of such reproduction shall likewise be admissible in evidence. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.7 </I></B><B><I>Cooperation on Tax Matters</I></B>. Following the Closing, the
parties shall cooperate reasonably with each other and shall make available to the other, as reasonably requested and at the expense of the requesting party, and to any taxing authority, all information, records or documents relating to tax
liabilities or potential tax liabilities of Sellers and the Partial Subsidiaries for all periods on or prior to the Closing and any information which may be relevant to determining the amount payable under this Agreement, and shall preserve all such
information, records and documents (to the extent a part of the Assets delivered to Buyers at the Closing) at least until the expiration of any applicable statute of limitations or extensions thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.8 </I></B><B><I>Cost Reports</I></B>. After the Closing, Sellers, at their expense, shall prepare and timely file, in a manner that
complies with applicable legal requirements, all terminating and other cost reports required or permitted by law to be filed under the Medicare and Medicaid or other third party payor programs and the State Health Agency for periods ending prior to
the Effective Time, or as a result of the consummation of the transactions described herein (&#147;Seller Cost Reports&#148;).&nbsp;&nbsp;&nbsp;&nbsp;Upon the reasonable request of Sellers, Buyers shall reasonably cooperate with Sellers in providing
certain information needed by Sellers when preparing any Seller Cost Reports, including, but not limited to, completion of Sellers&#146; standard hospital data collection template, invoice and general ledger analysis, and other documentation
historically prepared by the Hospitals (including all free-standing emergency and other departments) for cost reporting purposes. If requested by Sellers, the applicable Buyer shall include the applicable Seller&#146;s Medicare bad debts that are
returned from collection agencies subsequent to the Closing Date on the applicable Buyer&#146;s cost report for the respective period to which the Medicare bad debt relates provided that Sellers provide detailed supporting information, as required
by Medicare regulations, for the Medicare bad debt account amounts to be included on the applicable Buyer&#146;s Medicare cost report. The applicable Buyer shall forward to Sellers any and all correspondence relating to the Seller Cost Reports
within five (5)&nbsp;business days after receipt by such Buyer. The applicable Buyer shall remit any receipts of funds relating to the Seller Cost Reports or to Sellers&#146; Medicare bad debts included on a Buyer&#146;s cost report promptly after
receipt by such Buyer and shall forward to Sellers any demand for payments within three (3)&nbsp;business days after receipt by such Buyer. Notwithstanding anything to the contrary in this Agreement, Sellers shall retain all rights to the Seller
Cost Reports including any amounts receivable or payable in respect of such reports or reserves relating to such reports and all liabilities relating thereto. Such rights shall include the right to appeal any Medicare or Medicaid determinations
relating to the Seller Cost Reports. Sellers shall retain the originals of the Seller Cost Reports, correspondence, work papers and other documents relating to the Seller Cost Reports. Sellers will furnish to Buyers copies of such cost reports, and
related correspondence, work papers and other documents upon Buyers&#146; request. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.9 </I></B><B><I>Misdirected Payments,
Etc.</I></B> Sellers and Buyers covenant and agree to remit, with reasonable promptness any payments received, which payments are on or in respect of accounts or notes receivable owned by (or are otherwise payable to) the other. In addition, and
without limitation, in the event of a determination by any Government Entity or third-party payor that payments to Sellers or the Facilities resulted in an overpayment or other determination that funds previously paid by any program or plan to
Sellers or the Facilities must be repaid, Sellers shall be responsible for repayment of said monies (or defense of such actions) if such overpayment or other repayment determination was for services rendered prior to the Effective Time and Buyers
shall be responsible for repayment of said monies (or defense of such actions) if such overpayment or other repayment determination was for services rendered after the Effective Time. In the event that, following Closing, any Buyer suffers any
offsets against reimbursement due to such Buyer under any third-party payor or reimbursement programs, as a result of amounts owing under any such programs by Sellers or any of their Affiliates, Sellers shall promptly upon demand from such Buyer pay
to such Buyer the amounts so billed or offset. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.10 </I></B><B><I></I></B><B><I>Employee Matters</I></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a) </I></B>As of the Effective Time, Sellers shall terminate all of the employees at the Facilities (the &#147;Seller Employees&#148;),
and Buyers shall offer or cause to be offered employment to all active Seller Employees (including any Seller Employees who are on statutory family or medical leave, military leave, short-term disability, or other short-term leave of up to ninety
(90)&nbsp;days) who are in good standing as of the Effective Time in positions and at compensation levels generally consistent with those provided by Sellers as of the Effective Time; provided, however, that Buyers shall not be required to offer
employment to any Chief Executive Officer (or equivalent), Chief Medical Officer/Chief Nursing Officer (or equivalent), Chief Financial Officer (or equivalent) or similar <FONT STYLE="white-space:nowrap">&#147;C-Suite&#148;</FONT> executive officer
of the Hospitals unless Buyers decide, in their sole discretion, to do so. Between the date of this Agreement and Closing, Sellers shall cooperate with Buyers in their efforts to interview and interact with such
<FONT STYLE="white-space:nowrap">C-Suite</FONT> officers. Nothing herein shall be deemed to affect or limit in any way normal management prerogatives of Buyers with respect to employees or to create or grant to any such employees third party
beneficiary rights or claims of any nature. All such employees who accept such offers and commence employment with a Buyer (together, the &#147;Hired Employees&#148;) shall be credited with employment service with Sellers for purposes of eligibility
and vesting purposes (but not for purposes of benefit accrual) under Buyer&#146;s employee benefit plans or programs (the &#147;Buyer Plans&#148;), unless such service credit is not allowed pursuant to the express terms of any insurance policy (or
policies) used to fund the benefits provided under such Buyer Plans, in which case such service credit will not be allowed just for such insured plan(s). Notwithstanding anything contained herein to the contrary, this
<U>Section</U><U></U><U>&nbsp;10.10(a)</U> shall not apply to any physician employee of any Seller who has entered into an employment agreement with any Seller (&#147;Physician Employees&#148;), and such persons shall not be deemed to be Hired
Employees for purposes of this <U>Section</U><U></U><U>&nbsp;10.10(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b) </I></B>Buyers shall offer or cause to be offered
enrollment in the appropriate Buyer Plan that is a group health plan to any Hired Employee (including Physician Employees) together with the eligible dependents of such Hired Employee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c) </I></B>Within the period of ninety (90)&nbsp;days prior to the Closing, Sellers shall not violate the WARN Act and/or the
regulations thereunder. With respect to terminations of employees prior to the Effective Time, Sellers shall be responsible for any legally required notifications. With respect to terminations of employees following the Effective Time, Buyers shall
be responsible for any legally required notifications. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d) </I></B>Notwithstanding anything herein to the contrary and prior to the
Effective Time, Sellers shall terminate the active participation of all of the Seller Employees, including for this purpose the Physician Employees, in each Benefit Plan listed in <U>Schedule 3.12</U> and intended to be a <FONT
STYLE="white-space:nowrap">tax-qualified</FONT> retirement plan described under Section&nbsp;401(a) of the Code (the &#147;Seller Plans&#148;). After the Effective Time, Sellers shall timely allow to be made appropriate distributions to, or for the
benefit of, all of the Seller Employees (including Physician Employees) in respect of the Seller Plans which are in force and effect with respect to the Seller Employees immediately prior to the Effective Time in accordance with the terms and
conditions of the Seller Plans, as may be requested by the Seller Employees. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(e) </I></B>Sellers shall be responsible for providing continuation coverage pursuant
to the requirements of section 4980B of the Code, and Part 6 of Title I of ERISA (&#147;COBRA&#148;) with respect to qualifying events occurring before the date on which such Seller Employees become Hired Employees, for Seller Employees who do not
become Hired Employees, and with respect to qualifying events occurring by virtue of the Closing, and Sellers shall continue to be fully responsible for such COBRA coverage for such Seller Employees following the Effective Time. Buyers shall be
responsible for providing COBRA coverage with respect to each of the Hired Employees (and their dependents) whose qualifying event occurs on or after the date on which each of the applicable Seller Employees becomes one of the Hired Employees. The
obligations pertaining to COBRA coverage for Physician Employees shall be apportioned between Sellers and Buyers consistent with the methodology set forth above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.11 </I></B><B><I>Indigent Care Policies</I></B><B><I>. </I></B>Buyers shall adopt and maintain reasonable policies for the treatment
of indigent patients of the Hospitals. Buyers shall cause the Hospitals to treat any patient presented to the emergency room who has a medical emergency or who, in the judgment of a staff physician, has an immediate emergency need. No such patient
will be turned away because of age, race, gender or inability to pay. Buyers shall cause the Hospitals to continue to provide services to patients covered by the Medicare and Medicaid programs and those unable to pay for emergent and medically
necessary care. This covenant shall be subject in all respects to changes in governmental policy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.12 </I></B><B><I>Use of
Controlled Substance Permits</I></B>. To the extent permitted by applicable law, each applicable Buyer shall have the right, for a period not to exceed one hundred eighty (180)&nbsp;days following the Closing Date, to operate under the licenses and
registrations of the corresponding Seller relating to controlled substances and the operations of pharmacies and laboratories, until such Buyer is able to obtain such licenses and registrations for itself. In furtherance thereof, Sellers shall
execute and deliver to the corresponding Buyer at or prior to the Closing limited powers of attorney substantially in the form of <U>Exhibit A</U> hereto. Buyers shall apply for all such licenses and permits as soon as reasonably possible before and
after the Closing and shall diligently pursue such applications. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.13 </I></B><B><I>Medical Staff Matters</I></B>. As a result of
the acquisition of the Assets by Buyers, without the consent of the medical staff of the Hospitals, there will be no change or modification to the current staff privileges for physicians on the medical staff of the Hospitals; provided, however, that
the consummation of the transactions contemplated hereby will not limit the ability of the Board of Trustees or medical executive committee of the Hospitals to grant, withhold or suspend medical staff appointments or clinical privileges in
accordance with the terms and provisions of the medical staff bylaws. Each applicable Buyer shall adopt the current medical staff bylaws of the Hospitals as the medical staff bylaws of the Hospitals following the Closing, except for <FONT
STYLE="white-space:nowrap">non-substantive</FONT> changes that may be required to reflect Buyer&#146;s legal name and description, and except to the extent that: (i)&nbsp;modifications thereof are required to comply with accreditation standards or
legal or regulatory requirements, (ii)&nbsp;modifications thereto may be proposed by the medical staff, or its executive committee, and agreed to by Buyers (pursuant to the process set forth in the medical staff bylaws), (iii) modifications thereto
are proposed by Buyers and agreed to by the medical staff (pursuant to the process set forth in the medical staff bylaws), and (iv)&nbsp;modifications thereto may otherwise be permitted by law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.14 </I></B><B><I>Information Services Agreement</I></B>. At the Closing, an
appropriate Affiliate of Sellers and Buyers will enter into an Information Technology Transition Services Agreement substantially in the form attached hereto as <U>Exhibit B</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.15 </I></B><B><I>Hospital Transition Services Agreement</I></B>. At the Closing, an appropriate Affiliate of Sellers and Buyers will
enter into a Hospital Transition Services Agreement substantially in the form attached hereto as <U>Exhibit C</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.16
</I></B><B><I>Clinic Billing and Collection Agreement</I></B>. At the Closing, an appropriate Affiliate of Sellers and Buyers will enter into a Clinic Billing and Collection Agreement substantially in the form attached hereto as <U>Exhibit D</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.17 </I></B><B><I>License Agreement</I></B>. At the Closing, Sellers and Buyers will enter into a License Agreement for Policy
and Procedure Manuals substantially in the form attached hereto as <U>Exhibit</U><U></U><U>&nbsp;E</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.18 </I></B><B><I>Access
to Records Including as to Recovery and Audit Information</I></B><B><I> </I></B>. If any Government Entity or Person acting on its behalf makes a claim, inquiry or request to any Buyer or Seller relating to Sellers&#146; operation of the Facilities
prior to the Effective Time (including but not limited to a notice to any Buyer or Seller from a Person responsible for retroactive payment denials, including recovery audit contractors) of their intent to review Sellers&#146; claims with respect to
the operation of the Facilities prior to the Effective Time, or otherwise seeks information pertaining to Sellers with respect to the operations of the Facilities, Sellers and Buyers shall: (i)&nbsp;comply with all lawful requests from such
Government Entity or Person in a timely manner; (ii)&nbsp;comply with all other applicable laws and regulations; (iii)&nbsp;except as restricted by law or regulation, forward to the other party all communications and/or documents sent to such
Government Entity or Person or received from such Government Entity or Person within five (5)&nbsp;business days of delivery or receipt of such communications and/or documents and (iv)&nbsp;except as restricted by law or regulation, provide Sellers
and their agents and attorneys upon reasonable request with reasonable access to records, information and personnel necessary for any appeal or challenge regarding any such retroactive payment denials (with the understanding that Sellers shall be
solely responsible for handling any appeals). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.19 </I></B><B><I>Telephone Access</I></B>. The parties shall take all steps
necessary to transition over to Buyers or an Affiliate all local and long distance telephone services at the Facilities as of the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.20 </I></B><B><I>Continuation of Insurance</I></B>. For a period of at least six (6)&nbsp;years following the Closing, Sellers shall
maintain in effect insurance on all claims-made professional and general liability insurance policies of the Facilities (including cyber/data breach coverages) for claims related to the period of Sellers&#146; ownership and operation of the
Facilities. The insurance shall have coverage levels equal to the coverage maintained by Sellers (or by CHS or its Affiliates with respect to the Facilities) for other comparable healthcare facilities (and, in any event, not less than the coverages
described in <U>Schedule 3.19</U>). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.21 </I></B><B><I>Use of Excluded Marks</I></B>. To the extent the Facilities (or
their associated marketing, signage, or other promotion thereof) use any marks, logos, slogans, or other trademarks or service marks that are Excluded Assets and that were being used by the Facilities immediately prior to the Effective Time, Buyers
shall take reasonable steps after the Closing Date to promptly phase out and cease all such use of such marks, provided that certain marks may continue to be used for a limited Transition Period as expressly permitted herein. All use of any Excluded
Marks, including the Transition Marks (as defined herein), shall inure to the benefit of Sellers or their Affiliates, and Buyers shall acquire no right, title, or interest to any of the marks. Solely during the Transition Period, Sellers and their
Affiliates grant to Buyers and their Affiliates an exclusive (even as to Sellers, except as otherwise provided herein), irrevocable (except for material breach of this provision), royalty-free, and fully
<FONT STYLE="white-space:nowrap">paid-up</FONT> right and license to use the family of BRAVERA HEALTH, BRAVERA HEALTH BROOKSVILLE, BRAVERA HEALTH SEVEN RIVERS, BRAVERA HEALTH SPRING HILL, BRAVERA MEDICAL GROUP, and their associated logos (the
&#147;Transition Marks&#148;), an in association therewith, Sellers shall further allow Buyers and their Affiliates to use the associated brand guidelines and image files provided that any use of the Transition Marks and associated image files and
brand guidelines shall be solely in connection with the operation of the Facilities, in a similar manner as used by Sellers or their Affiliates immediately prior to the Effective Time, and consistent with Sellers&#146; and their Affiliates&#146;
quality standards, for a period not to exceed twelve (12)&nbsp;months after the Closing Date (&#147;Transition Period&#148;). Buyers shall not materially alter the Transition Marks nor otherwise combine the Transition Marks with any other marks.
Sellers and their Affiliates shall have the sole right but not the obligation, at their sole cost, to bring any action for infringement or registration of the Transition Marks and domain names during the Transition Period. Buyers and TGH shall not
use the marks in connection with any other facilities or businesses except for the Facilities. During the Transition Period, Sellers and their Affiliates shall not use the Transition Marks, except (a)&nbsp;in connection with ongoing activities
arising out of Sellers&#146; or their Affiliates&#146; operations of the Facilities prior to the Closing Date (including without limitation any ongoing billing or collection activities, reporting, litigation, or otherwise), or (b)&nbsp;to support
Buyers and their Affiliates in connection with any transition activities related to the Facilities.&nbsp;Sellers and their Affiliates shall not assign nor transfer ownership of the Transition Marks during the Transition Period unless expressly
subject to this license to Buyers and their Affiliates. Upon expiration of the Transition Period, Buyers and their Affiliates shall cease all further use of the Transition Marks. Notwithstanding the foregoing, the license granted above does not
include any right to use, and the Buyers shall not use in any capacity, the following Excluded Marks: CHS, Community Health Systems, CHSPSC or HMA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.22 </I></B><B><I>Guaranties</I></B>. To the extent that any Seller or any Affiliate of Sellers has guaranteed the obligations of any
Seller under any of the Contracts (a &#147;Seller Guaranty&#148;), then at the request of Sellers, Buyers shall use commercially reasonable efforts to have Sellers and/or such Affiliate released as guarantor. If required to obtain a release from a
Seller Guaranty, Buyers or TGH shall execute a guaranty substantially in the form of the existing Seller Guaranty, or such other form as may be agreed to by Buyers and the beneficiary of such guaranty. If Buyers are unable to obtain a release for
any Seller Guaranty as set forth in this <U>Section</U><U></U><U>&nbsp;10.22</U>, Buyers (i)&nbsp;shall indemnify and hold harmless Sellers and their Affiliates against any liabilities arising from or relating thereto as if the obligations accruing
from and after the Effective Time under such Seller Guaranty were Assumed Liabilities, and (ii)&nbsp;agree not to amend, modify, supplement, extend or renew (or allow the applicable Buyer to amend, modify, supplement, extend or renew) the underlying
Contract in any manner that would reasonably be expected to materially increase the obligations of Sellers or their Affiliates under the Seller Guaranty, without the prior written consent of Sellers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.23 </I></B><B><I>Antitrust Cooperation</I></B>. Buyers and Sellers will cooperate
with each other, using commercially reasonable efforts to: (a)&nbsp;promptly and fully inform the other party of any written or oral communication received from or given to the FTC, DOJ, or any other Government Entity or any Person relating to any
inquiry, investigation, or proceeding relating to the transactions contemplated by this Agreement or any filing submitted to any Government Entity, and promptly provide the other a copy of any written communication or filing received from or
provided to any Government Entity or other Person regarding the transactions contemplated by this Agreement (subject to applicable laws regarding privilege), provided that no privileged information or information that is deemed to be competitively
sensitive is required to be shared and Buyers and Sellers may reasonably designate any competitively sensitive information provided to the other under this Section as &#147;Antitrust/Outside Counsel Only Material&#148;; (b) allow the other party to
review in advance and, to the extent practicable, consult with one another on and consider in good faith the views of the other with respect to any written communication or submission to any Government Entity relating to any inquiry, investigation,
or proceeding involving the transactions contemplated by this Agreement and/or information relating to that party that appears in any filing made with or written materials submitted to, any Government Entity in connection with any inquiry,
investigation, or proceeding relating to the transactions contemplated hereby; and (c)&nbsp;agree not to participate in any substantive meeting or discussion with any Government Entity regarding any filing, inquiry, or investigation relating to such
transactions unless, to the extent practicable and not prohibited by law, rule, regulation or order of any Government Entity, it consults with the other party in advance, and to the extent not prohibited by law, rule, regulation or order and
permitted by the Government Entity, gives the other party, including its outside counsel, reasonable notice and an opportunity to attend and participate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.24 </I></B><B><I>Hospital Lease</I></B>. Buyers shall negotiate in good faith with Hernando County, using commercially reasonable
efforts to negotiate the assignment of the Hospital Lease, including such amendments as may be reasonably negotiated between Buyers and Hernando County; provided, however, that Buyers shall only propose amendments to Hernando County with respect to
the matters described on <U>Schedule 10.24</U> (which shall include certain matters which constitute conditions to closing for Buyers under <U>Section</U><U></U><U>&nbsp;7.9</U> and certain other matters which do not constitute conditions to
closing). Sellers shall cooperate in good faith with Buyers and use commercially reasonable efforts in negotiating with Hernando County to receive the consent from Hernando County to the assignment of the Hospital Lease to the Spring
Hill/Brooksville Hospitals Buyer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.25 </I></B><B><I>Passwords, Keys, Websites, Social Media</I></B>. The parties shall cooperate
with one another to transition over to Buyers or an Affiliate, promptly following the Closing, all passwords system keys and manuals, administrator privileges, building and other physical property keys, alarm codes and manuals, website and domain
name assignments, social media account assignments, security deposits and other funds held under Contracts, with respect to the Facilities and the Assets, and Buyer will be permitted to download copies of the virtual data room materials provided by
Sellers to Buyers prior to Closing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.26 </I></B><B><I>PMATF Assessments</I></B>. Sellers, jointly and severally, shall
pay all assessments imposed by AHCA on the Hospitals prior to the Effective Time with respect to the Public Medical Assistance Trust Fund. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>11.
</B><B>INDEMNIFICATION</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>11.1 </I></B><B><I>Indemnification by Buyer</I></B><B><I>s</I></B>. Subject to the limitations set
forth in <U>Section</U><U></U><U>&nbsp;11.3</U> hereof, Buyers shall defend, indemnify and hold harmless Sellers and their Affiliates, and their respective officers, directors, managers, employees, agents or independent contractors (collectively,
&#147;Seller Indemnified Parties&#148;), from and against any and all losses, liabilities, damages, costs (including, without limitation, court costs and costs of appeal) and expenses (including, without limitation, reasonable attorneys&#146; fees
and fees of expert consultants and witnesses) (collectively, &#147;Damages&#148;) that any one or more of such Seller Indemnified Parties incur as a result of, arising out of or with respect to (i)&nbsp;any misrepresentation or breach of any
representation or warranty by Buyers under this Agreement, (ii)&nbsp;any breach by Buyers of, or any failure by Buyers to perform, any covenant or agreement of, or required to be performed by, Buyers or their Affiliates under this Agreement or any
agreements ancillary to this Agreement, (iii)&nbsp;any of the Assumed Liabilities, or (iv)&nbsp;any claim made by a third party with respect to the operation of the Facilities by Buyers following the Effective Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>11.2 </I></B><B><I>Indemnification by Seller</I></B><B><I>s</I></B>. Subject to the limitations set forth in
<U>Section</U><U></U><U>&nbsp;11.3</U> hereof, Sellers shall defend, indemnify and hold harmless Buyers and their Affiliates, and their respective officers, directors, managers, employees, agents, or independent contractors (collectively,
&#147;Buyer Indemnified Parties&#148;), from and against any and all Damages that any one or more of such Buyer Indemnified Parties incur as a result of, arising out of or with respect to (i)&nbsp;any misrepresentation or breach of representation or
warranty by Sellers under this Agreement, (ii)&nbsp;any breach by Sellers or their Affiliates of, or any failure by Sellers to perform, any covenant or agreement of, or required to be performed by, Sellers under this Agreement or any agreements
ancillary to this Agreement, (iii)&nbsp;any of the Excluded Liabilities, or (iv)&nbsp;any claim made by a third party with respect to the operation of the Facilities by Sellers prior to the Effective Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>11.3 </I></B><B><I>Limitations</I></B>. Buyers and Sellers shall be liable under <U>Section</U><U></U><U>&nbsp;11.1(i)</U> or
<U>Section</U><U></U><U>&nbsp;11.2(i)</U> (i.e., for misrepresentations and breaches of representations and warranties), as applicable, only when total indemnification claims exceed One Million Four Hundred Thousand Dollars ($1,400,000) (the
&#147;Basket Amount&#148;), after which Buyers or Sellers, as applicable, shall be liable only for the amount in excess of the Basket Amount. No party shall be liable for any indemnification pursuant to <U>Section</U><U></U><U>&nbsp;11.1(i)</U> or
<U>Section</U><U></U><U>&nbsp;11.2(i)</U>, as applicable, for any claims for misrepresentations and breaches of representations and warranties which are the basis upon which any other party shall have failed to consummate the transactions described
herein pursuant to <U>Section</U><U></U><U>&nbsp;7.1</U> or <U>Section</U><U></U><U>&nbsp;8.1</U>, as applicable, or which are based upon misrepresentations and breaches of representations and warranties which have been waived pursuant to the
initial paragraph of <U>Section</U><U></U><U>&nbsp;7</U> or <U>Section</U><U></U><U>&nbsp;8</U>, as applicable. The liability of Buyers and Sellers for indemnification under <U>Section</U><U></U><U>&nbsp;11.1(i)</U> or
<U>Section</U><U></U><U>&nbsp;11.2(i)</U>, respectively, shall be limited to an amount equal to fifty percent (50%) of the Purchase Price. Notwithstanding the foregoing provisions of this <U>Section</U><U></U><U>&nbsp;11.3</U>, the limitation on
liability and the Basket Amount shall not apply to claims arising under <U>Section</U><U></U><U>&nbsp;11.1(i)</U> or <U>Section</U><U></U><U>&nbsp;11.2(i)</U> and resulting from willful misrepresentation or fraud by the indemnifying party or its
Affiliates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>11.4 </I></B><B><I>Notice and Control of Litigation</I></B>. If any claim or liability
is asserted in writing by a third party against a party entitled to indemnification under this <U>Section</U><U></U><U>&nbsp;11</U> (the &#147;Indemnified Party&#148;) which would give rise to a claim under this <U>Section</U><U></U><U>&nbsp;11</U>,
the Indemnified Party shall notify the person giving the indemnity (the &#147;Indemnifying Party&#148;) in writing of the same within fifteen (15)&nbsp;days of receipt of such written assertion of a claim or liability. The Indemnifying Party shall
have the right to defend such third party claim(s) and control the defense, settlement, and prosecution of any litigation; <U>provided</U>, that the Indemnified Party may in any event retain separate
<FONT STYLE="white-space:nowrap">co-counsel</FONT> at its sole cost and expense and participate in the defense of the third party claim. If the Indemnifying Party, within ten (10)&nbsp;days after receipt of such written notice of such claim, fails
to agree to defend such claim, the Indemnified Party shall (upon further notice to the Indemnifying Party) have the right to undertake the defense, compromise, or settlement of such claim on behalf of and for the account and at the risk of the
Indemnifying Party, subject to the right of the Indemnifying Party to assume the defense of such claim at any time prior to settlement, compromise, or final determination thereof, provided such assumption does not materially and adversely impact the
Indemnified Party. Anything in this <U>Section</U><U></U><U>&nbsp;11.4</U> notwithstanding, (i)&nbsp;in the event that a proposed settlement requires the Indemnified Party to admit any wrongdoing or take or refrain from taking any action, then the
proposed settlement shall not be entered into unless it is reasonably acceptable to both the Indemnifying Party and the Indemnified Party, and (ii)&nbsp;the Indemnifying Party shall not, without the written consent of the Indemnified Party, settle
or compromise any claim or consent to the entry of any judgment which does not include as an unconditional term thereof the giving by the claimant to the Indemnified Party of a commercially reasonable release from all liability of the Indemnified
Party and its Affiliates in respect of such claim. The foregoing rights and agreements shall be limited to the extent of any requirement of any third-party insurer or indemnitor. All parties agree to cooperate fully as necessary in the defense of
such matters. No delay on the part of the Indemnified Party in notifying any Indemnifying Party shall relieve the Indemnifying Party from any obligation hereunder unless (and then solely to the extent) the Indemnifying Party is materially prejudiced
thereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>11.5 </I></B><B><I>Notice of Claim</I></B>. If an Indemnified Party becomes aware of any breach of the representations or
warranties of the Indemnifying Party hereunder or any other basis for indemnification under this <U>Section</U><U></U><U>&nbsp;11</U> (except as otherwise provided for under <U>Section</U><U></U><U>&nbsp;12.3</U>), the Indemnified Party shall notify
the Indemnifying Party in writing of the same within thirty (30)&nbsp;days after becoming aware of such breach or claim, specifying in detail the circumstances and facts which give rise to a claim under this <U>Section</U><U></U><U>&nbsp;11</U>.
Should the Indemnified Party fail to notify the Indemnifying Party within the time frame required above, the indemnity with respect to the subject matter of the required notice shall be limited to the damages that would have nonetheless resulted
absent the Indemnified Party&#146;s failure to notify the Indemnifying Party in the time required above after taking into account such actions as could have been taken by the Indemnifying Party had it received timely notice from the Indemnified
Party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>11.6 </I></B><B><I>Mitigation</I></B>. The parties shall cooperate with each other to resolve any claim or liability with
respect to which any party is obligated to indemnify any other party hereunder, including using commercially reasonable efforts to mitigate any liabilities that form the basis of a claim hereunder. In furtherance of the foregoing, the parties shall
use commercially reasonable efforts to seek recovery under all applicable insurance policies covering any liabilities for claims indemnified hereunder, to the same extent as they would if such liabilities and claims were not subject to
indemnification hereunder (provided, such efforts shall not be deemed to require </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
instituting litigation or other proceedings). The amount of any indemnification hereunder shall be reduced or reimbursed, as the case may be, by any amount received by the Indemnified Party from
any other party alleged to be responsible therefor (net of costs and expenses incurred in connection with such recovery). The Indemnified Party shall use reasonable efforts to collect any amounts available from such other parties alleged to have
responsibility (provided, such efforts shall not be deemed to require instituting litigation or other proceedings). If the Indemnified Party receives an amount from such other party subsequent to an indemnification provided by the Indemnifying Party
pursuant to this <U>Section</U><U></U><U>&nbsp;11</U>, the Indemnified Party shall promptly reimburse the Indemnifying Party for any payment made or expense incurred by the Indemnifying Party in connection with providing such indemnification up to
such amount received by the Indemnified Party (net of costs and expenses incurred in connection with such recovery). Each party shall act in a commercially reasonable manner in addressing any liabilities that may provide the basis for an
indemnifiable claim (that is, each party shall respond to such liability in the same manner that it would respond to such liability in the absence of the indemnification provided for in this Agreement). Any request for indemnification of specific
costs shall include invoices and supporting documents containing reasonably detailed information about the costs or damages for which indemnification is being sought. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>11.7 </I></B><B><I>Calculation of Damages</I></B>. Any and all materiality qualifiers (or words of similar import) in any representation
or warranty in this Agreement shall be disregarded and shall not have any effect solely with respect to the calculation of the amount of any Damages attributable to a misrepresentation as to, or inaccuracy in, any such representation or warranty.
For the avoidance of doubt the immediately preceding sentence applies only for purposes of determining the amount of Damages, and any qualification by the term &#147;material&#148; (or words of similar import) that is expressly contained in any
representation or warranty in this Agreement is still valid for determining whether there exists any breach or inaccuracy in such representation and warranty. Unless otherwise required by any legal requirement, any indemnity payment hereunder to or
from Sellers shall be treated for all tax purposes as an adjustment to the Purchase Price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>11.8 </I></B><B><I>Exclusive
Remedy</I></B>. The representations and warranties contained in or made pursuant to this Agreement shall be terminated and extinguished upon the earlier of the end of the applicable Survival Period (hereinafter defined) or any termination of this
Agreement; provided that with respect to any claim for breach that has been made prior to the end of such Survival Period or termination of this Agreement shall survive until such claim is finally resolved pursuant to this
<U>Section</U><U></U><U>&nbsp;11</U> as further described in <U>Section</U><U></U><U>&nbsp;12.17</U>. Thereafter, none of Sellers, Buyers or any shareholder, partner, officer, director, principal or Affiliate of any of the preceding shall be subject
to any liability of any nature whatsoever with respect to any such representation or warranty. Moreover, absent fraud or willful misrepresentation, the sole and exclusive remedy for any breach or inaccuracy, or alleged breach or inaccuracy, of any
representation and warranty made by Sellers or Buyers in this Agreement shall be the remedies provided by this <U>Section</U><U></U><U>&nbsp;11</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>12. MISCELLANEOUS. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.1
</I></B><B><I>Schedules and </I></B><B><I>Exhibits</I></B>. Each Schedule and Exhibit to this Agreement shall be incorporated herein and considered a part hereof as if set forth herein in full. From the date hereof until the Closing Date, Sellers or
Buyers may update their Schedules, subject to the other party&#146;s approval rights and other limitations described below. If a party, after having a period of ten (10) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
business days to review any modification or amendment to a Schedule proposed by another party, determines in its reasonable discretion that it should not consummate the transactions on the terms
contemplated by this Agreement because the modification or amendment to such Schedule discloses facts or circumstances not disclosed in the original Schedules that have a Material Adverse Effect, demonstrates a breach of any Fundamental
Representations or would have a material and adverse impact on Buyers&#146; ability to perform their obligations under this Agreement, in the case of a modification proposed by Sellers, or that would have a material and adverse impact on
Sellers&#146; ability to perform their obligations under this Agreement, in the case of a modification proposed by Buyers, then such party may terminate this Agreement by giving a written notice to the other party on or before the Closing (which
notice may include, in the alternative, proposed changes in the terms of this Agreement to compensate for any such matters) (a &#147;Termination Notice&#148;), whereupon the other party shall be entitled, for a period of ten (10)&nbsp;business days
after its receipt of the Termination Notice, to cure the matter that has triggered the Termination Notice (or accept such proposed alternative terms to compensate for such matters). Notwithstanding anything contained herein to the contrary, the
inclusion of new or different information on a Schedule after the date of this Agreement shall not prejudice or otherwise affect a party&#146;s right to seek relief for the other party&#146;s breach of a representation, warranty or covenant or
affect the party&#146;s right to indemnification under <U>Section</U><U></U><U>&nbsp;11.1</U> or <U>Section</U><U></U><U>&nbsp;11.2</U> (based upon the Schedule as of the date of this Agreement without taking into account any modification, update or
amendment). Notwithstanding anything herein to the contrary, after the date of this Agreement, (i)&nbsp;no new Schedules may be added, (ii)<U>&nbsp;Schedule 1.1(a)(i)</U> and <U>(ii)</U>&nbsp;and <U>Schedule 1.2</U> may not be updated in any
respect, including with the addition or deletion of any Owned Real Property or Leased Real Property (except, with respect only to leases other than the Hospital Lease and the leases listed as items 3, 8, 9 and 10 under &#147;Brooksville&#148; on
<U>Schedule 1.1(a)(ii)</U>, to the extent a lease expires or is terminated by a third party; provided that the leases identified as items 8, 9 and 10 under &#147;Brooksville&#148; on Schedule 1.1(a)(ii) may be assigned to FESC prior to Closing),
unless all parties hereto consent in writing to such update, (iii)<U>&nbsp;Schedule 1.1(g)</U><B> </B>may not be updated in any respect (including through the addition and/or deletion of contracts on such Schedule, except with respect to the removal
of Contracts that have expired or been terminated by third parties or the addition of Immaterial Contracts or renewals, extensions or replacements (on substantially similar terms) of Contracts in the ordinary course of business that do not
materially increase the costs, liabilities or obligations being assumed by Buyers thereunder) unless all parties hereto consent in writing to such update, and (iv)<U>&nbsp;Schedule 1.3</U> (except to reflect any reductions in the balances of any
capitalized/finance leases as of the Closing), <U>Schedule 1.6</U>, <U>Schedule 7.7</U> and <U>Schedule 10.24</U> may not be updated in any respect unless all parties hereto consent in writing to such update. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.2 </I></B><B><I>Additional Assurances</I></B>. The provisions of this Agreement shall be self-operative and shall not require further
agreement by the parties except as may be herein specifically provided to the contrary; provided, however, at the request of a party, the other party or parties shall execute such additional instruments and take such additional actions as are
consistent with this Agreement and are reasonably necessary or convenient to consummate the transactions contemplated hereby, with each party bearing its own costs and expenses incurred by such party related thereto. In addition and from time to
time after the Closing, Sellers shall execute and deliver such other instruments of conveyance and transfer, and take such other actions as Buyers reasonably may request, more effectively to convey and transfer full right, title, and interest to,
vest in, and place Buyers in legal and actual possession of, any and all of the Hospitals, other Facilities and the Assets in a manner consistent with this Agreement and the agreements ancillary hereto with each party bearing its own costs and
expenses associated therewith. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.3 </I></B><B><I>Consented Assignment</I></B>. Anything contained herein to the
contrary notwithstanding, this Agreement shall not constitute an agreement to assign any claim, right, contract, license, lease, commitment, sales order, or purchase order if an attempted assignment thereof without the consent of the other party
thereto would constitute a breach thereof or in any material way adversely affect the rights of Sellers thereunder (each a <FONT STYLE="white-space:nowrap">&#147;Non-Assigned</FONT> Contract&#148;), unless such consent is obtained. After Closing,
Sellers and Buyers will cooperate with one another in good faith using commercially reasonable efforts to obtain each such third-party consent reasonably necessary for the valid assignment of each <FONT STYLE="white-space:nowrap">Non-Assigned</FONT>
Contract; provided, however, in connection with such consents, Buyers shall not be required to acquiesce to amendments to <FONT STYLE="white-space:nowrap">Non-Assigned</FONT> Contracts or other terms that require the payment of additional amounts or
other material undertakings by Buyers as a condition for such consent. If any such third-party consent is not obtained, Sellers will cooperate with Buyers to deliver to Buyers, as applicable, the economic and other benefits that Buyers would have
actually received under the applicable <FONT STYLE="white-space:nowrap">Non-Assigned</FONT> Contract, including enforcement for the benefit of Buyers of any and all rights of Sellers against any other party with respect to such <FONT
STYLE="white-space:nowrap">Non-Assigned</FONT> Contract. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.4 </I></B><B><I>Consents, Approvals and Discretion</I></B>. Except as
herein expressly provided to the contrary, whenever this Agreement requires any consent or approval to be given by a party, or whenever a party must or may exercise discretion, the parties agree that such consent or approval shall not be
unreasonably withheld or delayed and such discretion shall be reasonably exercised. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.5 </I></B><B><I>Legal Fees and
Costs</I></B>. In the event a party elects to incur legal expenses to enforce or interpret any provision of this Agreement by judicial proceedings, the prevailing party will be entitled to recover such legal expenses, including, without limitation,
reasonable attorneys&#146; fees, costs, and necessary disbursements at all court levels, in addition to any other relief to which such party shall be entitled. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.6 </I></B><B><I>Choice of Law</I></B><B><I>; Jurisdiction</I></B>. The parties agree that this Agreement shall be governed by and
construed in accordance with the laws of the State of Florida, without regard to conflict of laws principles. T<SMALL>O</SMALL> <SMALL>THE</SMALL> <SMALL>EXTENT</SMALL> <SMALL>ALLOWED</SMALL> <SMALL>BY</SMALL> <SMALL>LAW</SMALL>, <SMALL>EACH</SMALL>
<SMALL>PARTY</SMALL> <SMALL>HERETO</SMALL> <SMALL>HEREBY</SMALL> <SMALL>SUBMITS</SMALL> <SMALL>ITSELF</SMALL> <SMALL>TO</SMALL> <SMALL>JURISDICTION</SMALL> <SMALL>IN</SMALL> <SMALL>THE</SMALL> S<SMALL>TATE</SMALL> <SMALL>OF</SMALL>
F<SMALL>LORIDA</SMALL> <SMALL>FOR</SMALL> <SMALL>ANY</SMALL> <SMALL>ACTION</SMALL> <SMALL>OR</SMALL> <SMALL>CAUSE</SMALL> <SMALL>OF</SMALL> <SMALL>ACTION</SMALL> <SMALL>ARISING</SMALL> <SMALL>OUT</SMALL> <SMALL>OF</SMALL> <SMALL>OR</SMALL>
<SMALL>IN</SMALL> <SMALL>CONNECTION</SMALL> <SMALL>WITH</SMALL> <SMALL>THIS</SMALL> A<SMALL>GREEMENT</SMALL>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.7
</I></B><B><I>Benefit/Assignment</I></B>. Subject to provisions herein to the contrary, this Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective legal representatives, successors, and assigns. No party
may assign this Agreement without the prior written consent of the other parties, which consent shall not be unreasonably withheld; provided, however, that, except for the obligations in <U>Sections 12.27</U> and <U>12.28</U>, any party may, without
the prior written consent of the other parties, assign its rights and delegate its duties hereunder to one or more Affiliates (provided such Affiliates have the ability, including the financial wherewithal, to perform the assignor&#146;s
responsibilities hereunder) so long as written notice is provided to the other parties. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.8 </I></B><B><I>No Brokerage</I></B>. Except as set forth on <U>Schedule 12.8</U>,
Buyers and Sellers each represent and warrant to the other that they have not engaged a broker in connection with the transactions described herein. Each party agrees to be solely liable for and obligated to satisfy and discharge all loss, cost,
damage, or expense arising out of claims for fees or commissions of brokers employed or alleged to have been employed by such party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.9 </I></B><B><I>Cost of Transaction</I></B>. Whether or not the transactions contemplated hereby shall be consummated, the parties
agree as follows: (i)&nbsp;Sellers shall pay the fees, expenses, and disbursements of Sellers and their agents, representatives, accountants, and legal counsel incurred in connection with the subject matter hereof and any amendments hereto;
(ii)&nbsp;Sellers shall pay for the stub-period audit required by the Agency For Health Care Administration (&#147;AHCA&#148;) with respect to the period ending on the Effective Time; (iii)&nbsp;Buyers shall pay the fees, expenses, and disbursements
of Buyers and their agents, representatives, accountants and legal counsel incurred in connection with the subject matter hereof and any amendments hereto; (iv)&nbsp;Buyers shall pay for, all premiums, fees and costs associated with the Title
Commitment, the Title Policy and the Surveys, any filing fees required to obtain approvals or waivers under the HSR Act, any environmental engineering reports, licensure application fees, recording fees, and mechanical, structural, electrical and
roofing engineering costs; (v)&nbsp;Buyers shall pay for any stub-period audit required by AHCA with respect to any period ending after the Effective Time; and (vi)&nbsp;Buyers (collectively) and Sellers (collectively) shall each pay fifty percent
(50%) of all state, county and local transfer, documentary or similar taxes payable in connection with the transfer of the Assets or the recording of the Deeds. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.10 </I></B><B><I>Confidentiality</I></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a) </I></B>It is understood by the parties hereto that the information, documents, and instruments delivered to Buyers by Sellers and
their agents and the information, documents, and instruments delivered to Sellers by Buyers and their agents are of a confidential and proprietary nature as further described in that certain Agreement for Use and
<FONT STYLE="white-space:nowrap">Non-Disclosure</FONT> of Confidential Information dated as of July&nbsp;25, 2022 and that certain Clean Team Confidentiality Agreement dated March&nbsp;21, 2023, each by and between CHSPSC, LLC and TGH (collectively,
the &#147;Confidentiality Agreements&#148;). Each of the parties hereto agrees that prior to the Closing it will maintain the confidentiality of all such confidential information, documents, or instruments delivered to it by each of the other
parties hereto or their agents in connection with the negotiation of this Agreement or in compliance with the terms, conditions, and covenants of such Confidentiality Agreements and will only disclose such information, documents, and instruments as
permitted by such Confidentiality Agreements and to its duly authorized officers, members, directors, representatives, and agents (including consultants, attorneys, and accountants of each party) and applicable Government Entities in connection with
any required notification or application for approval or exemption therefrom or as may be required in connection with any debt or bond financing, investment transaction, merger, acquisition or similar business combination or finance transaction
(subject to customary confidentiality protections being in place with such third parties). Each of the parties hereto further agrees that if the transactions contemplated hereby are not consummated, it will return all such documents and instruments
and all copies thereof in its possession to the other parties to this Agreement (subject to the terms, exceptions and conditions of such Confidentiality Agreements). Otherwise, the parties acknowledge and agree that the Confidentiality Agreements
shall terminate as of the Closing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b) </I></B>Each of the parties hereto recognizes that any breach of this
<U>Section</U><U></U><U>&nbsp;12.10</U> could result in irreparable harm to the other party to this Agreement and its Affiliates and that therefore either Sellers or Buyers shall be entitled to seek an injunction to prohibit any such breach or
anticipated breach, without the necessity of posting a bond, cash, or otherwise, in addition to all of its other legal and equitable remedies. Nothing in this <U>Section</U><U></U><U>&nbsp;12.10</U>, however, shall prohibit the use of such
confidential information, documents, or information as permitted pursuant to such Confidentiality Agreements for such governmental filings as in the opinion of Sellers&#146; counsel or Buyers&#146; counsel are required by law or governmental
regulations or are otherwise required to be disclosed pursuant to applicable federal or state law, rule, regulation or order of any Government Entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.11 </I></B><B><I>Public Announcements</I></B>. Sellers and Buyers mutually agree that no party hereto shall release, publish, or
otherwise make available to the public in any manner whatsoever any information or announcement regarding the transactions herein contemplated without the prior written consent of Sellers and Buyers, except for information and filings reasonably
necessary to be directed to Government Entities to fully and lawfully effect the transactions herein contemplated or required in connection with securities and other laws. For the sake of clarification, nothing contained in this Agreement shall
limit: (a)&nbsp;Sellers or their Affiliates from making any disclosures or filing any agreements that they deem necessary or advisable to be made in any filings with the Securities and Exchange Commission as a result of the transactions contemplated
by this Agreement or in connection with any future securities offerings of Sellers or their Affiliates; or (b)&nbsp;Buyers or any of their Affiliates from making any disclosures or filing any agreements that they deem necessary or advisable to be
made with the Municipal Securities Rulemaking Board (MSRB), whether on MSRB&#146;s Electronic Municipal Market Access as a result of the transactions contemplated by this Agreement or in connection with any future securities offerings of Buyers or
their Affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.12 </I></B><B><I>Waivers</I></B>. The waiver by any party of a breach or violation of any provision of this
Agreement shall not operate as, or be construed to constitute, a waiver of any subsequent breach of the same or any other provision hereof. Any waiver of a breach or violation of any provision of this Agreement must be in writing and signed by the
party waiving such breach or violation to be effective. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.13 </I></B><B><I>Notice</I></B>. Any notice, demand, or communication
required, permitted, or desired to be given hereunder shall be deemed effectively given when personally delivered, when received by receipted overnight delivery, or five (5)&nbsp;days after being deposited in the United States mail, with postage
prepaid thereon, certified or registered mail, return receipt requested, addressed as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="71%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Sellers:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">CHS/Community Health Systems, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">4000 Meridian Boulevard</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Franklin, TN 37067</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Attn: Vice President &#150; Acquisitions</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="71%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">With a simultaneous copy to:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">CHSPSC, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">4000 Meridian Boulevard</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Franklin, TN 37067</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Attn: General Counsel</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Buyers:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">c/o Florida Health Sciences Center, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">d/b/a Tampa General Hospital</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">One Tampa General Circle</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Tampa, Florida 33606</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Attn: Mark Runyon, EVP&nbsp;&amp; CFO</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">With a simultaneous copy to:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">James J. Kennedy, III, Esquire</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Carlton Fields, P.A.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4221 West Boy Scout
Boulevard, Suite 1000</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Tampa, Florida 33607-5780</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">or to such other address, and to the attention of such other person or officer as any party may designate, with copies thereof
to the respective counsel thereof as notified by such party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.14 </I></B><B><I>Severability</I></B>. In the event any provision
of this Agreement is held to be invalid, illegal or unenforceable for any reason and in any respect, such invalidity, illegality, or unenforceability shall in no event affect, prejudice, or disturb the validity of the remainder of this Agreement,
which shall be and remain in full force and effect, enforceable in accordance with its terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.15 </I></B><B><I>Gender;
Number</I></B><B><I>; General Interpretation</I></B>. Unless otherwise expressly provided, for purposes of this Agreement, the following rules of interpretation shall apply: (i)&nbsp;the gender of all words herein shall include the masculine,
feminine, and neuter, and the number of all words herein shall include the singular and plural; (ii)&nbsp;the words such as &#147;herein,&#148; &#147;hereinafter,&#148; &#147;hereof,&#148; and &#147;hereunder&#148; refer to this Agreement as a whole
and not merely to a subdivision in which such words appear unless the context otherwise requires; (iii)&nbsp;the word &#147;including&#148; or any variation thereof means (unless the context of its usage clearly requires otherwise) &#147;including,
but not limited to,&#148; and shall not be construed to limit any general statement that it follows to the specific or similar items or matters immediately following it; (iv)&nbsp;when calculating the period of time before which, within which or
following which, any act is to be done or step taken pursuant to this Agreement, the date that is the reference date in calculating such period shall be excluded; and (v)&nbsp;the phrase &#147;to the extent&#148; means the degree to which a thing or
matter extends, and does not simply mean &#147;if.&#148; In addition, the term &#147;Person&#148; means any individual, partnership, limited liability company, corporation, joint venture, trust, business trust, cooperative or other association or
entity, including any Government Entity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.16 </I></B><B><I>Divisions and Headings</I></B>. The divisions of this Agreement into
sections and subsections and the use of captions and headings in connection therewith are solely for convenience and shall have no legal effect in construing the provisions of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.17 </I></B><B><I>Survival</I></B>. All of the representations, warranties,
covenants, and agreements made by the parties in this Agreement or pursuant hereto in any certificate, instrument, or document shall survive the consummation of the transactions described herein, and may be fully and completely relied upon by
Sellers and Buyers, as the case may be, notwithstanding any investigation heretofore or hereafter made by any of them or on behalf of any of them, and shall not be deemed merged into any instruments or agreements delivered at the Closing or
thereafter. The representations and warranties contained in this Agreement shall survive the Closing for a period of two (2)&nbsp;years following the Closing Date (the &#147;Survival Period&#148;); provided that the &#147;Survival Period&#148; for
the representations and warranties made by Sellers in <U>Sections 3.1</U>, <U>3.2</U>, <U>3.3</U>, <U>3.7(c)(i)</U>, <U>3.8(c)</U>, <U>3.10</U> (the first sentence only), <U>3.11</U>, <U>3.14</U>, <U>3.26</U> and <U>12.8</U> and for the
representations and warranties made by Buyers in <U>Sections 4.1</U>, <U>4.2</U>, <U>4.3</U> and <U>12.8</U> shall be six (6)&nbsp;years following the Closing Date; and, with respect to the representations and warranties made by Sellers in
<U>Section</U><U></U><U>&nbsp;3.15</U>, the &#147;Survival Period&#148; shall be until all applicable statutes of limitations related to Taxes and the subject matter of such representations and warranties have expired. Notwithstanding anything to
the contrary in this Agreement, if a party makes a timely claim for indemnification in accordance with the terms of this Agreement with respect to any matter for which indemnification is provided hereunder prior to the expiration of the applicable
Survival Period, the representation, warranty, or covenant, as applicable, and the indemnification obligations and other obligations contained in <U>Section</U><U></U><U>&nbsp;11</U> with respect to such claim, shall survive indefinitely with
respect to all Damages arising out of or related to such matter or in connection with such claim, whenever incurred, until such claim is finally resolved and all amounts required to be paid hereunder have been fully paid in accordance with the terms
hereof. The parties to this Agreement expressly intend by this <U>Section</U><U></U><U>&nbsp;12.17</U> to contractually modify the applicable statute of limitations for the matters set forth in this <U>Section</U><U></U><U>&nbsp;12.17</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.18 </I></B><B><I>Affiliates</I></B>. As used in this Agreement, the term &#147;Affiliate&#148; means, as to the entity in question,
any Person that directly or indirectly controls, is controlled by or is under common control with, the entity in question and the term &#147;control&#148; means possession, directly or indirectly, of the power to direct or cause the direction of the
management and policies of an entity whether through ownership of voting securities, by contract or otherwise. For the avoidance of doubt, the Partial Subsidiaries shall <B><U>not</U></B> be deemed to be &#147;Affiliates&#148; of Sellers for the
purposes of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.19 </I></B><B><I>Waiver of Jury Trial</I></B>. EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES ANY AND
ALL RIGHTS IT MAY HAVE TO DEMAND THAT ANY ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR IN ANY WAY RELATED TO THIS AGREEMENT OR THE RELATIONSHIPS OF THE PARTIES HERETO BE TRIED BY JURY. THIS WAIVER EXTENDS TO ANY AND ALL RIGHTS TO DEMAND A
TRIAL BY JURY ARISING FROM ANY SOURCE INCLUDING, BUT NOT LIMITED TO, THE CONSTITUTION OF THE UNITED STATES OR ANY STATE THEREIN, COMMON LAW OR ANY APPLICABLE STATUTE OR REGULATIONS. EACH PARTY HERETO ACKNOWLEDGES THAT IT IS KNOWINGLY AND VOLUNTARILY
WAIVING ITS RIGHT TO DEMAND TRIAL BY JURY. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.20 </I></B><B><I>Accounting Date</I></B>. The transactions contemplated hereby shall
be effective for accounting purposes as of the Effective Time, unless otherwise agreed in writing by Sellers and Buyers. The parties will use commercially reasonable efforts to cause the Closing to be effective as of a month end, with equitable
adjustments made to the Purchase Price necessary to give effect to the foregoing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.21 </I></B><B><I>No Inferences</I></B>. Inasmuch as this Agreement is the result of
negotiations between sophisticated parties of equal bargaining power represented by counsel, no inference in favor of, or against, either party shall be drawn from the fact that any portion of this Agreement has been drafted by or on behalf of such
party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.22 </I></B><B><I>Limited Third Party Beneficiaries</I></B>. The terms and provisions of this Agreement are intended
solely for the benefit of Buyers, Sellers, CHS and TGH, and their Affiliates and their respective permitted successors or assigns, and it is not the intention of the parties to confer, and this Agreement shall not confer, third-party beneficiary
rights upon any other person other than Sellers and Buyers, which the parties agree are express third party beneficiaries of the rights of Sellers and Buyers, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.23 </I></B><B><I>Entire Agreement/Amendment</I></B>. With the exception of the Agreement for Use and
<FONT STYLE="white-space:nowrap">Non-Disclosure</FONT> of Confidential Information dated as of July&nbsp;25, 2022 and the Clean Team Confidentiality Agreement dated March&nbsp;21, 2023, each by and between CHSPSC, LLC and TGH (both of which shall
terminate at Closing), this Agreement supersedes all previous contracts, and constitutes the entire agreement of whatsoever kind or nature existing between or among the parties respecting the within subject matter, and no party shall be entitled to
benefits other than those specified herein. As between or among the parties, no oral statements or prior written material not specifically incorporated herein shall be of any force and effect. The parties specifically acknowledge that in entering
into and executing this Agreement, the parties rely solely upon the representations and agreements contained in this Agreement and no others. All prior representations or agreements, whether written or verbal, not expressly incorporated herein are
superseded, and no changes in or additions to this Agreement shall be recognized unless and until made in writing and signed by all parties hereto. This Agreement may be executed in two or more counterparts, each and all of which shall be deemed an
original and all of which together shall constitute but one and the same instrument. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.24 </I></B><B><I>Risk of
Loss</I></B><B><I>; Casualty</I></B>. Notwithstanding any other provision hereof to the contrary, the risk of loss or damage to any of the Assets, the Facilities and all other property, transfer of which is contemplated by this Agreement, shall be
borne by Sellers until the Effective Time and by Buyers after the Effective Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a) </I></B>If, prior to the Closing, all or any
part of a Hospital or other material tangible Assets is lost, destroyed or damaged, in whole or in part, by fire or the elements, theft, vandalism or by any other cause, where such loss, damage or destruction is in the aggregate (the &#147;Aggregate
Damage&#148;) less than $19,000,000, the parties&#146; duties and obligations under this Agreement shall not be affected and the Closing shall proceed as scheduled; <U>provided</U>, <U>however</U>, at Buyers&#146; election, either (i)&nbsp;the
Purchase Price shall be reduced by the fair market value of the lost, damaged or destroyed Asset (determined immediately prior to the loss, damage or destruction), or (ii)&nbsp;Sellers shall assign, transfer and set over to Buyers or their
designated Affiliate all of Sellers&#146; right, title and interest in and to any and all insurance proceeds (including business interruption insurance) and pay to Buyers the amount of any deductibles under such insurance policies on account of such
loss, damage or destruction and, if such insurance policy proceeds are insufficient to repair, restore and/or replace the Hospital or other affected Assets, the difference between the cost to repair, restore and/or replace and the amount of such
proceeds shall be deducted from the Purchase Price. If, prior to the Closing, all or any part of a Hospital or other tangible Assets is lost, destroyed or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
damaged by fire or the elements, theft, vandalism or by any other cause where the Aggregate Damage equals or exceeds $19,000,000, Buyers may elect to (x)&nbsp;purchase the Hospitals and Assets,
and the Closing shall proceed as scheduled (<U>provided</U>, <U>however</U>, at the Closing, Sellers shall assign, transfer and set over to Buyers all of Sellers&#146; right, title and interest in and to any insurance proceeds (including business
interruption insurance) on account of such damage or destruction loss plus the amount of any deductibles under such insurance policies), or (y)&nbsp;terminate this Agreement as to all, but not less than all, of the Hospitals and Assets by the
delivery of a written notice to Sellers (the &#147;Casualty Termination Notice&#148;). If Buyers and Sellers are unable to agree upon the amount of the Aggregate Damage, the amount of the Aggregate Damage shall be determined by an independent
consulting firm experienced in the healthcare industry mutually selected by Sellers and Buyers (the &#147;Independent Consultant&#148;) pursuant to <U>Section</U><U></U><U>&nbsp;12.24(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b) </I></B>If pursuant to <U>Section</U><U></U><U>&nbsp;12.24(a)</U>, the amount of the Aggregate Damage (and any applicable Purchase
Price adjustment) is to be determined by the Independent Consultant, within thirty (30)&nbsp;calendar days after the occurrence of the loss, damage or destruction at issue (the &#147;Submittal Date&#148;), each of Buyers, on the one hand, and
Sellers, on the other hand, shall submit to the other and to the Independent Consultant their proposed calculation of Aggregate Damage (and any applicable Purchase Price adjustment) as a result of the event(s) contemplated by
<U>Section</U><U></U><U>&nbsp;12.24(a)</U>, along with a reasonably detailed description of the basis for such amount and any applicable adjustment. Within ten (10)&nbsp;business days after the Submittal Date (or such longer date as may be agreed to
by the parties) (the &#147;Decision Date&#148;), the Independent Consultant, acting as an expert and not as an arbitrator, shall determine the definitive amount of the Aggregate Damage (and any applicable adjustment to the Purchase Price), taking
into account any submissions by Sellers or Buyers by the Submittal Date. If the Aggregate Damage equals or exceeds $19,000,000, Buyers shall thereafter have the right to terminate this Agreement by delivery of a Casualty Termination Notice to
Sellers as contemplated by <U>Section</U><U></U><U>&nbsp;12.24(a)</U>. The decision of the Independent Consultant shall be conclusive and binding as between Buyers and Sellers, and the costs of such review shall be borne equally by Sellers and
Buyers. Upon any such determination of the adjustment to the Purchase Price in accordance with this <U>Section</U><U></U><U>&nbsp;12.24</U>, the parties shall, subject to the terms and conditions of this Agreement, consummate the transactions
contemplated by this Agreement at a mutually agreeable time and place, in accordance with the provisions of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.25
</I></B><B><I>Material Adverse Effect</I></B>. As used in this Agreement, the term &#147;Material Adverse Effect&#148; means an event, change, state of facts, condition, development or circumstance which, individually or together with any other
event, change, state of facts, condition, development or circumstance, has or would reasonably be expected to have a material adverse effect (whether or not covered by insurance) on (i)&nbsp;the business (as currently conducted by Sellers), assets,
financial condition, liabilities, or results of operations of the Hospitals, taken as a whole, or (ii)&nbsp;the ability of Sellers to perform their obligations under this Agreement and the other agreements being executed and delivered in connection
herewith at or prior to the Closing or to consummate the transactions contemplated hereby and thereby; <U>provided, however</U>, that with respect to clause (i)&nbsp;of this definition, none of the following occurring after the date of this
Agreement shall constitute a Material Adverse Effect or be taken into account in determining whether a Material Adverse Effect has occurred: (a)&nbsp;changes or proposed changes to any law, reimbursement rates or policies of governmental agencies or
bodies that are generally applicable to hospitals or health care facilities; (b)&nbsp;changes or proposed changes in requirements, reimbursement rates, policies or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
procedures of third party payors or accreditation commissions or organizations that are generally applicable to hospitals or health care facilities; (c)&nbsp;any changes or any proposed changes
in GAAP after the date of this Agreement; (d)&nbsp;any hostilities, acts of war, sabotage, terrorism or military actions, or any escalation or worsening of any such hostilities, acts of war, sabotage, terrorism or military actions; (e)&nbsp;changes
resulting solely from the public announcement of this Agreement or the pendency of the transactions contemplated hereby (including, without limitation, changes in private payor agreements or policies and their effects and the departure of
employees), or Buyers being the proposed purchaser of the Assets; (f)&nbsp;compliance with the terms of, or the taking of any action required, by this Agreement or consented to by Buyers; (g)&nbsp;any failure in and of itself to meet internal or
published projections, estimates or forecasts of revenues, earnings, cash flow, or other measures of financial or operating performance for any period (<U>provided</U>, <U>however</U>, that any event, state of facts, condition, change, effect or
development that caused or contributed to such failure to meet any projections, estimates or forecasts or revenue, earnings, cash flows or other measures of performance shall not be excluded under this clause); or (h)&nbsp;any epidemic, pandemic,
disease outbreak (including <FONT STYLE="white-space:nowrap">COVID-19)</FONT> or other health crisis or public health event, or the worsening of the foregoing; <U>provided</U> <U>further</U>, <U>however</U>, that the matters referred to in clauses
(a), (b), (d) and (h)&nbsp;above shall be taken into account to the extent they have had or would reasonably be expected to have, individually or in the aggregate, a disproportionate adverse impact on the Assets, Assumed Liabilities or Facilities
relative to other similar healthcare provider facilities operating in the healthcare industry. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.26 </I></B><B><I>Radon
Gas</I></B>. Radon is a naturally occurring radioactive gas that, when it has accumulated in a building in sufficient quantities, may present health risks to persons who are exposed to it over time. Levels of radon that exceed federal and state
guidelines have been found in buildings in Florida. Additional information regarding radon and radon testing may be obtained from your county public health unit. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.27 </I></B><B><I>CHS Guaranty</I></B>. CHS hereby unconditionally and absolutely guarantees the prompt performance and observance by
Sellers and their Affiliates of each and every obligation, covenant and agreement of Sellers and Affiliates arising out of, connected with, or related to, this Agreement or any ancillary documents hereto and any extension, renewal and/or
modification thereof. The obligation of CHS under this <U>Section</U><U></U><U>&nbsp;12.27</U> is a continuing guaranty, may not be assigned in whole or in part to any other Person without TGH&#146;s express written consent, and shall remain in
effect following Closing, and the obligations of CHS shall not be affected, modified or impaired upon the happening from time to time of any of the following events, whether or not with notice or consent of CHS: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a) </I></B>The compromise, settlement, release, change, modification, or amendment (except to the extent of such compromise, settlement,
release, change, modification or amendment) of any or all of the obligations, duties, covenants, or agreements or any party under this Agreement or any ancillary documents hereto; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b) </I></B>The extension of the time for performance of payment of money pursuant to this Agreement, or of the time for performance of
any other obligations, covenants or agreements under or arising out of this Agreement or any ancillary documents hereto or the extension or the renewal thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.28 </I></B><B><I>TGH Guaranty</I></B>. TGH hereby unconditionally and absolutely
guarantees the prompt performance and observance by Buyers of each and every obligation, covenant and agreement of Buyers arising out of, connected with, or related to, this Agreement or any ancillary documents hereto and any extension, renewal
and/or modification thereof. The obligation of TGH under this <U>Section</U><U></U><U>&nbsp;12.28</U> is a continuing guaranty may not be assigned in whole or in part to any other Person without CHS&#146;s express written consent, and shall remain
in effect following Closing, and the obligations of TGH shall not be affected, modified or impaired upon the happening from time to time of any of the following events, whether or not with notice or consent of TGH: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a) </I></B>The compromise, settlement, release, change, modification, or amendment (except to the extent of such compromise, settlement,
release, change, modification or amendment) of any or all of the obligations, duties, covenants, or agreements or any party under this Agreement or any ancillary documents hereto; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b) </I></B>The extension of the time for performance of payment of money pursuant to this Agreement, or of the time for performance of
any other obligations, covenants or agreements under or arising out of this Agreement or any ancillary documents hereto or the extension or the renewal thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.29 </I></B><B><I>Knowledge of Sellers</I></B><B><I>. </I></B>As used in this Agreement, &#147;knowledge of Sellers&#148; or
&#147;Sellers&#146; knowledge&#148; (and any similar expression) means the actual knowledge of (i)&nbsp;each Hospital&#146;s Chief Executive Officer, Chief Financial Officer, Chief Nursing Officer and Chief Compliance Officer (or equivalent), and
(ii)&nbsp;CHSPSC, LLC&#146;s Vice Presidents of Acquisitions and Development, Senior Director of Project Management Design (Facilities Management Department), and Regional Chief Information Director, in each case after reasonable inquiry by such
Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[SIGNATURE PAGES FOLLOW] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties hereto have caused this Agreement to be executed in
multiple originals by their authorized officers, all as of the date first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HERNANDO HMA, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Terry H. Hendon</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Terry H. Hendon</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Vice President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>SPRING HILL HMA PHYSICIAN MANAGEMENT, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Terry H. Hendon</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Terry H. Hendon</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Vice President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>BROOKSVILLE HMA PHYSICIAN MANAGEMENT, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Terry H. Hendon</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Terry H. Hendon</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Vice President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>BRAVERA URGENT CARE, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Terry H. Hendon</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Terry H. Hendon</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Vice President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>CITRUS HMA, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Terry H. Hendon</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Terry H. Hendon</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Vice President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>CRYSTAL RIVER HMA PHYSICIAN MANAGEMENT, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Terry H. Hendon</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Terry H. Hendon</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Vice President</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to Asset Purchase Agreement] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>CHS/COMMUNITY HEALTH SYSTEMS, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Terry H. Hendon</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Terry H. Hendon</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Vice President</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to Asset
Purchase Agreement] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>FHSC NEWCO I, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Steve Short</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>FHSC NEWCO II, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Steve Short</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>FHSC REAL PROPERTY I, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Adam Smith</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>TGH AMBULATORY SERVICES COMPANY</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Adam Smith</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>FLORIDA HEALTH SCIENCES CENTER, INC. D/B/A TAMPA GENERAL HOSPITAL</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ John Couris</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">President and Chief Executive Officer</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to Asset
Purchase Agreement] </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>d504605dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g504605g61g93.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COMMUNITY HEALTH SYSTEMS ANNOUNCES DEFINITIVE AGREEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TO SELL THREE FLORIDA HOSPITALS TO TAMPA GENERAL HOSPITAL </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FRANKLIN, Tenn. (July 24, 2023)</B> <B>&#150;</B> Community Health Systems, Inc. (NYSE: CYH) announced today that subsidiaries of the Company have signed a
definitive agreement to sell <FONT STYLE="white-space:nowrap">120-bed</FONT> Bravera Health Brooksville in Brooksville, Florida, <FONT STYLE="white-space:nowrap">128-bed</FONT> Bravera Health Seven Rivers in Crystal River, Florida, <FONT
STYLE="white-space:nowrap">124-bed</FONT> Bravera Health Spring Hill in Spring Hill, Florida, and their associated assets to Tampa General Hospital and certain of its affiliates for cash consideration of $280&nbsp;million, excluding anticipated
purchase price adjustments for net working capital and the amount of capital leases assumed by the buyer. Total cash consideration to be received, inclusive of these items, is estimated to be approximately $290&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transaction is expected to close later this year, subject to customary regulatory approvals and closing conditions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The divestiture of these hospitals is among the additional potential transactions highlighted on the Company&#146;s first quarter 2023 earnings call. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About&nbsp;Community Health Systems, Inc. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Community
Health Systems, Inc.&nbsp;is one of the nation&#146;s largest healthcare companies. The Company&#146;s affiliates are leading providers of healthcare services, developing and operating healthcare delivery systems in 43 distinct markets across
15&nbsp;states. CHS subsidiaries own or lease 77&nbsp;affiliated hospitals with approximately 13,000 beds and operate more than 1,000 sites of care, including physician practices, urgent care centers, freestanding emergency departments, occupational
medicine clinics, imaging centers, cancer centers and ambulatory surgery centers. Shares in&nbsp;Community Health Systems, Inc.&nbsp;are traded on the&nbsp;New York Stock Exchange&nbsp;under the symbol &#147;CYH.&#148; The Company&#146;s
headquarters are located in&nbsp;Franklin, Tennessee, a&nbsp;suburb south of&nbsp;Nashville. More information about the Company can be found on its website at <U>www.chs.net</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Media Contacts: </B> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Community Health Systems </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tomi Galin, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">615-628-6607</FONT></FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive Vice President, Corporate Communications, Marketing and Public Affairs </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor Contacts: </B> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Community Health Systems </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kevin Hammons, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">615-465-7000</FONT></FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">President and Chief Financial Officer </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Anton Hie, <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">615-465-7012</FONT></FONT> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vice President &#150; Investor Relations </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-END- </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>cyh-20230724.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 7/25/2023 10:12:14 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2022"
  xmlns:cyh="http://www.chs.net/20230724"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.chs.net/20230724"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cyh-20230724_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cyh-20230724_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.chs.net//20230724/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>cyh-20230724_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 7/25/2023 10:12:14 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>cyh-20230724_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 7/25/2023 10:12:14 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.chs.net//20230724/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="cyh-20230724.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.chs.net//20230724/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g504605g61g93.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g504605g61g93.jpg
M_]C_X  02D9)1@ ! 0$ ;@!N  #_X1#R17AI9@  34T *@    @ ! $[  (
M   -   (2H=I  0    !   (6)R=  $    :   0T.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $9A=7-T;R!0
M875T80    60 P "    %   $*:0!  "    %   $+J2D0 "     S0S  "2
MD@ "     S0S  #J'  '   (#   ")H     '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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+ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139731782909248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jul. 24, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">COMMUNITY HEALTH SYSTEMS INC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001108109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 24,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-15925<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3893191<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">4000 Meridian Boulevard<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Franklin<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">37067<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(615)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">465-7000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CYH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>d504605d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cyh-20230724.xsd" xlink:type="simple"/>
    <context id="duration_2023-07-24_to_2023-07-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001108109</identifier>
        </entity>
        <period>
            <startDate>2023-07-24</startDate>
            <endDate>2023-07-24</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2023-07-24_to_2023-07-24"
      id="Hidden_dei_EntityRegistrantName">COMMUNITY HEALTH SYSTEMS INC</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2023-07-24_to_2023-07-24">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2023-07-24_to_2023-07-24"
      id="Hidden_dei_EntityCentralIndexKey">0001108109</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2023-07-24_to_2023-07-24">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2023-07-24_to_2023-07-24">2023-07-24</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2023-07-24_to_2023-07-24">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2023-07-24_to_2023-07-24">001-15925</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2023-07-24_to_2023-07-24">13-3893191</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2023-07-24_to_2023-07-24">4000 Meridian Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2023-07-24_to_2023-07-24">Franklin</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2023-07-24_to_2023-07-24">TN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2023-07-24_to_2023-07-24">37067</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2023-07-24_to_2023-07-24">(615)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2023-07-24_to_2023-07-24">465-7000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2023-07-24_to_2023-07-24">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2023-07-24_to_2023-07-24">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2023-07-24_to_2023-07-24">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2023-07-24_to_2023-07-24">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2023-07-24_to_2023-07-24">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-07-24_to_2023-07-24">CYH</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-07-24_to_2023-07-24">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2023-07-24_to_2023-07-24">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    (  ""^58'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    "   @OE6I CUZ.\    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M2L0P$(9?17)OITVI8NCFHGA2$%Q0O(7)[&ZP:4,RTN[;V];=+J(/X#$S?[[Y
M!J;!H+"/]!S[0)$=I:O1MUU2&#;BP!P40,(#>9/R*=%-S5T?O>'I&?<0#'Z8
M/8$LBFOPQ,8:-C #L[ 2A6XL*HQDN(\GO,45'SYCN\ L K7DJ>,$95Z"T//$
M<!S;!BZ &<84??HND%V)2_5/[-(!<4J.R:VI81CRH5IRTPXEO#T]OBSK9JY+
M;#JDZ5=RBH^!-N(\^;6ZN]\^""T+667%32;KK2Q46:OZ]GUV_>%W$?:]=3OW
MCXW/@KJ!7W>AOP!02P,$%     @  (+Y5IE<G",0!@  G"<  !,   !X;"]T
M:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M
M3A^%$5B-;'EDD81_OT<V$,N6#>V23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R
M>&#9+]O6N[<OWN!7,B0103 9IZ_PP JE3%ZU6FD PSA]R1,2P]R"BPA+>!3+
MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!
M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K
MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2
MBW <!.!1NY["G?1LOZ1!";2C:=!DV/;:KI&FJHU33]/W?=_KFVB<"HU;3]-K
M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M&H'QZR,&4CJ\B[MQD:_)N[=CT9:?W>37",U?E]B&QRV-W;W(V"<A5UN3HM]
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MKW#.RW^0\Y^M<\TUMTQ>DO:C_S=7^2V,D_'T7!S1JP,Z6PE<A!OZ%>Y7>>9
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M)$WS/(X %F>0IA@"IQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04
M"   @OE6EXJ[',     3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">
M, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]
M$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<
MUYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A
M(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X
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M%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    "   @OE6!T%-8H$
M  "Q    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4
M Q0    (  ""^5:D"/7H[P   "L"   1              "  :\   !D;V-0
M<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (  ""^5:97)PC$ 8  )PG   3
M          "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @
M (+Y5M^2S&]0!   C1   !@              ("!#@@  'AL+W=O<FMS:&5E
M=',O<VAE970Q+GAM;%!+ 0(4 Q0    (  ""^5:?H!OPL0(  .(,   -
M          "  90,  !X;"]S='EL97,N>&UL4$L! A0#%     @  (+Y5I>*
MNQS     $P(   L              ( !< \  %]R96QS+RYR96QS4$L! A0#
M%     @  (+Y5APX9>H_ 0  / (   \              ( !61   'AL+W=O
M<FMB;V]K+GAM;%!+ 0(4 Q0    (  ""^58D'INBK0   /@!   :
M      "  <41  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0
M   (  ""^59ED'F2&0$  ,\#   3              "  :H2  !;0V]N=&5N
B=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  /03      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d504605d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chs.net//20230724/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName -  d504605d8k.htm 7</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" original="d504605d8k.htm">d504605d8k.htm</File>
    <File>cyh-20230724.xsd</File>
    <File>cyh-20230724_lab.xml</File>
    <File>cyh-20230724_pre.xml</File>
    <File>d504605dex21.htm</File>
    <File>d504605dex991.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d504605d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d504605d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cyh-20230724_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cyh-20230724_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cyh-20230724.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "cyh",
   "nsuri": "http://www.chs.net/20230724",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d504605d8k.htm",
      "contextRef": "duration_2023-07-24_to_2023-07-24",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.chs.net//20230724/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d504605d8k.htm",
      "contextRef": "duration_2023-07-24_to_2023-07-24",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230724/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230724/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230724/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230724/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230724/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230724/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230724/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230724/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230724/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230724/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230724/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230724/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230724/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230724/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230724/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230724/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230724/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230724/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230724/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230724/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230724/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230724/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001193125-23-193446-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-193446-xbrl.zip
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M\!"&!^/A:#S\ :X_PEDBPV%*(U+,%<N-I/-%#-\%WT.2=2HX)XR1#9Q3[O.
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M&(RR,YKX;1:)K-DK#H;71%(1GO'P5#\Q;\KCD^2.P;1;$15!&*A:!+&934N
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MGR!0;X)Z;3UOS/_!")6)_9G24T'6?53K1OX8OAG$P^#X?U!+ P04    "
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M/OBJ+B2T$HZ.;OG]W8^".D7J#O?V7[62=S.2_E\44DR@=B<22#AN2;A1EZ,
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M"__(%^'?Y@JY;QI',WV3)!LC]7#^ @K) .E!+^[2Z%/\35W*]@=28 *W]-*
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MHARN1$*T1Y=0-<WZ3LUN2O8I''D1.CO[KR3[Z:$=P"%6 8>TI3HFN\!,*;&
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MQ"TAE8M S*\C+."FH&0,=T@9COS*5?<47,9@'?[$2O>1SM9R[2'<I-]=ID9
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MT!T6$GVM-&:T)A(D'9]-XAOO)'RT A)>=^4;NG+IF%9GGTTM.6NVG,ZJ3WJ
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M[:V"M1<S&<G41AL/I](5</P4DIV@DB1%GT1-P/ 96Y9-B_R:K^5II'H24)[
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M+TP??P'AZ.^J-#6R4YYVXBMX>N7^N**90+ZVC;&0PY_4C6US3OQ CHL4N;%
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MVX.X0E=_TPXB@]9F]^G% M.0H-%&"<J#DW]<WL&GSWY&#K\Q[^ :M]!GJ V
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M*R4&Y-7QTV!$<KN?;3,4SCXK'MXB1L@^O!3#-_',XZ/74"3= 9K^G?69:4%
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MN2H:98D7;T9J"F0753:>DEZZ[3R(33W09BL6(Y%; $$_V</<0\&\*(9%6_[
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M;6_28IH2'9I;VR87 4R;N-O;$.3F%"[0Q/D?*QU'4P"M5O,)C$XF]< _::^
M;[&0"[0F)3DPKB%921_3^J9Z,-0 =!O-L*VT4I78?CDL=S#JO 2<5W<K9G'
M7]@*5?3C)F H^@.6@ XAK)5,B!ZPK>51B6R?V*Z*!"@76E^1'#TNL=C6G7I.
M[M3!7P.W(A1M$R@ZQM4W4F]C!:1]%+@2(Q"7-KHQ[.JRXAF<"B6P0L.+(**>
M[?(PQVDAIK+4$J_KFKY*"E(RARZ&70%O A#3MNS<:'_/ZY_&W#-0QV5]<O@M
MTDA+>GD" 8/2X@>3;90J#DM%RG/O?[:1=]5^>"#*CQ\U-/KLZ&=H],N(WUC;
M,*@&X8ENJW1HXZ(9/]!$77)N.L]N;;9VW@5SB[RVV/OKW!18B;).@"YWYJP8
M+X=&JCS"8)$S"2-?C]P8P?4B]LY2BH:%6%]+G4.V'(R$YF'VJZ=715:U"3AL
M!R]"0BJI&$_5?_OX%>2Z,!BP;1P/H"==%?I 5$E4<NFE_-X2]T(]M[W@LUO;
M=\3N8@ZQRF&7D:D;P>]2CWE<$GG@&%B%V'._AE/A\6[&V);L7\($A_M0, YC
M<9H!*%U/<M1Q/@85[$A;,S[<V7Q0!4 M4!5.%KJK,SR9ED3"6.P:(/MB!VZ6
M>(>;904^][R,LX$P5_?W4N6@A7."9N@N1<G2<$.0=$/BH90)(0(:U1!>.W2L
M62J6-H5=#9BI-Y??6YMFRKBZ+6R[5NP+3CVCE=5B54OP\@B:19D&Y>@"UY5=
ME&6KN"W_,++';NL%]#]98%Y361+'"(FP04/?"V&9IZ5\2(>RK1+UFDY AX5F
MTSC:^Y)4BT'"*=4K6[V)#'ZWD8GAV:YAMD>T6\WJY&0<N/8HDM,")D2<P-[*
M^D-Z1/>_O]4)96Z-=-$IB(!I&O?N:W'('LME6Q-%--%P'M3%ZJ[DKA[Z$*:Y
M(RQKNO524OI#BO9]//_7+K?RF/;]UV)19._<W$#\6"<?^Z,POS_U7-@8S S>
MRH-[(U=O/5C,[;Y)OM.N_-*7L)V:<^@")*I&*]1^SO6O"X7I:84D*F8(G1L7
M\(?N)DUQN056E0==<FGHG83"Q4*4?#(E=1I@J,\RW7:[)&"?\9I4N%TRU<LO
M#>Q.#,J#+:K- ^^TCM(UK=^P%&XCXK1$M<<N+S(3%U,/+S1' M$M*Z*2;,4+
M=.Z"3'M/;BNDN;$JD*I5%*2_PEY/:WW-04?UGB?MQL #G^Z^>*")SOT XE@U
MS,A 7^;Z.S>Y6XRU+$KS0W=@>OV /F(BN/MV,TOI]/N]9$66JEPL99J-1"_-
MY> I5@"$1&^-.]/@1@$CX>T3 9."YHG&,.?((V1U/<+!L-^$PPU9U;I!9G\6
MJ4<OQRO9</TP8LV KG>)*5J<^5C(:ZEAB0M\925'PW8<1LL9]H=0 B7<1]3J
M%2C]_AY"_LUYJP>:T;:-9B+/HZ#?38_\,WMW?G%R\E:X5%TO+V=T5"ZDDZ![
M(]+C(2YZ7)I*: CM?4O3G//IUQ@L-"2N)Z,%77%=3LN[6W!P3^6)%_I$I$;D
M_8I+R-V0R? Y#[@@O;/-$<X/]?S)%6Z\"Q_@O*B;.73;W>TJ.W%/^1TK9>#V
M)Y0+?'IT]$R>7TGN&T"@L";NBRFL"7Y1H#X_;4HPS"Y5D?9$($V0[ESSZPM.
MIY]"P/I<ZB5@I" 6R-OK%;LZ@;4_@@^&C0=%,9/7Q>EY]NO5%1\%A#.I  T#
MSX&F6>"4U4,68"HQE(7S],*4)>A<Q>%W+S%_HKQV?Z&JTY0V?/XW KJ1B'O!
M.=M_U#WR//#._<L6V%?O "Q4+Z'*& X#KQZNQIE7Q0XW4XU 8^';$*77;52Y
MMA)'$916XH=&V8)ITX+FVMZ)A/AP_5!5GC YM*P5A8C0?']/C- 6XQH_;(SQ
M^&>,\<MBC*/B#B<=Y#]+7)ERO).9FY,9!-P00^'5Q9(XMSU^PD,'8EE<XDDV
M[%!JS0D"A(<5'9B(D:9H.L_+4133$JJD4%LQF-$MTRYBA)&W%\XLTH;>K3H-
M#62_RFE9J<*<J1W(>76%5P"!$S><:]7Z?J M8827N5("!M'#L8<$_&59_DF4
MP,/! $QC7R@0BDR6/_"&$I[T-%Y\!$AXB]*M:HAQX40Y'S6K.[269T7+*#F_
M??F71?/86BYQ5\,Q @*!/"/,Z]+WK>YPD*R%GAX)KZVYW/8%G6MT"EFY2\/0
MJGL@V(U$0=MVU G5K (]OVAV:EW<N &0BU!0<BA>OC:@)?_P)ZSBF[[C6Z.0
M25E*YZ#0X0[U .6P6L *=>.B31!8G1#;!@0>^C8CU.UDCC3ZP\_R5%-P^;BE
M_U W3 ]&?#"4K#=L:Z0:QJM4>F*BF'Y]#9-Y#9:)F1)#PE1JFE<U4F&LWSJO
MZEYF-6=_RYD[(D%Q$)@_4#N!6]P:LQCZCVH<N'!IQ&9VNNG<1D;(W@>;#B,1
M=4Z&BTL<NN"V*8;!/*/M-Y?- !Q)[3'B=M:)Z4QNURW-RHJ#N%V>I3?ITINR
M]HSDO+."/_7AQ#;16PV!W]S10#PX&?"50WN!VY+IT^4<IU4YSC;O:B'# $6U
MS5I%R]]9B0>_#'QH0]JWOW?N>F1,X+(V^;-3\[/EW. YN*5M&6NU^LTH?JVO
M]C(  _XU[,+P,&#7!2IYQ*6A[X5TT%R ^,?X.G1-^3@H[Q$(Y?M':AI3 :&U
M7G9'EY*J/'D(S![ VXO7$4!$UP*4.M&E9['-787\#%W<-CDD7[UJX#T%LFI+
MM(^V[X1KV^U/[":(5>WO<:!JK$21"0:FQX?Y'A,P(6.H899PGT2"$D^49%C'
M@*:QZ#1"M9.5H$?"T4PQ$NE[N4&0\)K5\VI1!RD!#//!:RJ:,/2@NF,HKE7=
M?**2\K5T)B]".I/L^.71X?'1LT%4JZG-C&-L<?0*ESOFSS%(T(?=".:+A*78
M.4?.4 P%@2D%D2#X7PX$H?XO_I<#00N\BC<PX9KS5I>!5X;S@FTB&W9M#06K
MQ%0]V:3[)+>\%]T;3% &8GX#F$?$$E?H3K+5P3ZVXOKR2$E)PTH^ZDRI?_\R
M?H5(#_>"8\*H)R'[3(]U3%.M!(O#MJZ59#88+8>\/WT$:$],**"B"AV)N3>-
M]4 =VY&)B+M<!TPJMDZ$ Z8(#6Y!C;H)6MU5^!%$-/T.'?4 -827?-%F/6I6
MVVTCN]O$1X_/VXA RMHP<:RQFTHX@/+\O!,-<JO%]1#[DN$LV<#>3=H(=8LG
MK $#P""-9*FGH#'NLR57(7-%B?!=L./K/NW@0!Y_[$<U:OM[ =/_4+(KHA:D
M'E)0:167;,0Q[[:>+!XP#S:IFAG]Z]99S/2O>;F ;5PTSR8%EDW?N3>;U*+!
M)Z%'J0DAT"4R+6,7*>0O2*<STJZ*ZO#L*^[O:2<JG=Y676= 0AAE-,5PLL_E
M2G]%Q-#>30COBMF7.&QN_0NNFPFGGB6';F*$\8\8OGOZ,WSW;6E,-QRFWEQF
M92Z3Q@OQ;+" =*]-*">B>61"(+WI:?17J"#4N67WY0J,$\[B2LD&AZL!78^F
M2S%=,;TZ&!I-U7["!&[;^B(1B0H0\0*\[QS-06?JSY'@Q7 :XY8P5"T=MA!Z
M#,$ 0>8M0>@*R+:0!Z<VJ?$<C3%*KN(F-,!F(!5./+PE!.:T>$PBM@'WO#@0
M'@J(IB!K: /D)W4#V^S]O3XC>ENXN9>4\6AMLW'!:9EWE$-31[2:ZY*:Y[,/
M0)3N4WLH>E8BN./_Z4D>!T#7E+'74_EI"PA]^5$$-TB7& WDH.K  S(L+RC"
MLYUF60 *, O)'K?4.>+&"]N)2O*$VEV1S!7K1;KY]@ZT+,$(XHI&%M:$.7N*
M>I>73%'[V_4I-.M_N[>'"\P-8R0;VJO^K-U6MF(CW9KAMS&D4(K5.&@'(9-;
MO[GFS</]O3Z,CD?J]@Q09W!V)XU7!CH';I]VQANGU*E#>-,+BJ[ IPMJ.V7[
MH=S\+$![FS@M^OH+B',6%$:#314C''B8C K M<C")GI,78%*E\QP\$> 0[@D
MC.NN4ZS'S&4<J$A&>'G<V*O9':33T9:$*'<8@/"X>I0 1XP&L?2@0YX"X4@)
MD+NL6_O; <[WQU9ZRWEWA_^+A6FTJ#HE3[/%Z0#'@OL;[IQ0<3,,VR3AD*&,
MO#]"H/-]$^I)X 'PI".=]?G8\S'YWP-3&@:?E\.V&E<8<)>?X2RA'QIH31S]
M\K41LJ^@+H.[^'U,ID2\HAQP\RA?W![]+5(_KSNB;SLL)WP=38%.'P8,NM\!
M O21P-[NG.CD2D:UNYMHN<.FQO5K.>T@4$LH5%HKI5G4G8=)-86?-)B2#P0*
M@>0H24F[V>C,B]&GX#F92(1#5H@H4()/_;/\1T0PQ\>R%P_"U>%,'$SLB&0P
M>#T#W>IK+, U_(F][0( =JIAB>;(Q*?...SK^QC^HX ARF.RTP+W^!J+XO-S
M#Z8X.K1]7\<\W:I_W)UG_W0]+PE\=SVJ%L+[_<>9)^VX&LFIX6P^.P%]M "1
MJS?%G%5-G0/RU*@7?]0RRW,>!J+GX$"OK5?AZ8@@9YRC>% /13Q!MT*D6M)?
MH>'&*=1GYD7&%;!MU9(;1XNRP03F'.%Z,H.(?W3NO/?&IG)]'F98CU>66!S1
MV301D#@+K94"H50KU]KO(HZYF5G8VKD]9&1V5 $DPM*]K=9H) XR6(SL&V#G
M>%<<-%"=T3ZE^T>SR7YE'PNVXVA:R&6C6W<AG++$DY:+70,&LM]:[9YE/C9W
MXGCXN 9"E>7,DA/9CQ%M.,B! :0I"3I"T\5O,O[^I%0AJ5+C#2,WA/0==<J,
M*)[<<(R)S:FW0W_@^-JSG_&U;QQ?2^^?!U@(2VRG*=K;U\0+CIJ7=8TIM/T]
M(M G9[A:^/K"Q/:M9!-:!I8Z0#D;Y29U]Q8$9P!>0-I^IDC)0G;T^ZJ<;ZL%
M2J^2AZX]MHW=+&(*8@*?A5(! 9G\-,=J C>:N:<"PJ5*NR4E$N PU$TS3S79
MW1F;K-P*A-YU?= :UF<?D!3V-0$&2XX#NFRJ[ON.I8Y<-_]V=G5*_,A?VI[C
M9X]ND&O-,;4&F@'9IT*,W*QKXR*/-)\:D,U"IH<I<+DP]3V5%5#10BF"]IZR
M#7/$/*MI3-P?OTWKIAH7M*O#6D$Z^6XC[E"* IT\97X3MYV)_M')A]01A2.H
M7%J6"'.7S>L'2C+IK\;Z,Z)Z7TA="FAA ,040\ FC@J7: J0<O[?QI'_O %]
M2@/Z#J#R[HC-WOU^PI['!**(-8/^"7G&X)7%0ZU^@K/%RL7JR83XV+>0>F^K
MOYY JN"VY5J(_;V#IV]>'+X<N+&OR(SIGU0)#P?F$,Y'(SQ[L6R<40)CA-]
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MZY:P5]X&$5IX&W,#PD%(<T0AA@1VT7[F>)_Q "7$CO6P<(U;D&Z8T72F<BI
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M?,YNPE/#AF,PH4[^,Z5#:]7<L%PQJ6PH%Y4KA=ZZGIC45LJ#Y[1;T9*"!(!
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M4!7N3<='AT^?&URE:W.="L-CEB#JK1\8 OGL9^COFX U8I)0?T"BQ7C6P@*
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MC*E]BSTF+G\,8[YO?5*(0"V2S8A"Z#[(LBZI]J-%QSU+D4$5(E!&H@!3.+=
M(UQ/4+2P6<*U(P(0ANQ(3@;\C005=.>MA7^"G)?:J@[%PE&*R?<ZMX@0XGT,
M-HU10?=&K*]K^;*Q+(6XX=PL"W"U2BJV"6S:!NI@1'3;M-Y'T##0OV$. %]/
M@6<3I;1$\J.35O58/C-4/NN$ 1W&QMF\V/HD:T*T=T._28A)UX-/RC'*C$[9
M<\$CQAG171BH,31@7?@SL"7"Z"<2H>EZ^#;QST>$/WU-K$RX[;GBGE+UU^?9
M=8\=@S<:_J2XYA7_18A>_B,3V8#LPT<,B9Y^_/WB[/HL#$H3J;4GZ2>PP0([
M=X&/YM+R*"[DA;LGU<2-U,$+Y_'"OC7'M5<TJSAS09[=VKU+[<V\1^(Z!^2R
M^P_5R(.#[-9D?<>:9<T2O _<)G/7S?,"W!+:4E"D17D?O*3=$-B8^?D:Z'#3
M$&RF$>P-6DD$>^-L"&SB=6.JSA>KNQ*CANT29'E=3^+A[#QJU.F=C^C:Y>+.
MK7<LVX"[LOBG>Y\9DLO#]C3!HH5E-1TS]</=[:JMW&8(2738;. EV,MQ>^1T
M"GU,F2.\9_ +3?7P()# BT_\N"%'P*X<!VB'GIQ^S(5QK,#=$F@KGQT-GLR
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M4S TR'5LNU[(,H<6&"8B;%_A(XB0^.HHYH2*;NY 6HY*7Z(B'+VP\R-\:<Z
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MB;@"""UA5@*3F&%R VL6_,GENSE/1G<2+ OF$OJIN/RZ=H;%F&EDA'\=[&\
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MBRUA=*6PT[ LDR%;T[*X!R(P1+@#+Q7]W=XZ&_ )XB#'P-O+1%P^Y^>_QU]
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MH,M53,=2Y<%V'BN.L9H6NN%F_0..0S;-*A"*&N?1TV]H@$Q.:W.#BD-UF0#
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M!6R-29LT$N]8\8#N/]AW?UE/""*F *]+P8<08P6>C%:7:E)E"TU!JJ.+PT:
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M>'.*'KBYX:<A8N0)U=?\?J7#SM]#6")8>:&9PZWE-F3 A3QZADE;/D)C_YT
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MT56HT)+15=AA"P@B/D)3\0*QZW+PK%H[RU;,79-N8*:S$E>3/XV$ZWR,62.
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M48,6GS!@"X+_O*7+SD4V7O=BU+RUQ4 1$!1RTX-V!K'H&)IC7[.XO,(JO%F
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MI*C:-Z_++S]L[ 7CB[WMJ?L7@X]@9/-YK5PB-^:^PV'0?[[[%U!+ 0(4 Q0
M   (  ""^59L71RR.P,  #L+   0              "  0    !C>6@M,C R
M,S W,C0N>'-D4$L! A0#%     @  (+Y5F*(B1YA!@  OT,  !0
M     ( !:0,  &-Y:"TR,#(S,#<R-%]L86(N>&UL4$L! A0#%     @  (+Y
M5KC59UFU!   <BH  !0              ( !_ D  &-Y:"TR,#(S,#<R-%]P
M<F4N>&UL4$L! A0#%     @  (+Y5H7%84%E%P  CX4   X
M ( !XPX  &0U,#0V,#5D.&LN:'1M4$L! A0#%     @  (+Y5I>(QM64-0$
MRCT( !               ( !="8  &0U,#0V,#5D97@R,2YH=&U02P$"% ,4
M    "   @OE6GP7DFWH&  #%$P  $0              @ $V7 $ 9#4P-#8P
A-61E>#DY,2YH=&U02P4&      8 !@![ 0  WV(!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
